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ABSTRACT 
 
One key barrier to the timely and efficient production of biopharmaceuticals is that they are 
prone to both chemical and physical instability including aggregation. Protein-protein 
molecular interactions are known to be a factor in protein solution aggregation behaviour; 
however their practical and elementary importance has not been fully established. The 
osmotic second virial coefficient (B22) is a fundamental physiochemical property that 
describes the molecular interactions between proteins in solution which could result in 
aggregation. This experimental study reports on the B22 of five different proteins (lysozyme, 
lactoferrin, catalase, concanavalin A and anti-TNFα dAb) using Self-Interaction 
Chromatography (SIC) over a wide range of solution conditions including the effects of pH, 
salt concentration, salt type as well as excipient stabilisers. It was established that current 
practise for SIC peak analysis was inadequate, and an improved method of SIC peak analysis 
was deployed which provided improved B22 data quality and robustness. Protein aggregation 
performance was evaluated under identical solution conditions to those used for the B22 
determinations using a simple Dynamic Light Scattering based measurement of initial 
solution aggregate size. This data shows a direct and strong correlation between B22 values 
and protein aggregation performance for all systems studied here. Specifically, proteins 
solution systems with B22 values of ~ 1 x 10
-4
 mL mol g
-2
 or less, regardless of solution 
composition, all exhibited aggregation behaviour. This thesis establishes the decisive 
importance of B22 as a predictor of aggregation performance. Preliminary validation data is 
presented for a method which allows for B22 estimation from osmotic cross virial coefficients 
(B23), removing the need for immobilisation of the protein of interest and therefore allowing 
rapid B22 screening. 
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-1
)  
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Wcharge (r)   Electrical repulsion potential of charge-charge interactions (kJ mol
-1
) 
Wdip (r)   Interactions of permanent and induced dipole moments (kJ mol
-1
) 
Wdisp (r)   Dispersion attraction potential of Hamaker (kJ mol
-1
) 
Whs (r)   Hard sphere potential (excluded volume) (kJ mol
-1
) 
Wosm (r)   Attractive potential from solutions with high ionic strengths (kJ mol
-1
) 
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CHAPTER 1  
1 PROTEIN THERAPEUTICS, BIOPROCESSING AND PROTEIN 
AGGREGATION 
1.1 Protein Therapeutics 
During the late 1970s, progress in genetic engineering and molecular biology lead to the 
creation of recombinant DNA (rDNA) protein technology. Found to be a safe and robust 
technique for the manufacture of therapeutic proteins, this method replaced extraction from 
native sources e.g. human growth hormone and insulin. Therapeutic proteins are proteins 
either extracted from human cells or are recombinant proteins manufactured using non-
human mammalian, bacterial or fungal cell lines engineered to express certain human genetic 
sequences (Glick and Pasternak 2010). The first protein therapeutics were recombinant 
versions of natural proteins but the next major step was proteins purposefully designed and 
modified to enhance their clinical potential (Vasserot et al. 2003). The ability to manipulate 
DNA revolutionised both the pharmaceutical and agricultural industries (Pavlou and Reichert 
2004). Recombinant DNA technology offers limitless possibilities. Indeed, it has already lead 
to the discovery of a vast number of new and innovative products that would not have been 
possible with traditional chemical synthesis techniques, most notably monoclonal antibody 
(mAb) therapeutics and designed recombinant proteins (rDNA) (Pavlou and Reichert 2004), 
(Bhopale and Nanda 2005). Combined with improvements in large scale bioprocessing, the 
advent of recombinant DNA technology has transformed the therapeutics industry. Protein 
therapeutics now include a wide variety of products including enzymes, growth factors, 
receptors, hormones, cytokines, blood factors, anticoagulants, fusion proteins and 
recombinant vaccines. 
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Of all the macromolecules in the body, proteins have the most diverse and dynamic range of 
functions and are necessary for virtually all cellular activity in the body. Each protein has a 
specific role from providing intracellular scaffolding support to catalysing biochemical 
reactions and transporting molecules within a cell or from one organ to another.  
Mutations or abnormally high or low concentrations in any one of the proteins in the body 
can result in disease or non-normal cellular functioning. As such, the ability to manufacture 
proteins for use in therapeutics represents a tremendous opportunity for the alleviation of 
such diseases (Leader et al. 2008). 
 
Proteins are composed of complex polypeptide chains folded into unique 3-dimensional 
structures. These structures are stabilised by a combination of van de Waals, electrostatic, 
steric and hydrophobic interactions. In addition to these intermolecular interactions, it is 
important to note that the internal structure of the protein molecule possesses a significant 
degree of molecular flexibility. Protein molecules have four hieratical levels of structure. The 
first level of structure, referred to as primary structure, refers to the linear arrangement of the 
constituent amino acids in a protein and the position of covalent linkages, for example, 
disulphide bonds connecting the residues. Areas of folding or coiling within a protein chain 
are referred to as the secondary structure. These structures are often stabilised by hydrogen 
bonding. Tertiary structure refers to the final three-dimensional structure of the protein. This 
structure is a consequence of a significant number of non-covalent interactions between 
amino acid residues. A quaternary structure is not always present but occurs in proteins that 
require association to be active. This fourth level of structure refers to the bonds that form 
between individual protein molecules in a complex ensemble (Lodish 2007).  
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Protein-based medicines have several advantages over small-molecule drugs which are the 
current mainstay of the therapeutics industry. Firstly, because proteins often serve a highly 
complex and specific set of functions, they are also able to target disease in a very specific 
mode that small-molecule drugs cannot. It is also due to this specificity that proteins are less 
likely to cause adverse side effects as there is less intrinsic potential that they will interfere 
with normal biological functions. They are also less likely to elicit immune responses from 
patients and are generally well tolerated because the proteins that are used as therapeutics are 
often similar to or identical to those the body produces naturally anyway. Finally, for genetic 
disorders where a gene is mutated or deleted, protein therapeutics can provide an effective 
replacement treatment without the need for gene therapy, which is not currently available for 
most genetic diseases (Leader et al. 2008). 
 
The production of protein therapeutics is now one of the fastest growing sectors in the 
pharmaceutical industry, being currently used to treat patients suffering from many 
conditions including various cancers, diabetes, heart attacks and cystic fibrosis (Pavlou and 
Reichert 2004), (Bhopale and Nanda 2005).  Biologics currently account for 10% of total 
sales in the pharmaceutical industry, and over 1/3 of drugs currently in development. The 
number of licensed biotherapeutics is forecast to grow at a rate of approximately 20% a year 
and it is foreseen that by 2014 half of the top 100 medicines will be protein based drugs 
(Bioscience et al. 2003). Biopharmaceuticals are frequently breakthrough products, where 
previously no effective treatment was available, and as such there is a lot of commercial and 
societal pressure to get these new products to the market and clinic as quickly as possible. 
However, even with the increasing success in discovery of protein based medicines, rapid 
commercialisation of protein drug candidates has not yet been fully realised. Indeed, they are 
rapidly gaining a reputation as costly therapies that push the boundaries of economic 
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acceptability. This problem is because bioscience products are so much more complex than 
chemical drugs and consequently the manufacture of these proteins in a cost effective and 
reliable fashion remains a major international challenge (Rader 2008). Of course the 
manufacture of small pharmaceutical molecules has been practised by industry for over 150 
years, which means that cost effective manufacturing methods are already well developed.   
 
It is difficulties in this manufacturing process that is limiting the ability of the 
biopharmaceutical industry to deliver affordable clinical solutions to patients. The 
development of new bioprocessing technologies will play a pivotal role in addressing these 
issues and consequently the future of the industry.  
 
 
1.2 Bioprocessing 
The manufacturing processes necessary for production of biotherapeutics are very different to 
those used in pharmaceuticals. Small molecule drugs have structures composed of relatively 
few atoms with a molecular mass of less than 400 amu and can generally be manufactured 
with high consistency using highly standardised chemical processes to a very high degree of 
purity and can generally be assumed to be chemically identical for all practical purposes. On 
the other hand, biotherapeutics are much larger and more complex molecules. They are 
composed of significantly more atoms with resulting molecular masses usually two to three 
orders greater and involve many additional levels of structural complexity. Due to this 
complexity and their biological source, their manufacture involves inherent diversity and 
randomness, often defying rigorous analysis (Rader 2008).  
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Protein therapeutics from different manufacturers may be considerably different biologically, 
including having different profiles of safety and efficacy, but can still appear 
indistinguishable using the most advanced analytical technologies. This is a major factor 
complicating the regulation of biosimilars (e.g. generic biopharmaceuticals). Currently, 
detailed information on the biological source and processing of protein therapeutics are 
required in order to completely describe their nature and identity. Many functional, structural, 
efficacy and safety associated features of biologically active agents, beyond primary 
structure, are greatly dependent on their in depth methods of production (Rader 2008). This 
includes the size and folding of polymeric chains, 3D conformation, formation of multimers 
or complexes of side chains, aggregation behaviour, variable oxidation states, amidation, 
inter- and intra-chain disulphide linkages, glycosylation and other post-translational 
modifications. Most protein therapeutics, including apparently simple, well-defined and 
highly characterised recombinant proteins, entail significant (micro)heterogeneity, as such the 
therapeutic agent is in fact a complex mixture of molecular subspecies with a array of 
variations in structural characteristics (as a result of e.g. side-chain modifications, amino acid 
substitutions and aggregation) (Rader 2008). 
 
Downstream manufacturing costs currently account for over 80% of final product costs for 
many biopharmaceuticals (Roque et al. 2004). Understanding the way these therapeutic 
proteins behave in solution or the effects that formulation can have on the 
stability/performance of these products is still far from complete. One undisputable barrier to 
the timely and efficient production of these protein pharmaceuticals is that, due to their 
molecular size and complexity, they are prone to both chemical and physical instability 
(Wang 1999), (Wang 2000),  (Manning et al. 1989), (Manning et al. 2010). This instability 
can occur via many different routes, arguably the most common and troubling manifestation 
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of protein instability is the formation of protein aggregates, which is an industry wide 
problem occurring in all phases of drug development. Protein drugs typically undergo a 
complex series of bioprocessing steps that include cell culture, harvest, puriﬁcation, 
formulation, filling and transport before finally being stored, sometimes for long periods of 
time under high concentration conditions. At each stage of this process the protein therapeutic 
will experience many different stress conditions; including extremes of temperature and pH, 
variable ionic strengths, high protein concentrations, shear stresses and a variety of solid-
liquid interfaces as well as air-liquid interfaces. Each of these stresses can have a negative 
impact on the final product in terms of potency and homogeneity due to physiochemical 
degradation of the protein and its complex structure. Current steps to minimise the creation of 
aggregates during manufacturing include adjusting solution conditions, process hold times, 
choice of raw materials, use of specialist additives and refolding steps. All these additional 
methods will drive production costs up (Cromwell et al. 2006). It remains today one of the 
major bottlenecks hindering rapid commercialisation of protein therapeutics. 
Aggregation is a major cause of economic and technical problems in the biotherapeutic 
industry, where the presence of any kind of protein aggregate is generally deemed to be 
undesirable (Cromwell et al. 2006). At minimum, aggregates are considered an impurity that 
must be robustly controlled to meet regulatory constraints, and their presence in the final 
formulation will usually render the protein drug unacceptable for product release.  Aggregate 
formation often leads to a decrease in product yields, reduction or even total loss of 
bioactivity, enhanced immunogenicity and complication of delivery methods. Despite the 
many advances in recent years, protein aggregation is still a significant obstacle to product 
development and has even been known to plague licensed protein therapeutics (Cromwell et 
al. 2006).  
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Aggregation can have many causes, but essentially arises from the perturbation of the native 
protein structure by unfavourable solution conditions. Aggregation can occur at virtually 
every stage of the production process as unfavourable or stressful conditions are intrinsic to 
many production unit processes including purification (where the protein must be separated 
from impurities by exploiting differences in affinity, size, charge etc), formulation, freeze-
thawing, freeze-drying, ultrafiltration/diafiltration, vial and syringe filling, pumping, 
transportation and storage. Aggregation often arises under a range of circumstances where 
several factors affect the aggregation rate including protein concentration, temperature as 
well as mechanical stress such as shaking and stirring, pumping, and freeze-thaw processes 
(Wang 1999). The result is that the protein experiences a wide variety of potentially 
damaging conditions including extremes of interfacial stresses, pH, ionic strength, protein 
concentrations, high or low temperatures, air-liquid interfaces, solid-liquid interfaces, 
freezing and dehydration. Each of these conditions can directly impact the degree of protein 
aggregation observed, the type of aggregation phenomena and its reversibility. 
At the cell culture stage, an accumulation of high concentrations of protein can lead to 
intracellular aggregation (often forming inclusion bodies) caused by interactions of unfolded 
protein molecules or by inefficient recognition of the nascent peptide chain by the molecular 
chaperones leading to incorrect folding during protein expression.  Upon secretion or lysis the 
protein will enter the cell culture medium, where it can be commonly exposed to conditions 
unfavourable for protein stability. Other typical steps in the purification process include 
affinity chromatography which employs acidic conditions to elute the protein; cation 
exchange chromatography, which requires the protein to be eluted under high ionic strength 
conditions, and anion exchange chromatography, which requires a high pH solution 
(Cromwell et al. 2006). An example of these issues in affinity chromatography can be seen in 
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the work reported on CamPath-1H (also known as alemtuzumab). Elution from an affinity 
column with 0.1M sodium citrate at pH 3.2 produced a product pool containing protein with 
roughly 25% aggregate material compared to 0% before elution (Phillips et al. 2001). 
The final product filling stage is critical as there is no further purification after this stage and 
aggregation here can directly lead to reduced product half-life, altered efficacy, altered 
bioavailability and enhanced immunogenicity in the final product.  Aggregation of 
biotherapeutic products is particularly troubling as macromolecular aggregates have been 
identified as one of several potential risk factors that can illicit adverse immunogenic 
responses in patients on administration (Rosenberg 2006). The presence of non-native protein 
aggregates in protein formulations have been shown to produce adverse responses in patients 
ranging from immune reactions to anaphylactic shock. To this end, it is vital that the specific 
compatibility of the protein formulation and the filling equipment be assessed before 
production with respect to risks of protein aggregation. 
Protein aggregation behaviour is not only important in the manufacture of biotherapeutics but 
is also the focus of concentrated biomedical investigation having been linked with more than 
20 human diseases including Parkinson’s and Alzheimer’s (Carrell and Lomas 1997), 
(Dobson 2003) and (Chiti and Dobson 2006). These diseases are all at least partially caused 
by abnormal protein aggregation arising from either mutations or physical and chemical 
changes in the cellular environment (Koo et al. 1999).  
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1.3 Protein Aggregation 
In order to perform their biological function proteins adopt a three dimensional (native) 
structure that most often corresponds to the thermodynamic (free energy) minimum 
conformation at physiological conditions (Dill and Chan 1997). However, their energy 
landscape is dynamic and responds to any perturbations in its environment including pH, 
ionic strength and temperature (discussed in detail later). This energy landscape can also be 
affected by changes to the protein primary structure such as mutations and chemical 
modifications such as oxidation and deamidation. It is through these changes or stresses that 
energy barriers to aggregation (via different pathways) might be lowered or raised. 
The term protein aggregation is frequently used as an umbrella term to summarise several 
different protein interaction phenomena; notably protein self-association and protein 
aggregation. For the purposes of this thesis, protein aggregation denotes the effectively 
irreversible formation of oligomers containing non-native structures from initially native, 
folded proteins (Saluja and Kalonia 2008), while protein self-association refers to the 
formation of small, soluble oligomers from a native species that are reversible upon simple 
dilution with buffer. The formation of insoluble protein aggregates will be referred to as 
irreversible aggregates in this work, but this may simply be a manifestation of very slow rates 
of disaggregation, with an equilibrium lying far in favour of the aggregate over the native 
form. Nevertheless, the process is effectively irreversible under those conditions. 
There is no consistent definition in the literature or industry of what is meant by “soluble” or 
“insoluble” aggregates. So for the purpose of this thesis soluble aggregates will refer to 
particles not visible to the naked eye and that may not be retained by filters with a pore size 
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of 0.22µm. Any aggregates larger than this size will be referred to as insoluble aggregates. 
Both soluble and insoluble aggregates can causes serious issues in the production of 
therapeutic proteins.  
A great number of studies (Chi et al. 2003b), (Frieden 2007), (Morris et al. 2009) and (Philo 
and Arakawa 2009) on the mechanisms of protein aggregation have been undertaken and they 
broadly identify three main pathways by which individual protein molecules can come 
together to form oligomers/polymers resulting in soluble aggregates and/or visible and 
subvisible particulates, fibres and precipitates.  
• Aggregation of native monomers (native aggregation/self-association) 
• Aggregation of conformationally altered monomers (non-native aggregation) 
• Aggregation of chemically modified monomers 
Within these pathways there are two distinct aggregation mechanisms; the physical and the 
chemical. The aggregation of chemically modified monomers refers to pathways where new 
covalent bonds form between protein molecules, the most common of which is the formation 
or the exchange of disulphide bonds.  Many of these chemical reactions can change the 
hydrophobicity of a protein or directly crosslink protein chains which indirectly changes the 
aggregation behaviour of the protein. The other aggregation mechanisms of native or 
conformationally altered monomers represent the physical aggregation pathway in which 
non-covalent association of protein molecules occurs, where no changes in primary structure 
are observed (Wang 2005). It is sometimes the case that both chemical and physical 
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mechanisms can occur simultaneously (Sluzky et al. 1992), (Sluzky et al. 1991), (Costantino 
et al. 1994).  
There exists a diversity of more specific protein aggregation pathways not covered in detail in 
this work, but overall, conformational stability has come to be considered the most important 
factor governing protein aggregation. Unsurprising then that it is the current paradigm in the 
biotherapeutic industry that in order to modulate protein aggregation during manufacturing 
and storage, the roles of conformational stability and protein-protein interactions must be 
carefully considered. Therefore, in this thesis I will be mainly focusing on non-native 
aggregation. 
 
1.3.1 Self-Association 
It is important to be aware that many proteins require self-association to be in a biologically 
active state. In these cases, these multimeric forms or ensembles are considered to be the 
native state (Chi et al. 2003b). As such the problematic self-association discussed earlier does 
not refer to those types of native states, but instead focuses on proteins systems where the 
associated states are undesirable. Self-association, or native aggregation as it is sometimes 
known, results from weak non-covalent interactions between native state proteins by which 
the proteins assemble to form soluble aggregates that can range in size from dimers and small 
oligomers, to so called high molecular weight aggregates composed of tens, hundreds or 
sometimes even more monomers per aggregate. As observed for example in insulin.  The fact 
that the self-association process is usually reversible and indicates the presence of a 
thermodynamic equilibrium between oligomer and monomer species in the solution that can 
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be shifted by altering conditions such as pH or by diluting the solution to reduce protein 
concentration. 
Although the aggregate assembly process may be technically reversible, that is not to say that 
self-association may not cause problems in the biotherapeutic industry. The re-dissolution of 
self-associated proteins is dependent on the rate of dissociation, which can be very slow, and 
for all intents and purposes appear irreversible, thus rendering the drug unsuitable for clinical 
use. Furthermore, soluble aggregates formed by self-association can themselves become 
precursors of protein aggregation, over time leading to the formation of irreversible 
aggregates.  
For example, recombinant human interleukin-1 receptor antagonist (Alford et al. 2008b) and 
monoclonal antibodies (MAb) (Liu et al. 2005a) are particularly prone to self-association and 
dimerisation under high protein concentration conditions and this was shown to be 
contributing to their propensity to aggregate under accelerated stability studies. Therefore, it 
is very important than even self-associated proteins forming small soluble aggregates are 
removed before the final filling operation to help prevent or minimise protein aggregation 
occurring during storage (Cromwell et al. 2006), (Saluja and Kalonia 2008). It was 
demonstrated for one of the monoclonal antibodies studied that self-association induced an 
increase in solution viscosity, which in turn cause serious subsequent problems in the 
manufacturing and formulation of any biotherapeutic (Liu et al. 2005a).  
However, some native aggregation processes are not problematic and are actually used to 
purify native proteins, for instance protein crystallisation and reversible, amorphous 
precipitation or salting-out processes (Judge et al. 1995), (Scopes 1993). These kinds of self-
association are often governed practically by thermodynamics of phase separation. 
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1.3.2 Non-native Aggregation 
Protein aggregation is a very complex phenomenon and is not well understood (Frieden 
2007). One of the greatest challenges to the investigation of the causes of protein aggregation 
is that there is no single established pathway by which proteins can form such an aggregate. 
The forms of protein aggregates range from amorphous structures without order to highly 
structured fibrils, each form arising by distinct aggregation mechanisms. The final structure 
of protein aggregates and the kinetics of their formation will depend heavily on protein 
sequence, concentration and solution conditions. However, it is clear that the protein can 
undergoes a variety of structural changes independent of chemical modification, sacrificing 
stabilising intrachain contacts in favour of configurations that promote interchain interactions 
(Krishnan et al. 2002). In the past researchers thought that denaturation was a requirement for 
protein aggregation to occur. This belief was supported by both theoretical model predictions 
and experimental data (Deyoung et al. 1993), (Stigter and Dill 1993). However, protein 
aggregation has also been observed to occur, albeit more slowly, under physiological 
conditions that greatly favour the native state both in vitro and in vivo (Kendrick et al. 
1998a), (Kendrick et al. 1998b). Current understanding is that aggregation progresses through 
a non-native conformation state or transition state species that is slightly perturbed in 
structure and exists within the native state assembly (Kendrick et al. 1998a), (Webb et al. 
2001), (Roberts 2003), (Fink 1998) even though these intermediates are usually unstable and 
poorly populated (Figure 1). 
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Figure 1. Schematic diagram of non-native aggregation pathways 
 
Some degrees of unfolding are required to facilitate aggregation since the process is initiated 
by the attraction between interchain hydrophobic patches that resemble those in the folded 
monomer intrachain contact. The theory is that the native conformation of a protein does not 
exist as a discrete single structure, but is flexible and effectively exists as an assembly of 
native sub-states with a distribution of structural expansion and compaction (Kendrick et al. 
1998a), (Kendrick et al. 1998b). These partially unfolded states tend to exhibit sizeable 
patches of adjoining surface hydrophobicity that encourage interchain stabilisation and are 
much more inclined to aggregate than the native, but also the denatured state (Fink 1998), 
(Uversky et al. 1998), (Wang 2005) which tend to have their hydrophobic side chains are 
either mostly buried out of contact with water, or randomly scattered (Uversky et al. 1999). 
The propensity of these conformational intermediates to aggregate more rapidly may also be 
due to their high rate of diffusion in comparison to the native state (Wang 2005). High 
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diffusion rates can significantly increase the chance of the partially unfolded states 
associating.  
The transition from folded to partially unfolded states is in theory a reversible process, but the 
two states are not necessarily at a thermodynamic equilibrium. The thermodynamic stability 
of protein conformations can be characterised by the free energy of unfolding. Intermediate 
states have a higher energy than the native state but they are separated from it only by a low 
energy barrier. The difference in energy between the partially unfolded states of the protein 
molecule in solution is often no more than the energy of three (Privalov 1979) to 10 hydrogen 
bonds (Gitlin et al. 2006). The energy of formation of approximately 10 hydrogen bonds is 
41.8 kJ mol
-1
; as such this means the native conformation is only marginally more stable. A 
protein’s stability can be thought of as it’s thermodynamic ‘‘preference’’ for achieving and 
maintaining the native (folded) state. 
Under perturbing solution conditions (e.g. acidic pH, high temperature, and mechanical 
stresses) the free energy of the folded native state will be increased to that of the partially 
unfolded states. If the free energy barrier for folding of the protein is reached the solution 
equilibrium will be shifted in favour of partially unfolded protein molecules. The significance 
of this finding (Kendrick et al. 1998a), (Krishnan et al. 2002) is that aggregation will be 
favoured by factors and conditions that promote the population of these intermediates or 
unfolded states. As such it is the properties of those intermediates not the denatured or native 
states that are the key to determining whether aggregation takes place. Moreover, the 
characteristics and properties of these intermediates are often considerably different from 
those of both the native and unfolded conformations.  
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Protein aggregation is often accompanied by significant changes in the protein’s secondary 
and tertiary structure.  Protein aggregates often have very little tertiary structure, except under 
very specific conditions such as those used in salting-out procedures (Fink 1998) but 
normally contain substantial secondary structure. In fact, increased levels of secondary 
structure can often be found in protein aggregates, this observation is particularly true of β-
sheets (Chi et al. 2003a). If a protein contains both β-sheets and α-helices in its native 
structure then the aggregation induced increase in β-sheets is usually accompanied by a 
decrease in α-helices. An example of this behaviour is insulin (Nielsen et al. 2001a), (Nielsen 
et al. 2001b). These alterations in protein secondary structure are irreversible and often mean 
that observed protein-protein interactions are more pronounced. The fact that protein 
aggregation is accompanied by the loss of native protein structure and that partially unfolded 
protein molecules are particularly prone to self-association makes it appear clear that the 
intrinsic conformational stability of the native protein state relative to that of the transition 
state defines its governing role in the systems inclination to aggregate.  
 
1.3.3 Protein Aggregation Kinetics 
In 1954 Lumry and Eyring presented the first kinetic model of protein aggregation from the 
native state (Lumry 1954). They proposed that the native protein (N) undergoes a reversible 
intramolecular transformation into an aggregation-competent intermediate (I) which 
associates to form the first aggregate (A2). This mechanistic framework is captured by the 
two following chemical reactions: 
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N   ↔   I         Equation 1.1 
I   +    I   →   A2        Equation 1.2 
This aggregate can then associate with other molecules to form higher molecular weight 
species. This framework has since been employed and further elaborated in numerous protein 
aggregation experiments (Chi et al. 2003b), (Kendrick et al. 1998b), (Lumry, 1954). This 
model has been used to analyse the aggregation pathways of many proteins (Kendrick et al. 
1998a), (Sanchezruiz 1992). It is well known that the rate of a reaction is controlled by both 
thermodynamics and kinetics factors. The apparent order of the aggregation reaction is 
determined by the reaction order of the rate limiting step.  Different mechanisms of non-
native aggregation are differentiated with regard to the rate limiting step of the aggregation 
process (Roberts 2007):  
 unfolding-limited aggregation;  
 association-limited aggregation or downhill polymerisation;  
 aggregation by nucleation and growth;  
 aggregation via condensation  
The unfolding-limited aggregation is only controlled by the unfolding thermodynamics, 
whilst the three other aggregation processes depend on two contributions, namely the 
unfolding thermodynamics and the association dynamics. 
The rate limiting step for some protein systems going through nucleation and growth 
assembly can be the formation of a pre-nucleus species (Krishnan et al. 2002). Soluble 
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aggregates can form without any assembly into higher order aggregates or precipitates (e.g. 
during long term storage in aqueous formulation). If that soluble aggregate is a pre-nucleus 
species and it reaches a critical size it can then promote rapid assembly into higher-order 
aggregates. Therefore a product that appears to have acceptable physical stability for several 
months, could in the space of a few weeks or even days, suddenly develop unacceptable, 
possibly dangerous levels of self-associated protein. So, should there already be soluble 
aggregates in the bulk drug product the long term stability of the final formulated product 
would be compromised. This effect is notable example of soluble aggregates being 
problematic for biopharmaceutical production. In some cases it may become essential to 
introduce specific or additional processing steps to reduce the levels of soluble aggregates, in 
order to achieve acceptable long term stability in the final formulation of the protein 
therapeutic product (Chi et al. 2003b). 
Several proteins have been found to follow first order aggregation kinetics (Kendrick et al. 
1998a), (Verheul et al. 1998), (Shukla et al. 2007), (Lumry 1954). This implies that the rate 
limiting step is unimolecular (i.e. a conformational change) rather than a bimolecular reaction 
which would be limited by collision frequency. However, some proteins follow a second-
order reaction suggesting that in this case the rate-limiting step is bimolecular, such is the 
case with the aggregation of rh-GCSF in pH 7 phosphate buffer saline (PBS) (Roberts 2007). 
The proposed mechanism for this reaction is that native rh-GCSF undergoes an irreversible 
reaction to form a dimeric aggregation-capable intermediate and is described by the 
framework laid out in Equations 1.3, 1.4 and 1.5 below. This phase progresses through the 
formation of a transition state that is an expanded conformational species existing within the 
native state assembly. The transition state then irreversibly dimerises, and this transition is 
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the rate limiting step. The dimer then undergoes further assembly reactions to form 
aggregates. 
rh-GCSF aggregation mechanism with I* as the transition state species, I2 is the aggregation-
capable dimer, N is the native monomer and A is the aggregate; 
N  ↔  I*         Equation 1.3 
2I* → I2         Equation 1.4  
I* + Ix → An+1         Equation 1.5 
 
1.4 Factors affecting Aggregation Propensity 
The small conformational stability of the protein native state means that even relatively small 
alterations in external variables can destabilise the structure of the protein sufficiently to 
induce aggregation.  During the production of therapeutic proteins, the protein product is 
exposed to a wide range of variation in environmental (or solution) conditions as a necessary 
part of the processing operations (See Section 1.2). Descriptions of aggregation behaviour 
such as onset, aggregation rate and the ultimate morphology of the aggregated form 
(amorphous precipitates or fibrils) have been revealed to be heavily dependent on these 
solution environmental conditions (Fink 1998), (Carpenter et al. 1999).  
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1.4.1 Protein Concentration 
Protein concentration is an important factor affecting protein-protein interactions in solution. 
Protein aggregation is favoured by increases in protein concentration due to a phenomenon 
known as “macromolecular crowding”. There are two main aspects of this phenomenon to 
take into account. The first is that both repulsive and attractive intermolecular forces between 
protein molecules act over a distance greater than steric contact. In high protein solution 
concentrations there is less average space in the solvent so the protein molecules are on 
average closer together. The second factor is that the increased excluded volume present at 
higher protein concentrations (which describes the repulsive forces between protein 
molecules due to their mutual impenetrability) increases the effective concentration of 
macromolecules in solution (Minton 2005), (Ellis and Minton 2006). The crowding of protein 
molecules in increased protein concentration solutions generates two opposing effects on 
protein aggregation. Since the molecular motion of any given protein molecule is restricted 
by the close proximity of other protein molecules it protects the protein from unfolding, 
meaning that the protein is stabilised thermodynamically as its secondary structure stability is 
likely increased by the reduction in solvent exposed surface area (Harn et al. 2007). However, 
due to the high volume occupancy in concentrated protein solutions, the probability of protein 
molecules being brought closer together increases which enhances chances of their self-
assembly (Saluja and Kalonia 2008). A protein can be destabilised or stabilised depending on 
the solution or formulation parameters. 
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1.4.2 pH 
The most important solution condition to consider in processing or formulation is pH because 
of the different ionisable amino acids present in the sequence of a protein (Shaw et al. 2001). 
Depending on this sequence a protein molecule will have a different net charge as a function 
of the difference between pI of the protein and pH of the solution. Theoretically, this 
difference should be as large as possible in order to optimise protein stability as this 
difference increases the stabilising electrostatic repulsion between the protein molecules. 
However, this can also destabilise the native protein conformation as the increase in protein 
net charge also results in the increased probability of repulsion within the protein molecule as 
the unfolded protein molecule will have a lower charge density than the folded protein 
molecule (Chi et al. 2003a). Therefore, an optimal pH value will strike a balance between 
colloidal and conformational stability of the protein. It should be adjusted into a narrow range 
where the net charge of the protein is sufficient to induce electrostatic repulsion between 
other protein molecules in solution but not so high that it perturbs the native protein 
conformation. 
 
1.4.3 Ionic Strength and Type 
The solution ionic strength and type of salt used to deliver that strength are the second most 
important solution factor determining protein-protein interactions. Increasing the ionic 
strength of a solution will reduce electrostatic repulsions between protein molecules but also 
between charged groups present within the protein molecule. The addition of low 
concentrations of cations and anions usually reduces colloidal stability by the enhanced 
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shielding the repulsive electrostatic forces between the protein molecules. The effect is also 
highly dependent on solution pH. At high concentrations certain salts are known affect 
protein stability via a secondary route which is ion specific (Zhang and Cremer 2006). This 
effect was classified by the pioneering work of Hofmeister (Hofmeister 1888) into a series of 
strengths from high to low (Figure 2). This effect is to potentially decrease the 
conformational stability of the protein by the preferentially binding of specific anions or 
cations to the protein surface or interactions with water molecules in the first hydration layer 
of the protein (Zhang and Cremer 2006). The effect is more pronounced for certain salt types. 
It should be noted that the series is empirical in its nature and does not fit the behaviour of all 
proteins. 
 
Figure 2. The relationship between ions of the Hofmeister series and protein stabilisation 
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1.4.4 Excipients 
It has been found that protein stability can often be improved through the presence of certain 
excipients in solution including polyols and sugars, preservatives, amino acids and 
surfactants. The mechanism by which polyols and sugars e.g. sucrose, have been reported to 
increase the thermodynamic stability of the protein is that of preferential exclusion from the 
protein surface (Lee and Timasheff 1981), (Timasheff 1998). The protein surface becomes 
enriched in water as these excipients are depleted from the protein domain and protein 
conformational stability is increased in this manner because it favours the more compact 
native conformation. The aggregation prone partially folded states and structurally expanded 
transition states both have greater surface area than the compact native state and are 
consequently expected to be disfavoured energetically. Most amino acids are also known to 
stabilise proteins through this mechanism, with the exception of histidine and arginine which 
stabilise proteins through their weak binding capacity (Arakawa et al. 2007), (Katayama et al. 
2006). Non-ionic surfactants often reduce the thermodynamic stability of a protein; however, 
they are regularly added to prevent protein aggregation (Chi et al. 2003a). They prevent 
aggregation not through direct interaction with the protein (Hoffmann et al. 2009) but by 
inhibiting interface induced aggregation (e.g. at air/water interfaces and container surfaces) 
by limiting the extent of protein adsorption there. 
 
1.4.5 Temperature 
Temperature is one of the best understood causes of protein aggregation in solution. It has 
been common knowledge for some time that the incubation of protein solutions at high 
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temperatures results in perturbation of protein structure and eventually complete 
denaturation, either one of which promotes aggregation (Carpenter et al. 1999). The 
susceptibility of proteins to aggregation at high temperatures is down to the low 
thermodynamic stability of the native protein conformation. A protein is only around 20 - 
80kJ mol
-1
 more stable in its native conformation than it is in unfolded, biologically inactive 
conformations under physiological conditions (Dill 1990), (Jaenicke 1989), (Jaenicke 1991). 
This makes its structural stability much weaker than covalent or ionic bonds (400kJ mol
-1
) 
(Dill 1990).  It is important to note that protein aggregation during heating usually begins at 
temperatures well below its equilibrium melting temperature (the temperature at which the 
protein becomes unfolded), (Dong et al. 1995) which is the temperature at which the solid 
and liquid phases exist in equilibrium. Increased temperature also strongly affects reaction 
kinetics as the frequency of molecular collisions and hydrophobic interactions are increased 
(Chi et al. 2003b), (Wang 2005).  Furthermore, temperature has been shown to enhance the 
rates of chemical degradation of proteins, thus modifying the primary structure of the protein 
and hence distorting the protein conformation (Wang 2005). 
 
1.4.6 Mechanical Stress Factors 
Throughout production, the process feed stream containing the protein product is pumped, 
stirred and filtered. In addition to chemical and thermal factors stability is also affected by 
mechanical shear stresses (e.g. pumping), exposure to air (air-liquid interface) and sold-liquid 
interface interactions as a protein will encounter surfaces made of various materials including 
glass, stainless steel and plastic (Kendrick et al. 1998b), (Cromwell et al. 2006). Since the 
collision of native and/or denatured proteins can be considered a major step in protein 
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aggregation it appears clear that the mechanical stress (shear rate and stress time) will 
influence the aggregation rate (Mahler et al. 2005), (Colombie et al. 2001). Different kinds of 
simulations have been used to assess the effect of mechanical stress on protein stability 
comprising stirring, shaking and pumping unit processes. Each of these conditions provokes a 
type different type of stress for the protein investigated resulting in different forms of 
aggregates (Kiese et al. 2008). The different agitation stresses induce interfacial effects, local 
thermal effects, interfacial shearing, and the rapid motion of solutes in solution. The rapid 
formation of voids and bubbles within the solution, known as cavitation, can also have 
significant effects (Mahler et al. 2009). 
 
1.5 Prevention of Aggregation 
Our ability to restrict or reverse protein aggregation is crucial in the manufacture and 
formulation of biotherapeutics. Protein aggregation can be prevented or minimised through 
two main mechanisms. The first is to increase the thermodynamic stability of the protein 
native conformation, shifting the equilibrium away from the aggregation-prone partially 
unfolded transition states. This change can be achieved through the use of certain excipients 
(See Section 1.4.4) as cosolutes and has been shown to be an effective strategy for reducing 
protein aggregation (Chi et al. 2003b). The second method is based on reducing attractive 
protein-protein interactions by improving the colloidal stability of the protein system. Use of 
surfactants is one of the main ways colloidal stability improvements can be achieved. 
However, this aspect of the problem can also be solved by decreasing protein mobility such 
that you dramatically reduce the number of molecular collisions (Shire et al. 2004); this can 
be achieved for example by through lyophilisation where the removal of water means that 
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protein conformational flexibility is restricted. All in all, prevention of aggregation requires 
management of both conformational and colloidal stability, but the predominant mechanism 
of protein stabilisation will depend on what the rate limiting step of aggregation is for that 
particular protein. Currently, each protein is screened experimentally for the optimal range of 
excipients and storage conditions that minimise aggregation.  
However, the ultimate goal is to achieve a fundamental understanding of the various 
aggregation mechanisms that allows the discovery and implementation of reliable ways to 
rank protein therapeutics by their propensity to aggregate. The ability to predict the 
propensity of a new biotherapeutic to aggregate (either natively or non-natively) in the early 
stages of product development would be of great academic and industrial impact. 
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CHAPTER 2 
2 INTERMOLECULAR FORCES IN PROTEIN-PROTEIN 
INTERACTIONS 
 
The amalgamation of protein molecules into large non-native aggregates requires the 
assembly of a higher molecular weight species from the initial lower molecular weight native 
protein molecules. The mechanisms by which these protein molecules come together must in 
the end be controlled by attractive intermolecular forces. Therefore an understanding of 
protein aggregation processes requires a detailed knowledge of the nature and magnitude of 
intermolecular forces, all of which share a common origin – the electrostatics and polarity of 
molecules.  
The intermolecular forces responsible for protein folding and stability include hydrophobic 
interactions, van der Waals forces, hydrogen bonding, electrostatic forces, excluded volume 
effects and steric forces. All these forces, with the exception of hydrogen bonding, are 
relatively weak. 
Excluded volume is the only interaction that is solely repulsive in nature and electrostatic 
forces the only interaction that can be either repulsive or attractive. All other interactions are 
attractive, but the role of each force in protein-protein interactions depends on the 
concentration of the protein solution. In dilute solutions of natively folded molecules 
hydrophobic and electrostatic interactions are the major forces governing interactions while 
van der Waals, hydrogen bonding and excluded volume play minor roles. Steric interactions 
and van der Waals become more important at higher protein concentrations. 
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Force Strength Distance (nm) Characteristics 
Hydrogen 
Bond 
Moderate 12-30 kJ mol
-1 
0.3 Occurs between molecules with O-H, N-H 
and F-H bonds 
Ionic Moderate 5-50 kJ mol
-1 
0.25 Directionless, non-specific, occurs between 
charged molecules 
Van der 
Waals 
Weak 0.1 – 4 kJ mol
-1 
0.3 – 0.6 Extremely weak, non-directional, arising 
from random fluctuations in electron 
density leading to brief moments of 
electromagnetic attraction 
Hydrophobic  Moderate < 40 kJ mol
-1 
Varies Hydrophobic groups interact with each 
other to avoid contact with water 
 
Table 1. Summary of the nature and relative strengths of key intermolecular forces and the typical 
distances over which they act 
 
Individual non-covalent molecular interactions are relatively weak (around 20kJ mole, 
compared with a covalent bond which is typically 350-400 kJ mol
-1
, but there are a 
substantial number of them and collectively their energy can therefore be very significant. 
The secondary protein structure is held in place by a large numbers of small non-covalent 
interactions, but there are often also a large number of intermolecular forces driving towards 
unfolding of the protein such that the protein structure is held in an equilibrium conformation 
which is a delicate balance between these opposing forces. For this reason the 
unfolded/folded equilibrium constant of a protein is usually small, but it is the small 
difference between these cumulative forces determines the direction of the folding reaction. 
A small change in solution conditions can change the intermolecular balance of forces 
driving the reaction in the opposite direction. 
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2.1 The Osmotic Second Virial Coefficient 
The osmotic second virial coefficient (B22) has its origins in the virial equation of state, also 
called the virial expansion. The virial equation of state describes the behaviour of non-ideal 
gases. Real gases are not ideal and this non-ideality arises from molecular interactions 
between the gas molecules of finite volume. The sources of these non-idealities are the finite 
volume occupied by gas molecules and the adhesive forces between the gas molecules. The 
same principle can be applied to the thermodynamic properties of aqueous solutions and is 
known as the McMillan and Mayer theory (McMillan 1945). The osmotic second virial 
coefficient describes non-ideal solution behaviour that results from two-body interactions in 
dilute solutions. The behaviour of protein molecules in solution resembles charged colloid 
particles such that at concentrations higher than infinite dilution intermolecular forces cause 
the protein molecules to interact, resulting in non-ideal solution behaviour. Consequently, B22 
can be used to quantify net intermolecular forces exerted between two protein molecules in 
solution on a molecular level (Curtis et al. 1998), (Neal et al. 1998). The protein-protein 
intermolecular forces that contribute to the overall interaction include van der Waals, 
hydrophobic interactions, electrostatic, hydration forces, hard sphere and as well as other 
short-range interactions. It has been shown that the molecular forces that dominate B22 
usually persist over a distance less than the proteins diameter at medium ionic strengths, a 
few 10’s of nm (Saluja and Kalonia 2008). Based on statistical thermodynamics, the second 
osmotic virial coefficient is related to the potential mean force (PMF) of the pairwise protein-
protein interactions. PMF can be defined such that its negative derivative with respect to 
distance is the force between two protein molecules at infinite dilution averaged over all 
possible orientations and configurations of the protein molecule at infinite dilution (McMillan 
1945). B22 for globular proteins can be represented by the following equation;  
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  Equation 2.1 
Where NA is Avogadro’s number, MW is molecular weight, k is the Boltzmann constant, T is 
the temperature, W22 is the potential mean force between two interacting molecules and r is 
the centre to centre separation distance of two protein molecules. A factor of ½ corrects for 
double counting of an identical pair of molecules. If we assume W22(r) is a spherically 
symmetric field, then it can be expressed as: 
 
Equation 2.2 
Where Whs (r) is the hard sphere potential (excluded volume), Wcharge (r) represents the 
electrical repulsion potential of charge-charge interactions, Wdisp (r) is the dispersion 
attraction potential of Hamaker/London, Wosm (r) denotes the attractive potential resulting 
from solutions with high ionic strengths, Wdip (r) signifies interactions arising from 
permanent and induced dipole moments of the protein molecules and Wass (r) represents the 
square well interaction potential. The square well potential results from strong short range 
interactions such as hydrogen bonds, hydrophobic bonds and ionic bonds (Curtis et al. 1998). 
The first three terms are described by DLVO theory (described in detail Section 2.4) 
composed of ionic and van der Waals forces, the other terms represent hydrophobic 
interactions and other short range site specific interaction potentials which are less well 
understood. 
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B22 indicates the direction and magnitude of overall intermolecular forces between two 
molecules in solution by its sign and value respectively. Positive B22 values correspond to net 
repulsive forces (where protein-solvent interactions are favoured over protein-protein 
interactions) whilst negative values represent net attractive forces (McQuarrie 1976), (George 
et al. 1997). Negative B22 values indicate that the protein is driven to adhesive interactions, 
and thus aggregation behaviour. 
 
2.2 Ionic Interactions 
Ionic interactions occur between charged molecules, with opposite charges attracting and like 
charges repelling. They are one of the main forces that govern biological interactions. Ionic 
interactions are often referred to as electrostatic interactions but this term is misleading since 
essentially all molecular interactions are inherently electrostatic in their fundamental nature. 
Ionic interactions are directionless, non-specific interactions that can occur between charged 
groups separated by a distance comparable to the diameter of a protein (Gitlin et al. 2006). 
Ionic interactions are the longest ranged intermolecular force and can be approximately 
described by Coulomb’s law: 
ΔE = ZAZBє
2
/DrAB       Equation 2.3 
Where ZA and ZB are the respective net charges of two interacting molecules, є is one unit of 
electric charge, D is the dielectric constant of the solvent and rAB is the distance between the 
two charges. As such, the strength of ionic interactions is inversely proportional to the 
dielectric constant of the solvent and the distance between the two charges. Dielectric 
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constants vary widely among common solvents from, for example 80 in highly polar solvents 
like water to just 2 in non-polar solvents such as hexane.  
The dielectric constants of the protein molecules themselves are also important factors in 
ionic interactions. However, protein dielectric constants are not constant but depend on 
specific areas of the protein (Warshel et al. 2006). Two distinct regions within proteins have 
been identified (Gitlin et al. 2006). The protein surface usually has an intermediate dielectric 
constant (between 10 and 20) while the core region of the protein has a low dielectric 
constant (between 2 and 4). 
In neutral solutions, isolated amino acids in solution are zwitter ionic, meaning that they 
possess no nett overall charge but contain both positively and negatively charged groups. In 
proteins individual amino acids are polymerised into a peptide backbone which, with the 
exception of the ends of the chain, is electrically neutral overall. In most proteins the 
carboxyl end will carry a negative charge and the amino end a positive charge but certain 
amino acid side chains also carry charged groups. These include basic groups found on 
arginine, lysine and histidine and acidic groups found on cysteine, glutamate and tyrosine. 
Proteins acquire their charge predominately through the ionisation of these amino and 
carboxyl groups on the side chains. For native proteins the average charge density of a 
molecule is thought to be approximately 1.4 charged groups per 100Å
2
 of protein surface (Xu 
et al. 1997a). However, it is important to note that the charges on the surface of a protein are 
unevenly distributed, often grouped together in patches of charges. This means that their 
effect on intermolecular interactions can be much more significant than expected (Piazza 
2004a). 
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The pH of the solution, pK of the side chain and the side chain’s environment will affect the 
charge on each side chain. The pK of side chains can vary depending on the pH of the 
solution but can also be significantly altered by desolvation and interaction with other 
charged groups. In general, at high pH values protein molecules are negatively charged as 
charged groups are deprotonated with increasing pH. At low pH values protein molecules are 
positively charged. The isoelectric point (pI) of a protein is the pH at which the net charge of 
the protein (and electrophoretic mobility) is zero. When the pH of the solution is lower than 
the pI of the protein it will have a net positive charge and when the pI is greater than the pH it 
will have a net negative charge. The pI will vary from protein to protein. At any given pH 
each protein molecule has a large number of interdependently charged groups involved in 
electrostatic interactions.  
Electrostatic forces are favoured by increases in the net charge of the protein. This effect is 
due to the fact that the electrostatic free energy of a protein depends on the square of the net 
charge (Dill 1990). The typical strength of an ionic interaction is about 20 kJ mol
-1
. In terms 
of second virial coefficient measurements, changes in pH that result in reductions of the net 
charge of a protein are usually accompanied by a decrease of measured repulsive interactions 
(Tessier et al. 2002a), (Valente et al. 2006), (Dumetz et al. 2008). At pH values near the pI 
B22 values have been observed to exhibit negative values indicating that attractive forces 
dominate and repulsive interactions are negligible, if not lacking altogether. Therefore, these 
electrostatic contributions can only weakly (if at all) affect protein stability under these 
conditions. 
 
Ionic interactions are also greatly influenced by another solution condition; ionic strength. In 
ionic aqueous solutions the surface charges on a protein molecule are shielded by a 
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preferential accumulation of oppositely charged counter ions in the vicinity of the protein 
surface that occurs in a region known as the electrical double layer. This layer increases the 
ion concentration in the gap between interacting molecules relative to the bulk solution. As 
such the electrostatic potential (zeta potential) of the charge (at that pH) is diminished. When 
the ionic strength of a solution is increased the number of available counter-ions is increased 
resulting in a lowered zeta potential. Therefore, the strength of ionic interactions is expected 
to decrease with increasing ionic strength. However, this prediction is not always the case 
particularly if the salt ions bind to the protein, as this changes the effective protein charge 
(Saluja 2008). Ion binding has been suggested as the cause of increased repulsive interactions 
between proteins and increased B22 values for lysozyme have been observed with increasing 
ionic strength (Guo et al. 1999), (Tessier et al. 2002a). 
 
In general, it is believed that the screening of electrostatic repulsions (known as Debye-
Huckel screening) is a necessary for the aggregation of all proteins because it was assumed 
that electrostatic interactions generally oppose protein aggregation processes. However, 
electrostatic interactions themselves may enhance aggregation. Piazza and Iacopini’s 
theoretical investigations showed that in BLG-A solutions, attractive interactions could lead 
to the spontaneous formation of transient clusters, suggesting that electrostatic interactions 
could play a significant role in aggregation of BLG-A (Piazza and Iacopini 2002). However, 
the mechanism of aggregation and the role of electrostatics in that mechanism has not yet 
been fully elucidated. 
 
Second virial coefficients for many proteins reflect these different trends. The relative effects 
of ionic strength of B22 values ranges from significant in the case of lysozyme (Bonnete et al. 
1999), (Tessier et al. 2002a), (Teske et al. 2004b), (Ahamed et al. 2005), (Le Brun et al. 
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2010a) to moderate for IgG2 (Saluja et al. 2007) and the case of β-lactoglobulin A (BLGA) 
increasing salt concentrations were reported to have no or little effect on B22 values (Piazza 
and Iacopini 2002). The combination of pH and salt effects is more complicated, but in some 
cases it has been shown that the presence of salt in a solution can diminish the effect of pH on 
the protein (Velev et al. 1998), (Neal et al. 1999). 
 
2.3 Van der Waals Interactions 
Van der Waals interactions are the second most important force in protein-protein 
interactions. Van der Waals forces arise from a set of interactions between induced dipoles 
and dipoles, and include Debye, Keesom and London forces. Van der Waals interactions are 
usually attractive, short ranged compared to ionic interactions and much weaker typically 
between 0.1 and 4 kJ mol
-1
. These are the best understood of short range interactions. Van der 
Waals interactions are strongly dependent on the geometry of interacting surfaces due to their 
short interaction range (Lenhoff 2003). The van der Waals forces is generally described at an 
atomic level through the Lifshitz-Hamaker equation or a related form of the Lennard-Jones 
potential equation (Neal et al. 1998). The overall strength of van der Waals interactions can 
be represented by the Hamaker constant. Typically, van der Waals attractive potentials decay 
with an inverse sixth power of the intermolecular distance between the centre of the two 
interacting bodies (Dobson et al. 2006). As such the contribution from van der Waals forces 
can be expected to increase with increasing protein concentration (Saluja and Kalonia 2008). 
 
55 
 
2.4 DLVO Theory 
Named after Derjaguin, Landau, Verwey and Overbeek, DLVO theory is the classical 
explanation of the stability of colloids in aqueous suspension. It combines the effect of two 
opposing forces – van der Waals attractive forces and ionic repulsive forces due to the so 
called double layer of counterions that exist on particles surfaces as they approach each other. 
DLVO theory proposes that a stabilising energy barrier exists due to ionic repulsion between 
particles electrical double layers with each other. The energy barrier is at maximum when the 
particles are almost touching and reduces to zero outside the electrical double layer. The 
effect of the van der Waals attractive force is additive. This means that all colloidal particles 
exhibit an attraction to each molecule in the other colloidal particles. This is repeated for each 
molecule in the colloid and the total attractive force is the sum of all these and varies with 
distance. By combining attractive and repulsive forces the net interaction potential can be 
calculated as a function of distance (Figure 3). If there is a section of the curve where overall 
forces are repulsive then the point of maximum repulsive energy is known as the energy 
barrier. The height of the barrier indicates the colloidal stability of the system. If two particles 
collide with sufficient energy to overcome the energy barrier the attractive van der Waals 
forces will pull the particles into contact where they adhere strongly and irreversibly. In many 
cases the solution conditions can be adjusted to either decrease or increase the energy barrier, 
for instance changing ionic strength or pH, and in doing so affect the colloidal stability of the 
system. 
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Distance 
Figure 3. Classic DLVO plot showing interaction potentials as a function of distance 
 
DLVO theory has been shown to be useful for understanding protein-protein interactions in 
dilute electrolyte solutions where interactions are dominated by long ranged ionic forces. 
However, there are many situations where DLVO theory fails to give an adequate description 
of protein solution behaviour as it does not include important effects such as specific ion 
effects and solvation forces. The total interaction charged particles as summarised by DLVO 
theory can be represented by the following equation. 
 
          Equation 2.4 
Where W(D)Tot is the total interaction energy between two spheres, A is the Hamaker 
constant, R is the radius of the spheres, D is the intermolecular distance between the two 
spheres, ε0 is the permittivity of free space, εR is the relative static permittivity,ψ0 is the 
surface potential and κD is the Debye screening length. 
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2.5 Hydrogen Bonding 
A hydrogen bond is a polar type of attractive interaction where a proton is shared between a 
protein donor group and a protein acceptor; both atoms are usually highly electronegative 
(Jones and Thornton 1996). Unlike many of the other intermolecular forces considered in this 
thesis, they are highly directional. Optimal hydrogen bonds will have co-linear geometry 
between the atoms involves and a distance between the acceptor and donor of no more than 
3.1Å (Gitlin et al. 2006). This dimension is a distance shorter than those induced by van der 
Waals interactions. Hydrogen bonds are strong forces with the strength of a single hydrogen 
bond is typically between 16-20 kJ mol
-1
. Hydrogen bonds are strongest at low temperatures 
and weaken with increasing temperature. 
Hydrogen bonds are a major feature of protein structure. Hydrogen bonds in proteins are 
formed between amide hydrogen’s and the lone pair of electrons on the backbone oxygen 
atoms in the peptide. They are of vital importance and are present at high frequencies in the 
protein secondary structure and are involved in the formation of intramolecular β sheets and 
α-helix coils. They are also an important component of tertiary structure through the 
interaction of side chains. In native proteins hydrogen bonds are only absent in 12% of all 
NH groups and 11% of all C=O groups (Dill 1990). Hydrogen bonds have also been 
implicated as being of key structural importance to the formation of amyloid fibrils (Dobson 
2003). Those hydrogen bonds involved in intra-chain structure are stronger than those 
involved in interfacial bonding. This is because the side chains at the interface are more 
hydrophilic than those in the interior and that proteins on the interior are involved in protein 
folding rather than protein binding which is much more rigid. This rigidity means that 
hydrogen bonds do not have the same freedom to attain optimal binding configuration forcing 
58 
 
many groups buried in the interface to form hydrogen bonds with protein atoms, which are 
weaker than those with water. In order to compete with the binding of water, greater numbers 
of water molecules are involved in mediating hydrogen bond networks at the interface and as 
such control protein-protein interactions (Xu et al. 1997b). 
 
2.6 Hydration and Hydrophobic Interactions 
Hydration (or solvation) forces describe the solvation interaction of surfaces containing 
charged or polar groups (Curtis and Lue 2006). Hydration forces are the result of the 
arrangement of solvent molecules around the protein molecules. These forces act over a 
distance of between 1 and 5 solvent molecules diameters (Rosenbaum and Zukoski 1996). 
The configuration of bulk water (solvent) molecules only retains its structural characteristics 
at relatively large distances from the interface with the protein molecule. The solvent layer 
directly in contact with the protein surface is known as the first hydration layer and many of 
the water molecules in the first hydration layer will form hydrogen bonds with polar protein 
atoms (Eisenhaber 1999). The subsequent layers of the hydration shell result from the 
interaction of solvent molecules with those in the first hydration layer (Yousef et al. 1998b). 
Hydrophobic interactions are a type of hydration force that is considered the dominant force 
in protein folding and stabilisation of protein tertiary and quaternary structure (Piazza 2004a). 
Hydrophobic interactions are also a significant driving force in protein aggregation (Roberts 
2003), (Chiti et al. 2003). Hydrophobic interactions occur between non-polar amino acid 
residues such as leucine and tryptophan, which are unable to make favourable hydrogen 
bonds with water so in order to avoid contact with water molecules they tend to cluster 
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around each other (Dill 1990). This usually buries the groups involved towards the interior of 
the protein. This configuration has the lowest free energy and as such is the preferred 
configuration at equilibrium. Protein aggregation is usually accompanied by substantial 
changes in protein structure. Partially unfolded or intermediate state protein molecules are 
more expanded than their native form and as a result non-polar amino acid residues normally 
involved in internal hydrophobic interactions are exposed at the protein interface. 
Hydrophobic interactions are attractive in nature (Curtis et al. 2002) and typically act over a 
distance of between 1 and 5 solvent molecule diameters (Rosenbaum and Zukoski 1996). 
Unlike the other interactions discussed in this section which involve pairwise interactions, 
hydrophobic interactions do not arise as a result of direct force between non polar molecules 
but instead involve a considerable number of (water) molecules. The strength of hydrophobic 
interactions is usually about 12 kJ mol
-1
; as such they are comparable in energy to hydrogen 
bonds. However, the strength of hydrophobic interactions in the protein interior have been 
found to be higher than those at protein-protein interfaces (Tsai et al. 1997) due to the higher 
frequency of non-polar groups in the protein interior. Thus, protein-protein interactions 
should be mainly determined by ionic interactions and hydrogen bonding as the protein 
surface usually has higher proportions of polar and charged groups.  
 
Solvation forces are altered by increasing ionic concentrations. As ionic strength increases 
then more and more of the bulk water becomes associated with ions rather than the protein. 
This means there are fewer water molecules available to form hydrogen bonds in the 
solvation layer around the protein. This exposes hydrophobic patches on the protein, which 
increases the strength of protein-protein interactions, potentially leading to aggregation and 
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precipitation. This effect is known as “salting out”. The effect is ion specific and follows the 
Hofmeister series of reactivity (See Figure 2).  
The addition of co-solvent molecules to a solution also changes water activity which in turn 
affects the hydration forces acting on a protein. Osmolytes such as polyols, sugars, amino 
acids and some salts have been shown to stabilise protein structure through a mechanism 
whereby the excipient molecule is preferentially excluded from the immediate vicinity of the 
protein. This leads to an increase in the Gibbs free energy of the protein and increased 
compactness of protein structure. This could reduce protein hydrophobicity. The effect on 
protein stability has been shown to be most efficient in the presence of salt (to reduce ionic 
interactions) for a number of model proteins. Increased B22 values have been reported for 
lysozyme through addition of a number of osmolytes (Valente et al. 2005b). 
 
2.7 Excluded Volume Effect 
Liquid state theory describes the “excluded volume” of a molecule as the volume around each 
molecule that is inaccessible to other molecules as a result of the first molecule occupying 
that space, since two molecules cannot be in the same place at the same time. For the 
purposes of the excluded volume effect molecules, including protein molecules, they are 
modelled as hard spheres. In a dilute solution the centre of two identical hard spheres cannot 
be in any proximity closer to each other than a distance of twice their radii. Therefore the 
excluded volume of a molecule is in fact 8 times the volume it physically occupies. However, 
when considering pair-wise interactions the volume is distributed between the two molecules. 
Therefore, for protein-protein interactions the excluded volume is usually given as roughly 
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four times the volume of the protein molecule. However, it is likely that modelling protein 
molecules as hard spheres leads to an underestimation of the true excluded volume. 
Considering that proteins are not perfect spheres and have rough surfaces, the excluded 
volume of protein molecules has been calculated to be as much as 6.7 times greater than the 
volume of the protein molecule itself (Neal and Lenhoff 1995). Additionally, the volume of 
the solvation layer surrounding the protein molecule is sometimes thought to contribute to the 
excluded volume (Neal et al. 1998). The excluded volume effect favours any reaction where 
there is a decrease in volume. This includes the amalgamation of protein molecules to form 
aggregates. Increasing the protein concentration, decreases the intermolecular centre to centre 
distance between two molecules and increases the equilibrium constant and this decreases the 
entropy of the dissociated state relative to the associated. As such, excluded volume effects 
are amplified and at high concentrations can be very large. Macromolecular crowding effects 
at high protein concentrations will mean that short range interactions are favoured (Saluja and 
Kalonia 2008). 
When considering excluded volume effects on proteins, one must also consider the 
cosolvents, as proteins will also be excluded from some of the solution volume by their 
presence. They effectively increase the concentration of the solution as a whole and a high 
concentration of cosolvent molecules can favour association of protein molecules. There is 
direct evidence that this principle can be a driving force for protein crystallisation. Molecules 
such as polyethylene glycol (PEG) are frequently used for this purpose. 
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CHAPTER 3 
3 EXPERIMENTAL TECHNIQUES FOR THE DETERMINATION 
OF PROTEIN-PROTEIN INTERACTIONS 
 
3.1 Techniques for the Determination of B22 
 
Over the past few decades interest in protein-protein interactions has been rising, with an 
increasing number of analytical techniques being developed to investigate them. A number of 
these techniques linked to mathematically models for the determination of B22 values. These 
models are only accurate at lower protein concentrations as the probability that interactions 
only occur on a pairwise basis decreases with increasing protein concentration. B22 represents 
the overall interactions between molecules in solution and hence reflects their association 
dynamics. 
Historically, B22 values were first measured through membrane osmometry (Zimm and 
Myerson 1946), (Yousef et al. 1998b), (Yousef et al. 1998a) but static light scattering (SLS) 
overtook it in popularity (Edsall 1950), (George and Wilson 1994) and has since become the 
new reference method and the technique most reported in literature. More recently new 
techniques have been developed that improve on some of the drawbacks of the original SLS 
techniques. 
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3.1.1 Membrane Osmometry 
Membrane osmometry, the original technique adapted to measurement of B22, measures the 
solution osmotic pressure directly to determine B22. In this technique the protein solution and 
pure solvent are separated by a semi-permeable membrane (permeable to solvent but not 
protein). Pressure applied to the protein solution side of the membrane establishes 
equilibrium and prevents movement of solvent across the membrane (See Figure 4).  
 
 
Figure 4. Schematic of a Membrane Osmometer 
 
This additional pressure is the osmotic pressure. McMillan and Mayer’s (1945) theory 
expresses the osmotic pressure in terms of protein concentration by applying the imperfect 
gas law to protein aqueous solutions. The virial equation for the osmotic pressure of a single 
protein species is: 
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  Equation 3.1 
Where ∏ is the osmotic pressure, cp is the protein concentration, R is the gas constant, T the 
absolute temperature and Mw the number average protein molecular weight. This equation 
means B22 can be obtained by plotting ∏/RTCp versus Cp. The intercept will be equal to 1/Mw 
and B22 is given by the slope. An example such a graph is shown in Figure 5 below from 
experiments carried out by Moon and co-workers (Moon et al. 2000). 
 
Figure 5. Osmotic pressure data for lysozyme at pH 8 and 25ºC in 1M ionic strength (NH4)2SO4 
solution (Moon, Curtis et al 2000) 
 
The difficulties with this technique are caused mainly by the membrane system and include 
membrane fouling, leakage and asymmetry. Membrane osmometry is also a time consuming 
technique and its accuracy at low protein concentrations is poor. However, increasing protein 
concentration further to improve accuracy increases the time required for the system to reach 
equilibrium. At high protein concentrations problems may also be encountered where the 
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Donnan effect (Stoner et al. 2004) may lead to unequal partitioning of electrolyte across the 
membrane. 
 
3.1.2 Static Light Scattering 
The basis of the light scattering technique is that macromolecules in solution when irradiated 
with a light source, scatter, diffract and reflect that light. The properties of the scattered light 
vary depending on the size and nature of the macromolecules in solution and reflect 
interactions between them. Measurement of the intensity of the scattered light at various 
protein concentrations allows determination of B22. The scattering intensity is usually 
independent of the scattering angle because protein molecules tend to be smaller than the 
wavelength of incident light (< λ/20). The intensity of the scattered light is proportional to the 
Rayleigh ratio (Rθ) is a quantity used to characterise the scattered light intensity as a function 
of the scattering angle θ and can be represented by the following equation (Zimm and 
Myerson 1946); 
   Equation 3.2 
Where K is an optical constant, cp is the protein concentration, Mw is the weight average 
molecular weight. The optical constant K can be described by; 
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   Equation 3.3 
Where λ is the laser wavelength of the incident light, no is the refractive index of the solvent 
and dn/dCp is the refractive index gradient with respect to protein concentration Cp. A plot of 
KCp/Rθ should be linear with protein concentration. The plot is known as a Debye plot and 
the slope is equal to B22 and the intercept is 1/Mw. Light scattering is proportional to protein 
concentration in solutions where there is no protein association. However, self-association 
results in curvature as the presence of dimers in solution significantly reduces KC/ Rθ (Alford 
et al. 2008a). 
SLS is best utilised at low protein concentrations of less than 10mg/mL because Rayleigh 
light scattering theory is most applicable to dilute concentrations of solute. SLS has become 
the reference technique for determination of B22; however, the technique is not without its 
disadvantages. Measurement using SLS is a very slow method because making one B22 
measurement requires investigating the scattered intensity versus protein concentration for 5 
or more different concentrations of the protein of interest (Velev et al. 1998). As it does not 
usually produce run-to-run consistent results, several replications are often required to 
validate one data point. SLS also suffers from the disadvantages of being very sensitive to 
dust and impurities and it is unsuitable for use with peptides as they do not scatter sufficient 
light (Payne et al. 2006). 
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3.1.3 Sedimentation Equilibrium by Analytical Ultracentrifugation 
Sedimentation equilibrium measurements are an analytical ultracentrifugation (AUC) 
technique that can be used for measuring protein interactions or the molecular weights of 
proteins. In sedimentation equilibrium measurements a protein sample is spun in an AUC and 
the centrifugal force produces a protein concentration gradient across the sample cell. 
Sedimentation equilibrium exists when the rate of sedimentation is balanced by 
macromolecular diffusion in the opposite direction. The equilibrium protein concentration 
distribution across the cell can be detected either by refractive index or absorbance detectors. 
This method allows observation of the evolution of sample concentration as a function of the 
axis of rotation as a result of the applied centrifugal field. The apparent weight average 
molecular weight can be determined using the following equation (Liu et al. 2005a): 
  Equation 3.4 
Where c(r) is the protein concentration at the radial position r, c0 is the initial loading protein 
concentration, Mw,app is the apparent weight average molecular weight, v¯ is the partial 
specific volume, ρ is the buffer density, ω is the angular velocity, ξ = (r²-r0²) / 2, R is the gas 
constant and T is the experimental temperature. The second virial coefficient B22 can be 
determined from the following equation: 
    Equation 3.5 
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Where Cp is the protein concentration and Mw is the average molecular weight. 
Determination of B22 via sedimentation equilibrium experiments can be carried out at both 
high and low protein concentrations (Alford et al. 2008a). However, analysis of results at 
high protein concentration is more complicated because of the increasing solution non-
ideality under these conditions. There are a number of different mathematical models 
available for interpretation of the data but the model developed by Zorrilla and co-workers 
(Zorrilla et al. 2004) is the most commonly used. This method takes into account the 
possibility of both attractive and repulsive interactions in solution. 
 
3.1.4 Self-interaction chromatography 
 
 
Figure 6. Schematic of a Self-Interaction Chromatography column 
 
The SIC technique is based on weak affinity liquid chromatography principles, in which the 
target protein serves as both the chromatographic ligand and ligate. The technique 
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necessitates the covalent immobilisation of the protein of interest onto a suitable solid state 
chromatographic stationary phase. Once the column has been packed with a protein 
immobilised stationary phase, a protein concentration front or pulse of the same protein in a 
suitable buffer is then injected and eluted through the column stationary phase under isocratic 
conditions (See Figure 6 above). The column elutant is then monitored for protein 
concentration, with the retention or profile breakthrough time reported (Tessier et al. 2002a), 
(Patro and Przybycien 1996). Under the assumption that the immobilised protein retains its 
native three-dimensional and secondary structure, and that it is immobilised in a broad range 
of orientations (thus avoiding an unrepresentative side specific interaction), the resulting 
retention volume estimated from the protein chromatogram peak shape, or from the inflection 
point in the case of a breakthrough curve, will be a measure of the ensemble average strength 
of protein-protein interaction energy under the solution conditions used. The longer the 
protein retention time the more attractive the protein-protein interactions. 
This data can then be directly related to the B22, second virial coefficient, via statistical 
mechanics based analysis (Tessier et al. 2002a), (Patro and Przybycien 1996), (Zimm and 
Myerson 1946), (Tessier et al. 2002b) using the following equation: 
B22
app
 = BHS – (k')/ (ρS ф’)    Equation 3.6  
Where  k’ = (Vr - V0) / V0      Equation 3.7 
The SIC retention volume measurements are used to calculate the retention factor k’ , where 
Vr is the retention volume of the protein and Vo is the column dead volume. BHS represents 
the excluded volume or hard sphere contribution. The total number of immobilised protein 
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molecules per unit area is denoted by ρS and As is the total accessible surface area. The phase 
ratio ф is defined to be ф = As / Vo which is the total surface available to the mobile phase 
protein. The phase ratio can be interpreted using the work of (DePhillips and Lenhoff 2000). 
SIC has been shown to produce comparable B22 results to SLS measurements for model 
proteins including lysozyme and BSA (Tessier et al. 2002a), (Tessier et al. 2004), (Ahamed et 
al. 2005). Using SIC to measure B22 requires 10 times less protein than SLS, even when the 
protein immobilised on the column is included and also has the potential to be miniaturised to 
microchip level (Garcia et al. 2003), significantly further reducing required amounts of 
protein. Considering that the same SIC column can be used for months, giving reproducible 
results, and that after the initial time required to immobilise the protein and pack the column, 
a B22 value can be obtained through SIC every approximately every 30 minutes, the SIC 
technique is also significantly more efficient in terms of experimental time to generate data. 
The technique is compatible with chromatography automation methods meaning it could 
potentially be used as a high-throughput screening tool. It also has the added advantage that it 
can be used to measure cross-interactions (e.g. B23) between different proteins which was not 
previously possible (Tessier et al. 2004) and indeed not currently practised using any other 
technique. It is also important to note that SIC may also be more accurate than SLS as it is 
much less sensitive to experimental artefacts such as dust and impurities, meaning a higher 
success rate for SIC measurements. 
It is however, important to note that both SLS, MO and SIC suffer from some discrepancies 
compared to sedimentation equilibrium (Winzor et al. 2007). The main reason behind this 
discrepancy is sedimentation equilibrium measurements determine only protein-protein 
interactions whereas the other methods include the combined contributions of protein-protein 
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and protein-buffer interactions. These are important factors to consider in choosing a suitable 
experimental method and also when comparing literature data. 
However, SIC is not without its complexities as in common with most physiochemical 
chromatographic approaches. One of the core challenges is establishing whether linear 
chromatography theory can be applied to the data. In short this assumption requires that the 
chromatographic results are independent of the solute concentration. This assumption forms 
the basis of the analysis given in the equations above and all work previously work published 
on SIC. The main reported concern (Tessier et al. 2002a), (Johnson et al. 2009) with this 
technique is the risk of loss of immobilised protein from the packed column, irreversible 
adsorption of contaminate species or protein on the SIC column or that exposure to certain 
solution conditions results in the denaturation of the protein immobilised on the column. 
 
3.1.5 Small Angle Scattering of X-rays and Neutrons 
Small angle neutron scattering (SANS) and small angle X-ray scattering (SAXS) are both 
scattering techniques that measure the elastic scattering of neutrons and X-rays at very low, 
glancing, angles (0.1 to 10°). Determination of B22 values from these experiments is based on 
the same mathematical model as SLS. Although there is less data available on the use of 
these techniques for determination of B22 values, both SAXS (Bonnete and Vivares 2002) and 
SANS (Velev et al. 1998) have been shown to produce results consistent with SLS values and 
present some advantages over the traditional SLS technique. For example, it is possible to use 
SAXS to assess protein-protein interactions at very high protein concentrations (up to 
500mg/mL) (Zhang et al. 2007). 
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3.2 Other Techniques for Assessing Protein-Protein Interactions 
Although these techniques do not quantify B22 they can be used in the analysis of protein-
protein interactions through other parameters or indirect analyses. 
 
3.2.1 Dynamic Light Scattering 
Dynamic Light Scattering (DLS), also known as photon correlation spectroscopy (PCS), can 
be used to measure the diffusion coefficient of a protein molecule in solution. DLS measures 
the fluctuations in the intensity of scattered light produced by the velocity distribution of 
protein molecules. The diffusion coefficient (D) is dependent on intermolecular attractive and 
repulsive forces as well as the hydrodynamic radius of the protein molecules. Solutions in 
which intermolecular forces are too weak to influence diffusion of the protein molecules are 
considered to be ideal. In this instance the diffusion coefficient is independent of protein 
concentration and this parameter is known as the self-diffusion coefficient (Ds) (Zhang and 
Liu 2003). In non-ideal solution conditions, the diffusion coefficient is known as the mutual 
diffusion coefficient (Dm). The diffusion coefficient can be described by the following 
equations: 
Dm = (1 + kD cp)        Equation 3.8 
Dm = kB T / 3∏ η dH       Equation 3.9 
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where kD is a measure of intermolecular interactions, cp represents the protein concentration, 
T is the absolute temperature, kB is Boltzmann’s constant, η is the solution viscosity and dH is 
the hydrodynamic diameter.  
The magnitude and sign of kD gives information on the nature of the protein-protein 
interactions. Negative kD values represent a decrease in Dm to below Ds, indicating an 
inhibition of diffusion and therefore attractive intermolecular interactions. Positive kD values 
correspond to the opposite. A major limitation of this technique is the measurement 
resolution and range, DLS can only accurately resolve size difference of fivefold or greater 
(Mahler et al. 2009). 
 
3.2.2 Surface Plasmon Resonance 
The Surface Plasmon resonance (SPR) technique uses a highly specialised optical technique 
to detect changes in the refractive index within a 300nm vicinity of the surface (Phizicky and 
Fields 1995). The underlying principle of SPR is that when a light beam impinges onto a 
metal film at a specific resonance angle, surface plasmons resonate with the light, resulting in 
absorption of light. For protein-protein interactions the experimental procedure would 
involve immobilising the protein on a target gold surface and then monitoring its interaction 
with the protein free in solution through changes in refractive index and hence the resonance 
angle of impinging light near the surface which indicate changes in mass when proteins 
interact (Figure 7). All proteins have the same refractive index therefore changes in signal 
can be linearly correlated to changes of protein concentration in the vicinity of the surface. 
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SPR has found many applications in biology including kinetics, specificity and affinity of 
pairwise biomolecular interactions. 
 
Figure 7. Schematic of a typical SPR Instrument 
 
Self-interaction nanoparticle spectroscopy is a novel technique developed by Tessier and co-
workers (Tessier et al. 2008) based upon the SPR technique. The technique requires the 
adsorption of the protein of interest onto gold nanoparticles which are then suspended in 
solution. Spectrophotometry is then used to track changes in the colour of the gold 
suspension which reflect the strength of protein-protein interactions. This measurement is 
possible because the optical properties of gold nanoparticles will change with varying 
interparticle separation distance which will vary depending on the strength of the 
intermolecular forces. However, this technique is restricted by the fact that it is only useful 
for acidic proteins at pH values above their pI. This constraint is because the gold particles 
are negatively charged. As such oppositely charged proteins undergo non-specific 
aggregation with the gold nanoparticles when added to solution.  
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CHAPTER 4 
4 USE OF B22 TO PREDICT PROTEIN BEHAVIOUR 
B22 is a potential multiple predictive tool for protein-protein interactions in aqueous solutions. 
The literature shows that protein-protein interactions measurements are relevant in the 
determination of protein crystallisation, aggregation, solubility and viscosity behaviour. 
 
4.1 Crystallisation 
Growing crystals for protein structure determination is a complicated and very challenging 
task. More than 20 different solution variables are known to influence protein crystal growth 
(McPherson 1985) and methods for identifying the optimal solution conditions are poorly 
developed, with most identified on a trial and error screening basis. Typical crystallisation 
conditions involve the use of high concentrations of certain chemicals, such as polyethylene 
glycol or certain salts, in the solvent solution. George and Wilson (George and Wilson 1994) 
discovered a correlation between B22 and crystallisation solution conditions. When B22 values 
fall between -1 x 10
-4
 and -8 x 10
-4 
mol mL g
-2
 solution conditions favour weak protein-
protein interactions over protein-solvent interactions. This narrow B22 range became known 
as the “crystallisation slot” and in it the conditions were found to be favourable to post-
nucleation crystal growth. B22 values falling in this crystallisation slot have since been 
confirmed for a number of different proteins under crystallisation solvent conditions 
76 
 
(Bonnete and Vivares 2002), (Tessier et al. 2002a), (Tessier and Lenhoff 2003), (Berger et al. 
2005a), (Dumetz et al. 2008). 
However, the crystallisation slot may vary according to protein size. Increased protein size 
has been shown to squeeze the crystallisation slot so that only the smallest of B22 values in 
the crystallisation slot reflect effective crystallisation conditions (Bonnete and Vivares 2002). 
The crystallisation of IDEC-152 MAb by Ahamed and co-workers (Ahamed et al. 2007) in 
(NH4)2SO4 and PEG, is a good example of a protein with an extremely small crystallisation 
slot. The problem in this case was because B22 remained positive even at high concentrations. 
B22 values did decrease above a certain (NH4)2SO4 concentration, but drastically, leaving a 
very narrow range of suitable crystallisation conditions. 
The work of Rosenbaum and co-workers (Rosenbaum and Zukoski 1996) supports George 
and Wilson’s crystallisation slot theory and the use of B22 values to identify favourable 
solution conditions for crystal growth. Their model involves a two parameter equation-of-
state to describe the thermodynamics of a protein solution. The two parameters are protein 
size and a measure of inter-particle attractions. The protein phase behaviour predicted by B22 
values was shown to be in agreement with the so called adhesive hard sphere potential. This 
study emphasised the importance of short range (a small fraction of particle diameter) 
attractive interactions in protein phase behaviour and the usefulness of B22 in describing 
them. 
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4.2 Protein Aggregation 
B22 values describe the magnitude and direction of protein-protein interactions and as such 
could play a potentially significant role in the prediction of protein aggregation, which 
involves strongly attractive protein-protein interactions. 
B22 values have been measured for recombinant human granulocyte colony-stimulating factor 
(rh-GCSF) using SLS and were compared with the free energy of protein unfolding, 
representing the colloidal and conformational stability of the protein respectively (Chi et al. 
2003a). B22 values for rh-GCSF at pH 7.0 and 6.1 were negative and in this condition rh-
GCSF was shown to be aggregation prone. At pH 3.5 B22 values measured were positive and 
no aggregation was observed. Under solution conditions where the native structure is 
perturbed and protein conformational stability dominates (negative B22, large free energy of 
unfolding) increasing the free energy of unfolding was found to diminish protein aggregation. 
Under conditions with high colloidal stability (large positive B22 values) solution conditions 
that favoured repulsive rh-GCSF interactions decreased aggregation. The aggregation of rh-
GCSF was shown to be a two-step process, the first involving perturbation of the native 
structure and the second an assembly process for the formation of aggregates. As such rh-
GCSF is dependent on both conformational and colloidal stability. Thus, measuring B22 can 
be useful in the elucidation of protein aggregation mechanisms. However, since aggregation 
can be controlled by either conformational or colloidal stability as a rate limiting step it 
cannot wholly predict aggregation kinetics. The investigation of protein unfolding 
thermodynamic parameters helps complete the picture of aggregation behaviour.  
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The effect of pH, NaCl and temperature on the aggregation pathways, kinetics, unfolding free 
energy and B22 measurements of α-Chymotrypsinogen was examined using a combination of 
size exclusion chromatography (SEC), multi angle light scattering, circular dichromism (CD) 
and fluorescence spectroscopy (Li et al. 2010). Increasing pH values and increasing salt 
concentration both resulted in decreased B22. These values were found to be consistent with 
the aggregation behaviour of α-Chymotrypsinogen. Results indicated that the free energy of 
unfolding (indicative of conformational stability) affected aggregation rates but not 
qualitative kinetic types. On the other hand B22 was found to be predictive of which type of 
aggregation pathway and aggregate form occurred, meaning that B22 could be a potentially 
powerful predictor of qualitative aggregation behaviour.  
The effect of buffer species on the thermally-induced aggregation of interferon-tau (IFN-tau) 
was compared with B22 measured by SIC (Katayama et al. 2006) for phosphate, histidine and 
Tris buffers. IFN-tau at 1.0 mg/mL concentration in pH 7.0 20mM phosphate buffer was 
found to aggregate most quickly under thermal stresses, aggregation was slower in the Tris 
buffer and slowest in the histidine buffer (at the same pH and concentration). Second virial 
coefficients reflected this trend but the histidine buffer was only slightly more positive 
compared to the other buffer species suggesting that histidine has only a small effect on the 
colloidal stability of IFN-tau. Indeed, complementary investigations revealed that histidine 
molecules weakly bind to the native state of IFN-tau, stabilising the native state and thus 
reducing aggregation. 
The relationship between B22 and aggregation of IgG2 antibody and ovalbumin in long term 
storage was investigated by Bajaj and co-workers (Bajaj et al. 2006). The proteins were 
incubated for 3 months at 37ºC under a variety of solution conditions. B22 values were 
obtained using a modified method of flow mode SLS. B22 for IgG2 at pH 7.4 was just slightly 
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negative at -8.7 x 10
-5
 mol mL g
-2
 indicating very weak attraction between the protein 
molecules. However, at pH 4.0 the Debye plot used to obtain B22 values was seen to curve 
upwards; this type of non-linearity is typical of a self-associating system. Ovalbumin B22 
values reflected moderate attractive protein-protein interactions and were similar for all 
solution conditions measured. To correlate with the aggregation studies, both proteins 
aggregated readily at pH 4.0 as would be expected from the non-linear Debye plot and virial 
coefficient values obtained. IgG2 did not aggregate at pH 7.4; this observation is also in 
agreement with the only slightly negative B22 value. However, ovalbumin did not aggregate 
at pH 7.4 or pH 5.4 despite B22 values being similar to those observed at pH 4.0 when 
aggregation was observed. Complementary circular dichromism studies showed that at pH 
4.0 both proteins were partially unfolded, revealing that this form is the aggregation prone 
species. Bajaj and co-workers, thus concluded that it was unlikely B22 would correlate with 
long term aggregation because the structurally perturbed state could be present in a small 
fraction compared to the native species, yet the structural changes could be significant 
enough to lead to aggregation in the long term. 
 
4.3 Protein Solubility 
B22 and solubility of numerous proteins have been compared in literature theoretically and 
experimentally in order to establish supersaturation conditions for protein crystallisation 
investigations. The interdependence of B22 and solubility was first alluded to by George and 
Wilson (George and Wilson 1994) who demonstrated that for lysozyme the influence of 
temperature and ionic concentrations affected both solubility and B22 in a similar way. Guo 
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and co-workers (Guo et al. 1999) went on to show that lysozyme crystal solubility and B22 
were highly correlated for numerous variables such as temperature, pH, salt type and 
concentration. Plots of solubility against B22 revealed a linear correlation at moderate to high 
solubilities. A thermodynamic theoretical relationship was established between the two 
parameters (Guo et al. 1999), (Haas et al. 1999); 
B22 = (-Δμ2 / RT) x (1 / 2M2S) – (lnS / 2M2S)  Equation 4.1 
Where R is the gas constant, T the absolute temperature, Δμ2 = μ2
0
 (solution) - μ2
0 (solid), μ2
0
 
(solution) is the chemical potential of the protein in solution, μ2
0
 (solid) is the chemical 
potential of the protein in a solid form (e.g. crystal), M2 is the molecular weight of the protein 
and S is the solubility expressed in g mL
-1
. This relationship has since been confirmed to also 
applicable to other proteins including equine serum albumin (Demoruelle et al. 2002) and 
ovalbumin (Ruppert et al. 2001). 
 
4.4 Solution Viscosity 
Many therapeutic protein formulations require high protein concentrations so that the dosage 
volume is sufficiently small for administration. Solutions of high protein concentration may 
exhibit difficulties in protein solubility, stability and viscosity (Shire et al. 2004), (Harris et 
al. 2004). High viscosity solutions complicate delivery by injection and manufacturing 
processes that involve filtration. Increasing protein concentration also increases solution 
viscosity through protein self-association behaviour and this phenomena is in turn dependent 
on the macromolecular crowding effect (Liu et al. 2005a), (Kanai et al. 2008), (Yadav et al. 
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2011). However, every protein system is unique and solution viscosity behaviour does vary 
depending on the specific protein and the accompanying buffer conditions such as ionic 
strength and pH (Shire et al. 2004).  
The viscosity of a macromolecule in solution can be expressed through the following virial 
expansion (Shire et al. 2004), (Liu et al. 2005a); 
η = η0 (1 + k1C + k2C
2
 + k3C
3
 + ….)    Equation 4.2 
This expansion relates viscosity η to the solvent viscosity η0 and protein concentration C (g 
mL
-1
). In this equation k1 reflects contribution of individual solute molecules to viscosity 
while k2 and higher order coefficients represent the contribution of effects that arise from two 
or more body interactions. Therefore k1C reflects the intrinsic viscosity of a solution but 
(k2C
2
 + k3C
3
 + ….) describes intermolecular interactions, resulting from for example ionic, 
hydrophobic and van der Waals forces. Therefore B22 should correlate with k2 and hence 
reflect the influence of protein-protein interactions on solution viscosity. 
Liu and co-workers (Liu et al. 2005a) compared the solution viscosity, B22 values and self-
association behaviour of concentrated solutions of three different mAbs (all constructed from 
the IgG1 human framework). Two of the mAbs displayed low solution viscosity under all 
solution conditions tested. However, the viscosity of the third MAb was found to be highly 
dependent on pH, ionic strength and protein concentration. Under some solution conditions 
no B22 values could be obtained through sedimentation equilibrium experiments due to self-
association. However, the addition of NaCl reduced self-association and resulted in positive 
B22 values and viscosities comparable to the other two MAbs. 
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CHAPTER 5 
5 MEASUREMENT AND CHARACTERISATION OF PROTEIN 
AGGREGATION 
 
Protein therapeutics exhibit a wide range of aggregation phenomena. The challenge in 
analysing them is the large size range of protein aggregates which form. Protein aggregates 
can range from very small oligomers (a few nm) to visible particulates (up to 50µm); this size 
range can cover up to five orders of magnitude. A combination of particle size 
characterisation techniques is usually necessary to evaluate protein aggregation as no single 
method can cover this size range. However, there are advantages and disadvantages to each 
method deployed. A few of the favoured techniques are discussed below and Table 2 presents 
a summary and comparison of all the main techniques. 
 
5.1 Size Exclusion Chromatography 
Size exclusion chromatography (SEC) separates proteins on the basis of their molecular 
hydrodynamic volume or size. It is one of the most common methods in the 
biopharmaceutical industry for detection and characterisation of aggregates. In SEC protein 
molecules in a suitable buffer (aqueous, non-denaturing) are injected into a chromatography 
column containing a porous media. The pores of the beads are of a well defined size and 
smaller molecules penetrate the beads while large molecules such as protein aggregates 
cannot. As such smaller molecules take a longer average path, thus spending more time in the 
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column and are eluted later than larger molecules. Assuming monomers and aggregates of a 
protein share the same extinction coefficient SEC can be used to quantify the extent of 
aggregation in a sample. Analytical SEC typically uses small columns that require very small 
amounts of protein (in the order of a few µg) to obtain reliable results. It is a high throughput 
technique and can be fully validated. 
However, SEC has a few major limiting factors. Firstly, it only operates over limited buffer 
conditions. It is well recognised that proteins in low ionic strength solutions can interact and 
even non-specifically bind with the chromatographic media, altering the resulting peak shape 
and resolution (Carpenter et al. 2010). As a result high ionic strength buffers or organic 
solvents are often used to eliminate these issues. Unfortunately, this work itself can 
sometimes lead to the generation of artificial peaks in the chromatogram that may not have 
been present in the original sample. Recently it has been shown that adding arginine to the 
solution may have the potential to greatly reduce such interactions (Yumioka et al. 2010). 
Secondly, there is a size limit to the aggregates detectable by SEC, with poor resolution for 
larger aggregates. Larger protein aggregates may also be inadvertently filtered out by the 
column frits or even build up within the column itself, meaning that they are not detected and 
are consequently overlooked in analysis. Aggregates becoming stuck in the column in this 
manner can also degrade column performance manifested by decreased yields, broadened 
peaks and lower resolution. Weakly associated reversible aggregates may also be missed by 
this method as following a change in conditions from the sample to the chromatography 
column (e.g. temperature change or dilution) they may dissociate back into their monomeric 
form (Arakawa et al. 2010). 
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5.2 Dynamic Light Scattering 
The sensitivity of light scattering, more specifically Dynamic Light Scattering (also known as 
quasi-elastic light scattering or photon correlation spectroscopy), is regularly used for 
detection and characterisation of protein aggregates in the biopharmaceutical industry. It can 
provide information on the protein diffusion coefficient and particle size. Dynamic light 
scattering (DLS) is a well-established and popular technique for measuring the size 
distribution profile of small particles in solution over a size range of 1-2nm to 3-5µm. For 
non-stationary nucleating solutions, the aggregation can be examined by time-resolved DLS 
which provides information on particle size distribution and diffusion coefficient through 
measurement of the autocorrelation functions (ACF) of the scattered light. The technique 
uses the concept of Brownian motion wherein small spherical particles in suspension move in 
random paths. When a monochromatic light beam (e.g. a laser) is shone onto a colloidal 
dispersion, the light is scattered in all directions by the particles (Rayleigh Scattering) but at a 
different wavelength. This will occur so long as the particles are smaller than the wavelength 
of the incoming light. The change in the frequency is termed a Doppler shift or broadening 
and the shift in the frequency of the light is related to the size of the particles producing the 
shift. On average smaller particles move at a higher velocity than larger particles and as such 
cause a greater shift in the frequency of the light. This difference in frequency is used to 
determine the sizes of the particles present (Berne and Pecora 2003).  
The technique is non-invasive and the sample can be recovered for use in further 
characterisation experiments. This benefit is an advantage particularly if only small amounts 
of the protein are available such as in early stage development. This method has several other 
advantages: it is fast, accurate, simple and it is nearly entirely automated so that for regular 
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measurements may be undertaken by a non-expert user. Also, DLS is one of the few tools 
that can effectively detect the precursor species of visible particulates.  For the detection of 
large particles the sensitivity of DLS is unsurpassed, however, it is important to note that 
DLS cannot give quantitative results, only qualitative. The main limitation of DLS is the low 
resolution of results. Two peaks are not usually resolved as separate species unless their radii 
roughly differ by a factor of 2 (approximately 8 in terms of molecular mass). DLS is also 
biased towards larger particles as scattering intensity is proportional to the hydrodynamic 
radius of power six. Therefore, DLS is ideal for detecting the presence of trace amounts of 
protein aggregate which may be present in very low mass populations but is a poor tool for 
studying very small oligomers. 
 
5.3 Analytical Ultracentrifugation 
The analytical ultracentrifuge (AUC) is a powerful and versatile technique for the 
characterisation of macromolecules (Lebowitz et al. 2002). AUC is composed of a high speed 
centrifuge, a rotor with a number of cell compartments and optical systems that can measure 
the concentration gradients of the proteins under centrifugal force. AUC has two operational 
modes, sedimentation equilibrium and sedimentation velocity. AUC is mostly used in the 
sedimentation velocity mode. The study of concentration distributions in this mode can yield 
conformational, structural and molecular interaction information including sedimentation, 
diffusion and virial coefficients, binding affinity and molecular weight. AUC has increasingly 
been gain popularity in the biopharmaceutical industry for the detection of protein aggregates 
and characterising their size distribution. 
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There are a few major advantages of using AUC as a method of characterising protein 
aggregates. Firstly, AUC works under a wide range of solutions conditions, with the only 
exception being high protein concentration solutions where non-ideality may affect the 
results. This means the sample can usually be characterised under relevant buffer conditions, 
such as their formulation buffer (Philo 2006). This limits also disruption or formation of 
aggregates due to sample preparation or dilution. In addition AUC allows the quantification 
of protein aggregates. However, the reproducibility of results with this technique is low. The 
variability in results is usually attributed to cell misalignment and the quality of centrepieces 
especially for the quantification of small populations of aggregates (Gabrielson et al. 2010). 
Prevention of these problems requires intensive maintenance and regular calibration of the 
instrument. The aggregation levels reported may also vary depending on the software or 
mathematical calculations used to analyse the results. AUC is also only capable of analysing 
protein aggregation of greater than 3-5% in solution. These limitations mean that currently 
AUC is mostly used as a qualitative method or for cross-checking results from other 
techniques. 
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Table 2. Overview of the main techniques for the detection and characterisation of protein 
aggregates (den Engelsman et al. 2011). 
Technique Size 
Range 
Advantages Disadvantages 
Analytical 
Ultracentrifugation 
1nm – 
0.1 µm 
Measurement of particle size and 
shape, quantification of aggregates, 
high resolution, wide buffer and 
concentration range.  
 
Strongly dependent on instrument 
quality, complex data analysis, time 
consuming, expensive, experts required 
Atomic Force 
Microscopy 
nm 
range 
Morphological particle information, 
molecular resolution 
Particle resolution and measurement may 
create artifacts, time consumed, 
expensive, experts required 
 
Capillary 
Electrophoresis-SDS 
kDa – 
MDa 
High resolution, quantification, fast Possible interaction with capillary, does 
not detect non-covalent aggregates 
 
Dynamic Light 
Scattering 
1 nm – 5 
µm 
Simple, non-invasive, small sample 
volume, high sensitivity 
Not quantitative, low resolution, very 
sensitive to contamination, less suitable 
for polydisperse samples 
 
Fluorescence 
Microscopy 
> 1 µm – 
1 mm 
Selective for protein aggregates, high 
sensitivity, information on particle 
size and shape 
Must be labelled/dyed, no quantification 
possible 
 
Light Obscuration 2 – 100 
µm 
Fast, counting and clustering of 
particles 
Large sample volume, very sensitive to 
contamination, no shape information, 
may miss translucent particles 
 
Nanoparticle 
Tracking Analysis 
20 nm – 
1 µm 
Single particle detection and 
characterisation, useful for 
polydisperse samples 
Low sample throughput, trained 
personnel required, emerging technique 
 
Optical Spectroscopy > 1 µm 
to 1mm 
Simple, information on particle size 
and shape 
Low resolution, sample preparation may 
cause artefacts 
 
SEC 1 – 
50nm 
High sensitivity, robust Sample dilution, limited resolution, 
interaction with matrix may interfere with 
results 
 
Turbidity N/A Simple Result depends on both particle 
concentration and size, no information on 
size distribution, only suitable for 
comparative measurements 
 
Visual Inspection > 50 µm Simple, information on particle size 
and shape 
Subjective, Low resolution, limited 
particle discrimination 
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CHAPTER 6 
6 PREDICTING PROTEIN AGGREGATION PROPENSITY AND 
RATES 
 
The ability to predict the propensity of a new biotherapeutic to aggregate under varying pH, 
buffer and excipient conditions in the early stages of product development would be of great 
academic importance and industrial impact for process development and formulation. Such a 
tool is not yet available as the mechanisms of aggregation are diverse and poorly understood. 
This section will briefly discuss the main current methods that have been used for predicting 
protein aggregation in solution. 
 
6.1 Structure based Predictions 
Protein aggregation is mediated through short (typically 5-15 amino acid residues long) 
“aggregation prone” segments of the chain that in the protein native conformation would 
usually be buried inside the folded structure. However, they can become exposed to solvent 
through a mutation or change in conditions. These “aggregation prone” regions can be 
identified in the sequence of a protein with moderate accuracy and a plethora of prediction 
algorithms have been developed for this purpose. TANGO was the first (Fernandez-Escamilla 
et al. 2004) of these prediction algorithms and is still widely used.  
Structure based predictions are capable of ranking mutations in a proteins primary structure 
based on the likelihood that that mutation will cause an increase or decrease in the intrinsic 
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aggregation propensity of that protein. As such they are useful tools for rational mutagenesis 
to reduce aggregation propensity in therapeutic targets. However, these are purely qualitative 
predictions of relative protein aggregation rates are based on the assumption that such 
aggregation prone sequences are solvent exposed and therefore available to interact strongly 
with other protein molecules. Recent work in the field (Chennamsetty et al. 2010) has shown 
that such a ranking is valuable as long as the aggregation prone regions are predominately 
hydrophobic and structurally dynamic such that they are solvent exposed on short time scales. 
Most other aggregation calculators do not account for secondary or tertiary structure. 
 
6.2 Protein Melting Temperature 
The protein melting point (TM) is defined as the temperature at which a protein denatures and 
generally represents their relative thermal stability. The higher the TM the less likely a protein 
is to unfold. Since most therapeutic proteins will contain “aggregation prone” regions in their 
structure that become solvent exposed in their partially or fully unfolded conformational 
states TM values usually correlate with protein aggregation propensity. As such, proteins with 
higher TM values are generally thought to be less likely to aggregate or aggregate at a slower 
rate. It has been shown that it is possible to qualitatively rank protein formulations based on 
their TM at a given temperature and solution conditions (Sanchezruiz 1992).  
However, many proteins do not aggregate readily at, or even above their TM. This is the case 
for human interleukin-1 receptor antagonist (IL-1ra) whose TM is 63ºC but aggregation does 
not occur immediately at this temperature and was found to be almost totally reversible with 
CD analysis (Raibekas et al. 2005). As such using TM for the prediction of protein 
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aggregation propensity will not be reliable because higher TM does not necessarily correlate 
with a lower tendency to aggregate. For example, Perico and co-workers showed that 
increasing the pH of IgG2 MAb solution from pH 4.0 to pH 9.0 resulted in a more compact 
structure with higher thermal stability. However, this increase in pH also resulted in an 
increase in the rate of aggregation at 37ºC (Perico et al. 2009). This shows that changing the 
solution conditions can drastically change the aggregation propensity of a protein and it is 
often these solution conditions that control protein aggregation.  
However, TM can still be qualitatively useful for predicting aggregation propensity as TM it 
influences the aggregation rate of a given protein as a function of solution conditions. 
However, it cannot be used to quantitatively predict aggregation rates because it is at best 
only reflection of the contribution of conformational stability to protein aggregation rates 
(Roberts et al. 2011). 
 
6.3 Second Virial Coefficients 
The measurement of second virial coefficients, B22, has been identified as a method of great 
potential to quantify and predict protein-protein interactions in dilute solution. The use of B22 
data as a semi-quantitative tool for predicting optimal solution conditions for crystallisation is 
now well documented (George et al. 1997), (George and Wilson 1994), (Velev et al. 1998), 
(Bonnete et al. 1999), (Tessier et al. 2003), (Dumetz et al. 2007). Of course a precursor stage 
to crystal growth is the formation of critical nuclei in solution. Such nucleation events are 
intrinsically related to aggregation so it is not surprising that B22 data could potentially be a 
useful screening tool for predicting protein aggregation propensity, especially under varying 
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solution conditions that may be experienced during the purification process or in the final 
product formulation (See Section 4.1). Overall, the use of B22 for prediction of aggregation 
propensity has been largely qualitative and is based on trend analysis with changing solution 
variables.  
However, in terms of quantitatively predicting aggregation rates, it is important to remember 
that changing B22 values for a given protein will require changes in solution conditions. This 
can often change not only the B22 value (colloidal stability) but the TM value too 
(conformational stability), potentially in the opposite direction. In studies by Li and co-
workers (Li et al. 2010) and Sahin and co-workers (Sahin et al. 2010) the change from 
positive to negative B22 values corresponds well with a change from soluble aggregates to 
large insoluble particles. Although the latter was also found to have slower aggregation rates, 
probably caused by increased TM values which would mean – lower concentrations of 
(partially) unfolded monomers available to aggregate. As such, for obtaining predictions of 
protein aggregation rates using multiple potential predictors is advised.  
However, it is sometimes the case that this information will conflict, which is not surprising 
considering that changing conditions (or protein sequence) can mean that more than one stage 
of the aggregation pathway is affected at any point. Mathematical mechanistic models have 
been developed in an attempt to provide frameworks for quantitatively combining the effects 
of some or all of the stages of aggregation (Andrews and Roberts 2007), (Li and Roberts 
2009), (Pallitto and Murphy 2001). However, they have not been successful in predicting 
rates based purely on biophysical parameters such as TM or B22 or other analogous quantities. 
This failure can largely be attributed to the fact that none of these physical quantities captures 
the essential dynamics or time-scale(s) that govern the rate limiting step(s). As such this 
92 
 
could be why the techniques described have so far only been used for qualitative predictions 
or rankings of aggregation rates. 
 
6.4 Extrapolation or Interpolation of Measured Aggregation Rates 
Currently, in order to predict quantitative aggregation rates (i.e. an actual value for kobs or an 
analogous quantity) it is necessary to measure aggregation rates and use that information as a 
key to input to the predictions. This requires aggregation rates to be measured over a range of 
temperatures and pressures and/or solvent conditions to provide information regarding the 
intrinsic or inherent kinetics of aggregation. The measured experimental rates data can then 
be extrapolated or interpolated to provide a quantitative value for the overall rate of 
aggregation. This approach is currently the only way to determine the characteristic time 
scale(s) for the rate-limiting step(s) of aggregation as it cannot be predicted theoretically or 
monitored experimentally at present. Any measured aggregation rates include contributions 
from multiple steps simultaneously. Other approaches described previously (with the 
exception of “aggregation calculators”) focus mainly on the reversible processes of monomer 
unfolding and self-association (Weiss et al. 2009) or on the thermodynamic favourability of 
aggregate phase separation (Brummitt et al. 2011), (Li et al. 2010), (Sahin et al. 2010). 
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CHAPTER 7 
7 THESIS OBJECTIVES 
 
 
The manufacture of protein therapeutics in a cost effective and reliable fashion is a major 
international industrial challenge. One undisputable barrier to the timely and efficient 
production of protein pharmaceuticals is the formation of protein aggregates, which is an 
industry wide problem occurring in all phases of drug development. Aggregation is a major 
cause of economic and technical problems in the biotherapeutic industry. As such the 
technical ability to predict the propensity of a new biotherapeutic to aggregate (either natively 
or non-natively) in the early stages of product development would be a valuable tool for the 
limitation of aggregation in process and formulation development. This work aims to develop 
new analytical tools for the screening of proteins in aqueous solutions that are accurate and 
efficient in the prediction of protein aggregation. 
The first objective was to develop an improved method for measuring protein-protein 
interactions in solution, specifically B22 values. This objective will necessitate the 
development of improved experimental methods, and it is envisaged that the approach to be 
used will be based on self-interaction chromatography.  
The second objective was to assess whether B22 data are the best physicochemical descriptors 
for predicting the stability of proteins solutions to aggregation. A range of therapeutic and 
non-therapeutic protein systems will therefore be studied across a wide range of solution 
conditions wherein both B22 and aggregation behaviour will be quantified and correlated. 
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The third objective was to establish if SIC approaches could form the basis of a high 
throughput methodology for screening protein systems in order to identify solution conditions 
that minimise protein aggregation. Even though SIC approaches offer the useful data, it is not 
clear if these can form the basis of a rapid high throughput methodology as required by 
industry.  
 
  
95 
 
CHAPTER 8 
8 MATERIALS 
8.1 Lysozyme 
 
Figure 8. The structure of hen egg white lysozyme (Image from the Protein Data Bank) 
 
Lysozyme, an enzyme found in egg white, tears and other secretions is one of the most 
widely studied and best characterised of all proteins. Lysozyme is roughly ellipsoidal in 
shape and contains a large fissure in one side which is the active site of the enzyme with 
dimensions of roughly 4.5 x 3 x 3 nm. The primary structure of hen egg white lysozyme 
consists of a single polypeptide chain of 129 amino acid residues. Four pairs of cysteine 
molecules form disulphide bridges between positions 6 and 127, 30 and 115, 64 and 80, 76 
and 94 (counting from the N-terminal lysine). It has an alpha and a beta fold, consisting of 5 
to 7 alpha helices and a 3-stranded anti-parallel β sheet (Blake et al. 1965). Lysozyme has a 
relatively low molecular weight of 14.3 kDa and is a basic protein with an isoelectric point at 
pH 10.5-11.0. The hydrodynamic radius of lysozyme is ~ 1.9nm (Parmar and Muschol 2009). 
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All experiments were performed using hen egg white lysozyme (EC 3.2.1.17, mucopeptide 
N-acetylmuramylase, pI=11.0, molecular weight 14.3 kDa) purchased from Fluka Analytical. 
 
8.2 Catalase 
 
Figure 9. The structure of bovine liver catalase (Image from the Protein Data Bank) 
 
Catalase is a common enzyme found in virtually all living organisms exposed to oxygen.  
Catalase catalyses the conversion of hydrogen peroxide (a potentially harmful oxidising 
agent) to water and oxygen and is one of the most potent catalysts known with one of the 
highest turnover numbers of all enzymes at up to 200 000 events/second/subunit. It was one 
of the first proteins to be purified to homogeneity and has been studied extensively. It is a 
tetrameric enzyme composed of four identical, tetrahedrally arranged 60kDa subunits. Each 
subunit is consists of four polypeptide chains, each of over 500 amino acid residues. The 
active centre of each subunit contains a porphyrin heme group and NADPH (Figure 9). There 
are many different types of catalase and structures vary between them. Bovine liver catalase 
was used for the investigations in this thesis. Bovine liver catalase is not perfectly spherical 
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but slightly elongated and ellipsoid in shape with its active site deeply buried in the interior. 
Each monomer of bovine liver catalase contains 4 domains. The first domain consists of two 
α- helices and a large loop extending outwards, the second contains the heme moiety and a β-
barrel, several helical segments and various loops. The third domain lacks discernable 
secondary structure apart from 2 helices; the fourth and final domain is folded into 4 helices. 
Catalase is negatively charged with an isoelectric point of approximately (pI) pH 5.6. The 
hydrodynamic radius of the catalase tetramer is approximately 5.2 nm. All experiments were 
performed using bovine liver catalase, in the form of a lyophilised white powder (EC 
1.11.1.6, pI=5.4, tetramer molecular weight 250 kDa) purchased from Sigma Aldrich. 
 
8.3 Concanavalin A 
 
Figure 10. The structure of concanavalin A (Image from the Protein Data Bank) 
 
Concanavalin A is a member of a protein group known as lectins. Lectins react with specific 
sugar residues. Concanavalin A reacts with non-reducing α-D-mannatose and α-D-glucose. 
The conformation of concanavalin A is pH dependent. At pH 4.5 to 5.6 concanavalin A forms 
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a dimer but above pH 7.0 it is typically tetrameric. Each subunit is 237 amino acids in length, 
is heavily glycated and is approximately 26.5 kDa. Each concanavalin A monomer binds two 
metal ions, a transition metal (usually Mn
2+
) and Ca
2+
, both of which are necessary for 
saccharide binding. Structurally, each monomer contains two anti-parallel β-sheets. One 
formed from 7 strands the other from 6. There are only minor helical sections (Figure 10). 
The molecular weight of the tetramer is 104-112 kDa and the pI is between pH 4.5 and 5.5. 
The hydrodynamic radius of concanavalin A is roughly 3.3 nm as a dimer. The hydrodynamic 
radius of concanavalin A is roughly 3.3 nm as a dimer (Boss et al. 2012). All experiments 
were performed using concanavalin A from Canavalia ensiformis (Jack Bean), in the form of 
a lyophilised white powder (E.C. 234-258-2) purchased from Sigma Aldrich. 
 
8.4 Lactoferrin 
Lactoferrin, also known as lactotransferrin is a globular glycoprotein belonging to the 
transferrin family. It is a multifunction protein that is found in a variety of secretory fluids 
such as saliva, tears, milk and nasal secretions. The transferring proteins transfer Fe into cells 
to control the level of free Fe in the blood. Lactoferrin is also a component of the immune 
system and has antimicrobial, antifungal and antiviral activity (Gonzalez-Chavez et al. 2009). 
It exists in two forms, iron free apolactoferrin and iron rich hololactoferrin. Each lactoferrin 
molecule can reversibly bind two ions of iron, copper, zinc or other metals (van der Strate et 
al. 2001). Lactoferrin is composed of one polypeptide chain around 700 amino acids in 
length, folded into two homologous symmetrical lobes, denoted N and C. The two lobes are 
connected by a hinge region that provides extra flexibility to the molecules and contains parts 
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of an α-helix. The two lobes are composed of α-helix and β-pleated structures (Gonzalez-
Chavez et al. 2009).  It can exist in different polymeric forms ranging from monomers to 
tetramers. Lactoferrin is a basic protein with a high pI which theoretically is 9.4 and 9.5 for 
bovine and human lactoferrin respectively. Bovine lactoferrin has a hydrodynamic radius of 
roughly 3.3nm. However, experimental values reported have been shown to be around 8 nm 
for bovine lactoferrin and vary between 5.5 and 10.0 nm for human lactoferrin (Shimazaki et 
al. 1993). Lactoferrin can be purified from milk or produced recombinantly. The lactoferrin 
used in these investigations was recombinantly produced purified human (holo)lactoferrin, 
with a molecular weight of 89 kDa, supplied by Fujifilm Diosynth Biotechnologies in liquid 
form at a concentration of 100.7 mg/mL in phosphate buffered saline (PBS) consisting of 
15mM sodium phosphate and 50mM sodium chloride at pH 7.5 ± 0.2. 
 
 
Figure 11. The structure of human recombinant lactoferrin (Image from Protein Data Bank) 
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8.5 Anti-TNFα dAb 
Anti-tumour necrosis factor (TNF)α is a recombinant monoclonal antibody that targets 
tumour necrosis factor (TNF)α. TNFα a pro-inflammatory cytokine that is a principle 
mediator in a variety of inflammatory and autoimmune diseases such as rheumatoid and 
psoriatic arthritis, psoriasis, Crohns disease and ankylosing spondylitis. There are multiple 
registered anti-TNFα monoclonal antibodies serving this large and growing market. Antibody 
antigen binding usually takes place between paired light (VL) and heavy (VH) chain variable 
domains. These variable domains (half of the normal antigen binding site) were shown by 
Ward and co-workers (Ward et al. 1989) to display nanomolar binding affinities. This 
discovery lead the way to a new class of smaller antibody-based proteins, with possible 
advantages over traditional antibodies such as reduced immunogenicity, enhanced tissue 
distribution and lower manufacturing costs. These variable domains are known as domain 
antibodies or dAbs. The anti-TNFα dAb used in these experiments is the light chain in 25mM 
sodium acetate, 250mM sodium chloride buffer at pH 5.8. Anti-TNFα dAb, donated by 
Fujifilm Diosynth Biotechnologies (Billingham, UK), was received at 4.3 mg/mL in 25mM 
sodium acetate, 250mM NaCl at pH 5.8 buffer and was used without further purification. 
Purity was confirmed via ion exchange chromatography using an AKTA FPLC system (GE 
Life Sciences) with UNICORN software and gel electrophoresis with the Invitrogen 
NuPAGE SDS-PAGE Gel System. Protein concentrations were checked with UV absorbance 
at 280nm, measured using a Perkin-Elmer Lamba 4B spectrophotometer and with BCA 
protein assay. The extinction coefficient of the protein was between 1.557 and 1.546 mL/mg 
cm and was provided by Fujifilm Diosynth Biotechnologies (Billingham, UK). The 
molecular weight of anti-TNFα dAb is ~12kDa containing 108 amino acid residues and the 
theoretical pI is 8.66. 
101 
 
8.6 Buffer and Protein Solution Preparation 
The water used for preparing all buffer and protein solutions was deionised water processed 
by a Centra ELGA system. The pH was adjusted using hydrochloric acid or sodium 
hydroxide and measured using a Mettler Toledo FiveEasy pH meter. All solutions were 
filtered prior to use using 0.22µm filters from Millipore. Protein concentrations were 
determined using a Perkin Elmer Lambda 35 UV/Vis Spectrometer and a BCA protein assay 
kit (23227) from Pierce Biotechnology. Tris-borate-EDTA (TBE) buffer (T7527) was 
purchased from Sigma Aldrich.  
 
8.7 Other Materials 
Potassium phosphate, sodium cyanoborohydride, dibasic sodium phosphate, sodium nitrate, 
sodium bromide, sodium chlorate, sodium perchlorate, sodium sulphate, urea, sucrose, 
mannitol, L-arginine, ethanolamine, polyethylene oxide (PEO), hydrochloric acid and sodium 
hydroxide were all purchased from Sigma-Aldrich (ACS or BioXtra grade or suitable for 
electrophoresis). Sodium chloride, Sodium acetate trihydrate, glacial acetic acid and acetone 
were from Fisher Scientific and were of AR grade. Toyopearl AF-Formyl-650M 
chromatography particles (08004) were obtained from Tosoh Biosep.  
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CHAPTER 9 
9 METHODOLOGY 
9.1 Self-Interaction Chromatography 
For SIC theory see Section 3.1.4 
9.1.1 SIC Equipment  
Self-interaction chromatography measurements were performed using an Agilent 1100 series 
liquid chromatograph (Agilent Technologies, Cheshire, UK) consisting of a binary pump, 
degasser, autosampler, column temperature control unit and two variable wavelength 
detectors – one before and one after the column as shown in the schematic of the instrument 
set up below (Figure 12). 
Solvents were filtered through inlet filters, and the dissolved air in the solvents was removed 
with a Phenomenex Degassex model DG-4400 vacuum four-channel on-line degasser 
(Phenomenex, Torrence, CA). The LC system was controlled and data was collected using 
Chemstation software version Rev.A.10.02 for LC systems (Agilent Technologies. The 
lysozyme loaded stationary phase was slurry packed into an empty stainless steel LC column 
100mm long with an internal diameter of 4.6mm (Alltech Associates). The column ends were 
sealed with stainless steel end fittings and frit inserts.  
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Figure 12. Schematic of SIC equipment set up 
 
9.1.2 SIC Immobilisation and column packing 
The immobilisation of all proteins was based on a method described previously by Tessier et 
al (Tessier et al. 2002a). The protein of interest was immobilised onto Toyopearl AF-Formyl-
650M particles covalently via the surface-accessible carboxylic acid groups on the protein to 
primary amine groups on the surface of the chromatographic support. Approximately 3mL of 
Toyopearl particles were first washed with 250mL of deionised water on a glass frit with a 
0.2µm polyethersulfone membrane filter before being mixed with 10mL of protein solution. 
In order to catalyse the coupling, 90mg of sodium cyanoborohydride was added to the 
suspension and the reaction allowed to proceed overnight (~ 12 hours) on a rotary mixer. The 
beads were then washed with 200mL of buffer before the remaining active sites on the media 
were capped using 20mg of sodium cyanoborohydride and 15mL of 1M ethanolamine pH 8. 
The reaction was allowed to proceed for approximately 4 hours on a rotary mixer. The 
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protein loaded stationary phase was then slurry packed into the column and washed in situ 
with 100mL of the relevant buffer then 100mL of 1M sodium chloride and then once again 
with 100mL of the relevant buffer in order to remove any protein not covalently attached to 
the stationary phase. All buffers were filtered prior to washing with a 0.2µm pore size 
membrane filter. Samples were collected from the initial protein solution and each of the 
washes and in order to calculate the net amount of protein immobilised on the stationary 
phase by a mass balance in which the concentration of residual protein found in the washes 
was determined by UV spectroscopy at 280nm as well as directly via BCA protein assay. An 
average of the two results was used. When not in use the columns were stored in a pH 7, 
5mM sodium phosphate buffer at 4
o
C. Protein immobilisation densities used in this work 
were 33% or above as recommended by Tessier and co-workers (Tessier et al. 2002a). 
 
9.1.3 Experimental Conditions 
In order to determine the extent of dispersion or channelling (if any) in the packed bed a 
25µL pulse of 2% v/v dilute aqueous acetone was injected through a column filled with 
buffer and the resulting peak analysed for symmetry. A protein mobile phase was prepared by 
dissolving 15mg/mL protein in the same buffer (5mM sodium acetate pH4.5) and filtered 
with a 0.22µm pore size membrane filter prior to injection. Experiments were carried out at a 
laboratory temperature of 21
o
C+/-1
o
C. The column was equilibrated with buffer and 
injections were not initiated until the UV, pH and conductivity baselines were stable, 
typically 30 minutes. An experimental run consisted of injecting a pulse of dilute buffered 
aqueous protein and monitoring the absorbance at 280nm at the column exit until all of the 
mobile protein had emerged. A range of solute flow rates were used for both acetone and 
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protein injections and a flow rate of 5.0mL/min were used for the washing of the column. 
Acetone and protein injections experiments were repeated in triplicate to ensure the reliability 
of the results obtained. A range of injections sizes from 1 to 100µL and protein injection 
concentrations between 1 mg/mL and 50mg/mL were performed. 
 
9.1.4 Determination of the Osmotic Second Virial Coefficient 
Determination of the osmotic second virial coefficient B22 requires and is very dependent on 
the accurate measurement of the dead volume, V0, of the system. The dead volume is the 
interstitial space between the particles in the column as well as any other space in the 
instrument which is not column packing. Tessier et al (Tessier et al. 2002a) first pointed out 
that it is not appropriate to just use a small non-interacting molecule (e.g. acetone as used 
routinely previously) to measure the dead volume because proteins molecules are not able to 
access as much of the pore space of the chromatographic media.  
To this end, a second column, referred to as the dead column was prepared in the same 
manner as the lysozyme immobilised column except that the stationary phase was subjected 
to only the ethanolamine capping part of the procedure. This protein free column was used to 
measure the retention times of both acetone (Va) and protein (Vp) (under a range of 
conditions). To calculate the dead volume, Vo, the acetone retention time measured on the 
protein immobilised column is then multiplied by Vp/Va and the volume occupied by the 
immobilised protein molecules subtracted. For this calculation protein molecules are assumed 
to be spherical and the diameter is calculated from the molecular volume (Neal and Lenhoff 
1995). This value was also used to calculate the excluded volume (BHS = 16/3 πr
3
). The 
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density of immobilised protein is obtained by dividing the concentration of immobilised 
lysozyme (mass of protein/particle volume) by the porosity (volume of mobile phase/volume 
of particles) and the phase ratio (surface area/volume of mobile phase) of the column. Phase 
ratio data for the media used in this work was obtained from DePhillips and Lenhoff 
(DePhillips and Lenhoff 2000). 
Retention times for protein and acetone injections on all columns were determined using both 
peak maximum and first moment (or centre of mass) methodologies. B22 values were 
calculated as follows:  
B22
app
 = BHS – (k')/ (ρS ф’)      Equation 8.1 
Where k’ = (Vr - V0) / V0       Equation 8.2 
Where Vr is the retention volume of the protein and Vo is the dead volume.  BHS represents 
the excluded volume or hard sphere contribution. The total number of immobilised protein 
molecules per unit area is denoted by ρS and As is the total accessible surface area. ρs was 
calculated by dividing the immobilised concentration by the porosity (0.811 for Toyopearl 
AF Formyl 650M) and the phase ratio of one lysozyme molecule. The phase ratio is defined 
to be ф = As/ V0 which is the total surface available to the mobile phase protein. Retention 
times were measured on two columns with injections being performed in triplicate on each 
with the final B22 values averaged over both columns. In instances where there were outlying 
variances between the two columns under certain solution conditions B22 values were also 
measured on a third column. If the B22 values obtained for two of the columns were within 
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the average standard deviation the disagreeing measurement from the other column was 
excluded. 
 
9.2 Dynamic Laser Light Scattering 
For DLS theory see section 5.2. Dynamic laser light scattering (DLS) measurements were 
performed using a Beckman Coulter N4 Plus Submicron Particle Sizer instrument 
(www.beckmancoulter.com) at a temperature of 21
o
C with an error of +/- 0.2
o
C controlled 
with a Peltier controller. A 10mW, 632.8nm, helium-neon laser has been used to interrogate 
the protein solutions at a scattering angle of 90
o
. Prior to measurement all solutions were 
filtered with a 0.22µm filter to remove dust particles or any other particulate impurities. Salt 
and excipient solutions were prepared separately to protein solutions and only mixed 
immediately prior to measurement. The separately filtered solutions were rapidly mixed in 
appropriate ratios constituting 3mL total solution being placed in the UV grade plastic 
cuvettes. DLS measurements typically began within 30 seconds of solution mixing. Various 
buffers, salt types, concentrations and excipients were added. The final protein concentration 
in each experiment was 15mg/mL. Each measurement was repeated 10 times. Accumulation 
and analysis of the DLS data was performed with Microsoft Windows based software, PCS 
Control Version 3.01. Information produced includes mean particle size (nm), polydispersity 
index, diffusion coefficient (m
2
/s), counts/s, baseline error and overflow. 
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9.3 Nanoparticle Tracking Analysis 
Nanoparticle Tracking Analysis (NTA) is a relatively new technique for the measurement of 
particle size and concentration, implemented in the commercial Nanosight LM10 instrument. 
The sample is introduced into the viewing chamber and a finely focused laser is shone 
through a glass prism into the sample (See Figure 13). Particles illuminated by the beam are 
visualised using a conventional optical microscope and an image of the scattered light from 
the laser hitting the particles is captured by a CCD camera set on the microscope.  
 
Figure 13. Schematic of a Nanosight Instrument 
 
A video of the sample is recorded and then processed. Each individual particle is ‘tracked’ by 
the NTA software. So unlike more conventional light scattering techniques such as DLS, 
NTA can produce an image of the particles’ light scattering and be used to determine particle 
concentration. Particle concentration is estimated through the scattering volume (determined 
from the dimensions of the field of view at a given magnification) and the depth of the laser 
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beam.  Using the Stokes-Einstein equation, from molecules Brownian motion the software 
also calculates the molecules size. Another advantage of NTA over DLS is that particle size 
measured by DLS has a tendency to be biased towards larger particles that scatter light 
intensely. NTA has been shown to be very suitable for the analysis of protein aggregates 
(Filipe et al. 2010) and also gives the possibility of live monitoring of aggregation providing 
information on kinetics. 
Protein solutions were prepared in relevant buffers at a concentration of 10mg/mL. The 
solution was filtered with a 0.22µm filter. All buffers used were also filtered with a 0.22µm 
filter and the absence of contaminating submicron particles in solution was confirmed 
through visualisation in the Nanosight sample chamber. The solution was then diluted 500 
fold with buffer containing salt until the concentration was acceptable for Nanoparticle 
Tracking Analysis (NTA), i.e. between 10
7
 and 10
9
 total particles per mL. Particles were 
introduced into the Nanosight sample chamber within 5 minutes of mixing. The samples were 
injected in the sample chamber with sterile syringes (BD Plastik) until the liquid reached the 
tip of the nozzle. The instrument does not have the capability to control temperature but the 
temperature was measured for all experiments at ~21ºC. The sample was left to equilibrate in 
the chamber at room temperature for 30 seconds before beginning measurements. NTA 
measurements were performed with a Nanosight LM10 (NanoSight, Amesbury, United 
Kingdom), equipped with a sample chamber with a 640-nm laser and a Viton ﬂuoroelastomer 
O-ring.  
The software used for capturing and analysing the data was the NTA build 2.3. The shutter 
speed and gain of the camera were set to automatic as was the minimum track length (the 
minimum number of steps a particle must take before it is included in the particle size 
distribution plot). The focus was adjusted manually so that at any given time the majority of 
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particles on the screen were in focus. The samples were recorded for 90 seconds with a frame 
rate of 30 frames per second. The minimum expected particle size was set to 30nm and the 
expected polydispersity was set to high. The measurements of each sample were performed in 
triplicate.  
 
9.4 Capillary Electrophoresis 
Capillary electrophoresis (CE) also known as capillary zone electrophoresis (CZE) is a 
technique that separates molecules based on their differential migration of charged species by 
attraction or repulsion in an electric field. The separation is usually performed in narrow-bore 
fused silica capillaries of approximately 25 – 75µm internal diameter, typically filled only 
with a buffer solution. Electrophoretic mobility will depend on the size to charge ratio of the 
molecule being analysed and frictional forces. The velocity at which a molecule moves is 
directly proportional to the strength of the applied electric field. The greater the charge of a 
molecule the greater the force the electric field exerts. As such if two molecules are the same 
size the one with the greater charge will move faster in the electric field. However, larger 
molecules will move more slowly as greater frictional forces act on the molecule as it moves 
through solution. Therefore the electrophoretic mobility of a molecule depends on the charge 
to mass ratio. Two different sized molecules with the same charge to mass ratio should move 
through solution at the same speed.  
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Figure 14 Schematic of a Capillary Electrophoresis Instrument 
 
The instrument is relatively simple; it contains a source vial, destination vial and a capillary, 
all filled with aqueous buffer solution (electrolyte) (See Figure 14). The capillary is dipped 
into the sample vial and the sample is introduced into the capillary with pressure to induce 
capillary action. Initiation of migration is through application of the electric field between the 
source and destination vials (using a high voltage power supply). The fused silica capillaries 
used have silanol groups that become ionised in buffer to SiO
-
 ions and attract positively 
charged counterions which form two layers, a stationary and a diffuse layer. In the presence 
of an applied electric field the positive ions in the diffuse layer migrate towards the 
negatively charged cathode carrying the bulk solvent along with it creating an electroosmotic 
flow (EOF). It is important to note that all molecules whether positively or negatively 
charged are pulled through the capillary in the same direction by the EOF. Negatively 
charged species are attracted to the positively charged anode by get swept along with the bulk 
solvent to the cathode as well but at a slower rate. Positively charged species with the largest 
charge to mass ratios separate out first, followed by neutral species and then finally 
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negatively charged species with the smallest charge to mass ratios. The EOF can be altered 
by adjusting pH, viscosity, voltage, ionic strength and the dielectric constant of the buffer. 
Molecules are detected near the outlet of the capillary and displayed as an electropherogram 
which reports detector response to each molecule in peaks as a function of time.  
All experiments were performed using deltaDOT’s Peregrine-HPCE (High performance 
capillary electrophoresis) system with 512 pixel diode array detector, peltier air cooling and 
dual power supply (deltaDOT, London, UK). A fused silica capillary of 34cm (22 cm to the 
detector) and 50µm internal diameter (external diameter 375µm) was used. The temperature 
of experiments was controlled at 21ºC and UV detection was at λ 214nm. The capillaries 
were preconditioned with 1.0M NaOH for 20 minutes then water for 2 minutes. The 
capillaries were then washed with 0.1M NaOH (2 mins) and then buffer (5 mins) between 
each separation. The buffer used was x1 TBE pH 8.3 with 0.175% PEO. Samples of anti-
TNFα dAb were prepared in x1 TBE buffer at a 1 in 10 dilution containing various 
concentrations of urea or incubated overnight for ~ 12 hours at various temperatures. 
Separations took place at 14kV for 20 minutes. 
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CHAPTER 10 
10 THE ACCURATE MEASUREMENT OF SECOND VIRIAL 
COEFFICIENTS USING SELF-INTERACTION 
CHROMATOGRAPHY 
 
 
10.1 Introduction 
 
Due to its quick analysis time and use of small amounts of protein, Self-Interaction 
Chromatography (SIC) is becoming an increasing popular approach for determining B22 
values of bio-macromolecules. This section describes the best practise for calculating B22 
values from SIC chromatograms for aqueous protein solutions with more rigorous data 
analysis to provide more robust and more meaningful B22 values. A methodology is 
introduced for reporting both the mean and the variance in B22 as determined from SIC 
experiments. This method includes a correction in SIC peak shape due to normal longitudinal 
broadening, allowing the variance in B22 due to chemical effects to be quantified statistically.  
 
10.2 Good LC practice 
SIC is essentially like any other HPLC experiment and as such a number of good procedures 
that should be observed in HPLC investigations also apply to SIC. All buffers should be 
prepared freshly on the day required. This practice ensures that the buffer pH is unaffected by 
prolonged storage and that there is no microbial growth present. Changes in pH and microbial 
growth can affect chromatograph results (Kastner 2000). All HPLC solvents should be 
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filtered through a 0.45μm (or smaller) filter before use to remove any particulate matter that 
may cause column or frit blockages. After filtration, the solvents should be stored in a sealed 
reservoir to prevent contamination with dust. Pump plungers, seals and check valves will 
perform better and lifetimes will be maximised if filtered reagents are used. Before the 
freshly prepare mobile phase is pumped through the HPLC system, it should be thoroughly 
degassed to remove all dissolved gasses. 
The buffers should always be flushed from the analytical column and instrument after use to 
avoid salts being deposited on delicate frits, seals and other working parts. After the final run 
of the day it is advisable to flush the instrument with deionised, filtered water to remove any 
protein/buffer left in the system. In traditional HPLC experiments it is advised to store the 
column with a 50:50 mixture of water and methanol when not in use. Clearly this approach is 
not suitable for a protein containing columns so it proposed instead to pump water through 
the system at a low flow rate (~0.2ml/min) until next use or to store in a low salt buffer at 4
o
C 
to prevent salt precipitation and bacterial growth (Kastner 2000). The system should then be 
re-equilibrated with buffer ready for the next set of experiments. 
 
10.3 SIC Assumptions 
 
Calculation of B22 from SIC through Equation 3.6 and 3.7 (Section 3.1.4) incorporates a 
number of assumptions including: 
(i) the presence of spherical species 
(ii) no multi-body interactions between mobile and stationary phases 
(iii) mobile protein only interacts with one immobilised protein at a time 
(iv) that immobilised proteins retain their rotational freedom 
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(v) protein-protein interactions occur on a fully randomised basis, that is 
immobilised proteins are randomly orientated and therefore the former should 
occur. 
 
Also implicit within the above analysis is a 6th assumption that a single average value of B22 
is a sufficient measure of protein- protein interactions. Though clearly such mean field 
averages are popular and useful, the chemical heterogeneity of many protein systems implies 
that there exists a clear role for other more complex descriptors of B22 which allow some of 
the complex chemical heterogeneity of many protein-protein interactions to be described. 
 
It is also possible that some strongly binding impurities could compete with the protein in 
solution for the immobilised protein or that additives may irreversibly bind to the protein 
immobilised on the chromatographic support and accumulate over time to interfere with 
obtaining accurate B22 measurements. SIC may also sometimes produce overlapping 
chromatographic peaks that cannot be individually resolved. However, these problems were 
not observed in the current study which spanned many months of experimental work. The 
main reported concern (Tessier et al. 2002a), (Johnson et al. 2009) with this technique is the 
risk of loss of immobilised protein from the column or that exposure to certain solution 
conditions results in the denaturation of the protein immobilised on the column. However, the 
current study used a novel experimental set up with a variable wavelength detector present 
before and after the column (Yla-Maihaniemi and Williams 2007). This allowed a direct 
comparison between the UV/Vis absorption peak for the protein free in solution produced 
before entering the column with that post SIC. The total area under each peak can be 
calculated in order to determine whether the same amount of protein is leaving the column as 
was entering. As such, it allows us to determine whether any protein is being lost from the 
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column (peak area after the column is more) or has become irreversibly bound to the column 
(peak area after the column is less). 
 
10.4 Methods 
 
Lysozyme was dissolved in 0.1M postassium phosphate before being at pH 7.5 at 6.5mg/mL 
and mixed with Toyopearl AF-Formyl-650 M particles and immobilised and packed 
according to the protocol described in Section 9.1.2. B22 values were calculated via the 
method described in 9.1.4. The phase ratio used of one lysozyme molecule (radius 1.55nm) 
was 20.9m
2
/mL. All mobile phase solutions of lysozyme were buffered with 20mM sodium 
acetate at pH 4.5. 
 
10.5 Results and Discussion 
 
10.5.1 Peak Symmetry and Retention Times 
 
Peak asymmetry or tailed peaks are a common observation in all forms of chromatography. 
They are a significant feature of chromatograms and their presence can be crucial to the 
correct interpretation or analysis of the data. 
 
An examination of 18 recent papers on SIC revealed that for the vast majority of these 
papers, typical chromatograms were not reported in the paper nor were the retentions 
volumes computed using best chromatography practise; a centre of mass calculation (Table 3) 
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Table 3. Comparison of chromatogram analysis of 18 recently published papers on SIC 
Paper Ref. Protein(s)  
Studied 
Method of Peak  
Analysis 
Chromatogram  
Provided? 
Notes 
(Le Brun et 
al. 2010b) 
Humanised 
monoclonal IgG1 
antibody  
Peak Maximum No No mention of symmetry 
(Le Brun et 
al. 2009) 
Lysozyme Peak Maximum  Yes Quite good symmetry of peaks but some 
band spreading.  
(Ahamed et 
al. 2005) 
Lysozyme Peak Position used 
– methodology 
unclear 
No Discusses integrity of column, height to 
plate, shape and symmetry. Mentions 
reproducibility. 
(Dumetz et 
al. 2008) 
Ovalbumin, 
Catalase and 
ribonuclease A 
Unknown No No mention of symmetry 
(Johnson et 
al. 2009) 
Lysozyme Unknown Yes Good symmetry but not perfect, notably 
lysozyme worse than acetone and 
significant tailing with addition of NaCl 
(Lewus et al. 
2011) 
Monoclonal 
Antibody IDEC-
152 
Calculated by first 
moment to account 
for tailing. 
No  
(Teske et al. 
2004b) 
Lysozyme First absolute 
moment analysis 
No  
(Dumetz et 
al. 2007) 
7 proteins Unknown No  
(Tessier et al. 
2002a) 
Lysozyme Peak Maximum Yes Peaks shown for injection 
concentration. Peaks claimed to be 
Gaussian. Good symmetry but definitely 
not Gaussian. 
(Tessier and 
Lenhoff 
2003) 
Ribonuclease A Peak Maximum No  
(Berger et al. 
2005a) 
Calcium and 
Integrin Binding 
protein 
Unknown No  
(Valente et 
al. 2006) 
Pseudomonas 
Amylase 
Peak Maximum Yes  Peak broadening for proteins under salt 
and pH changes mentioned. 
(Valente et 
al. 2005b) 
Lysozyme Peak maximum Yes Symmetry quite poor. 
(Payne et al. 
2006) 
Enfuvirtide Peak maximum Yes Symmetry quite poor. Peak broadening 
evident. 
(Tessier et al. 
2002b) 
Myoglobin, 
Carboxymethyl 
BSA and BSA 
Peak Maximum No  
(Gabrielsen 
et al. 2010) 
Membrane 
protein LH1-RC 
Same as Tessier et 
al – can assume 
peak maximum 
Yes Quite poor peak symmetry. 
(Dong et al. 
2009) 
Native and 
denatured 
lysozyme 
Peak maximum Yes Claim Gaussian peaks were observed 
but in those shown some tailing is 
evident. 
(Berger et al. 
2005b) 
Membrane 
protein 
Does not say No Mentions that increasing salt 
concentrations coincide with increasing 
peak asymmetry 
 
 
In the vast majority of research published since the inception of SIC authors either do not 
describe the chromatogram analysis method used to obtain retention times, or almost 
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exclusively use a peak maximum for determining the retention time/volume. Classic 
chromatography theory is clear here that it is the first moment of the chromatogram which 
should be used for any physicochemical analysis of chromatograms (Conder and Young 
1979). In the case of fully Gaussian shaped chromatograms (peaks), then the first moment 
analysis and the peak maximum retention times/volumes will be coincident. However, as is 
reported here, though elution peaks obtained for dead volume measurement can indeed 
possess a high degree of Gaussian character, for the actual protein elution experiments true 
Gaussian peaks are very rare. An understanding and appreciation of this issue will be crucial 
for the development of SIC as a standard research method for B22 measurements. 
 
The peak maximum method describes the point on the peak at which the distance to the peak 
base measured in a direction parallel to the axis representing the detector response is a 
maximum. This technique assumes that the peak has a symmetric Gaussian shape (acetone 
peak, Figure 15), whereas almost all real world SIC chromatograms will not be (lysozyme 
peak, Figure 15), particularly those emerging from self-packed columns. There exist various 
chromatographic peak asymmetry ratios defined (Papai and Pap 2002), and here the ratio of 
the centre of mass retention volume to the peak maximum volume is used. Accurate 
determination of B22 should be based residence time of the peak, and the first moment 
analysis measures this characteristic. It is essentially the mean retention time taken from the 
centre of mass or centre of gravity of the peak and will be different from that measured at the 
peak maximum unless the peak is completely symmetrical. Lysozyme is the most extensively 
studied protein in terms of the osmotic second virial coefficient and for this reason was 
chosen for this study. 
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Chromatographic peak tailing is most commonly caused by a poor injection technique, the 
presence of dead volume in the solute flow path, the solute quantity being too large and 
overloading the column or detector, the residence time of the solute in the stationary phase 
not being long enough to achieve dynamic equilibrium or due to the solute retention 
behaviour being non-linear (Conder and Young 1979). 
 
The general expression for the n statistical moment     of a chromatographic peak is given 
by the below expression:  
 
 




0
0
dttc
dttt
m
n
n
     Equation 10.1
 
The first moment   is the centre of mass of the peak whilst the second moment, also known 
as the variance moment relates to the spread of the peak. The third and fourth moments refer 
to the asymmetry and the degree of vertical flattening respectively for the peak.  
 
 
Figure 15. SIC peak assymetry comparison for lysozyme and acetone. Normalised UV/VIS 
absorption appears on the same y scale for comparison (0.25M NaCl 20mM sodium acetate buffer 
pH 4.5, 10µL injections, 0.5mL/min flow rate) 
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Figure 15 shows both an injection used to determine column dead volume using acetone at 2 
%v/v and a SIC lysozyme chromatogram superimposed, for elution through a lysozyme 
immobilised column. The y axis scaling has been normalised. 
 
These two experiments were performed under identical flow, injection and temperature 
conditions with the two injection conditions chosen which exhibited virtually identical peak 
maximum retention times. This Figure highlights two interesting observations. Firstly, the 
clear non-Gaussian nature of the lysozyme SIC injection, which in this case corresponds to an 
asymmetry ratio of 15%. The second more intriguing observation is the fact that a significant 
number of the lysozyme molecules injected appear at shorter retention times than the dead 
volume injections. 
 
Figure 16. Retention of acetone and lysozyme on the dead column. Normalised UV/VIS absorption 
appears on the same y scale for comparison (0.2M NaCl 20mM sodium acetate buffer pH 4.5, 10µL 
injections, 0.5mL/min flow rate). 
 
Figure 16 shows data from the reference dead volume experiment on a packed column 
without immobilised lysozyme. There is small difference (0.17min) between the frontal edges 
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on the acetone and lysozyme chromatograms, with some limited tailing evident on the 
lysozyme peak. However, even taking this small difference into account, the data from Figure 
15 cannot be accounted for on this basis. Figure 15 shows a difference of >1.0min in the early 
appearance of the lysozyme front compared to that of the acetone front.  
 
10.5.2 Mobile Phase Flow rates 
 
Mobile phase flow rate has a significant impact on SIC system pressure, column efficiency 
and analysis time therefore one must choose a flow rate that is appropriate for the SIC system 
and column being used. Measurement of B22 should be performed at solution equilibrium, and 
therefore a higher than usual flow rate may adversely affect the quality of the 
chromatography. For example, at very high flow rates the mobile protein species may not 
have sufficient time to interact in an equilibrium fashion with the protein immobilised on the 
column. 
Regrettably, this is a common feature of much published work on physicochemical 
chromatography that researchers do not confirm the equilibrium nature of their retention data. 
This crucial question can be simply tested by evaluating the retention volume, or a derived 
property of interest, as a function of mobile phase flow rate. An example of such an 
experiment is shown in Figure 17. 
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Figure 17. The effect of flow rate on lysozyme B22 values measured by SIC and calculated via first 
moment and peak maximum methodologies (0.2M NaCl 20mM sodium acetate buffer pH 4.5, 10µL 
injections) 
 
Figure 17 shows that the mobile phase flow rate has a notable effect on the B22 values 
determined when the peak maximum analysis was used. It is also important to note that the 
first moment peak method of analysis significantly reduced this B22 variation. It can be 
concluded that the centre of mass based B22 values are much less susceptible to peak shape 
variations, especially as might be induced by flow rate changes or other experimental 
variations. As the centre of mass calculation is a weighted average of all of the measured 
data, as contrasted by the peak maximum approach which is essentially a selection of 1 datum 
point, this point is not a surprising conclusion. It is also noted that at very low flow rates, 
0.05mL/min, significant scatter in B22 values was observed and clearly data obtained with 
experiments conducted at such low flow rates must be considered with some care. 
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10.5.3 Peak Tailing 
 
From Figure 15 it is interesting to note that the acetone peak exhibits excellent Gaussian 
shape, with a peak asymmetry of less than 2%, and a standard deviation σ of the elution 
profile of less than 0.12 minutes. This therefore raises the question as to why the lysozyme 
peak shown in Figure 15 has a significant peak width (~5x greater) as well as very strong 
chromatogram tailing; this cannot be ascribed to normal equilibrium column processes such 
as longitudinal diffusion. The Gaussian nature of the dead volume peaks allows us to 
eliminate a number of the most common explanations for this peak broadening and tailing; 
column dead spaces and other kinetics factors related to the column and associated tubing. 
 
Fronting behaviour on the other hand is normally ascribed to an overloading of the mobile 
solute on the adsorption column. Further experiments with different injection volumes 
(Figure 18) show that the overall shape of the chromatograms is not significantly affected by 
injection size thus allowing us to conclude that fronting is not the specific reason for the 
faster elution times seen relative to the dead volume curves. Another potential explanation for 
the broadening of the lysozyme peaks in an enhanced level of longitudinal broadening of the 
lysozyme species as it transits the column in comparison with the acetone chromatogram. 
Naturally such an explanation is not logical and indeed the opposite would be expected for 
large macromolecules such as lysozyme compared to acetone. It was also considered that 
mass transfer within the pores of the media may be responsible for this result. However, if 
that were the case then this phenomenon should also be observed on the dead column. Figure 
16 clearly shows that this is not the case, so this possibility too was ruled out. This leaves us 
with the hypothesis that the shapes of the lysozyme chromatograms are directly related a non-
linear partitioning phenomena.  
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In this thesis the hypothesis will be advanced that this non-linearity reflects the heterogeneity 
of the SIC process being chromatographically characterised. That is, the chromatogram shape 
reflects not only the average B22 values being sensed, but also include details on the variance 
in the B22 values within the ensemble being tested. 
 
 
 
Figure 18. SIC peak assymetry comparison for different volumes of lysozyme injections (0.1M NaCl 
20mM sodium acetate buffer pH 4.5, 0.5mL/min flow rate) 
 
 
Tessier and et al (Tessier et al. 2002a) reported data for lysozyme which specifically showed 
non-Gaussian chromatograms as reported here with the additional observation that above a 
certain value retention times were independent of injection concentration but the 
chromatograms became more non-Gaussian with even longer retention times as the 
concentration of lysozyme injected decreased. It should be noted that the effect of lysozyme 
concentration was also dependent on immobilisation density (injection concentration has no 
effect on retention times at low immobilisation densities). However, at lower surface 
coverages lysozyme retention is strongly perturbed by non-specific electrostatic interactions 
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with the chromatographic matrix at low ionic strengths so this is not recommended for 
lysozyme B22 measurements. In my study of injection concentration dependence I observed 
the same effect. Using first moment analysis rather than peak maximum only makes the 
dependence effect more pronounced due to peak tailing (Figure 19). Figure 19 also illustrates 
that at injection concentrations where retention time would be perceived to be nearly 
independent of concentration by peak maximum methodology a very slight tailing of the 
chromatograms obtained results slightly increasing rentention times and hence B22 with first 
moment methodology but the effect is neglible. The same experiments performed on the dead 
column showed little effect on retention times of injection concentration. As such, 
interactions among mobile phase molecules cannot be held responsible for the non-linear 
retention behaviour. 
 
Figure 19. The effect of lysozyme injection concentration on B22 values (measured by SIC), 
calculated by peak maximum and first moment methodologies (0.1M NaCl 20mM sodium acetate 
buffer pH 4.5, 10µL injection, 0.5mL/min) 
 
In other physicochemical chromatographic approaches analogous to SIC, in particular inverse 
gas chromatography (IGC) (Charmas and Leboda 2000), such chromatographic behaviour 
would be ascribed to a non-linear retention process, in this case a non-linear adsorption 
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isotherm. Non-linear adsorption isotherms are commonly associated with gas phase 
heterogeneous surface chemical adsorption processes. A linear Henry’s law adsorption 
isotherm will give a single value of the adsorption partitioning coefficient (the Henry’s 
constant) whereas a non-linear isotherm means that the adsorption partitioning coefficient is 
concentration dependant and therefore non-single valued. In the current SIC context, a linear 
chromatogram with Gaussian peaks would yield to a single average value for B22. However, 
as non-Gaussian chromatograms are exceedingly common in SIC, the use of single average 
value for B22 seems to be inconsistent with such data. 
A number of workers have reported during the past 4 years new IGC methods for dealing 
with non-Gaussian chromatographic peaks in the context of measurement of the dispersive 
component of the surface free energy of solid state materials. Researchers have measured the 
heterogeneity in the dispersive component of the surface free energy of particulate materials 
based on non-linear gas adsorption behaviour (Yla-Maihaniemi et al. 2008), (Ho et al. 2010), 
(Gamble et al. 2012). These approaches move away from traditional methodologies reported 
in the previous 40 years which simply reported a single average value of the dispersive 
component of the surface free energy, dS, as the descriptor of materials surface interactions. 
These workers instead report a statistical range of dS values reflecting the surface chemical 
heterogeneity of their probed surfaces, highlighting the additional data chromatographic 
experiments provide. Such comments are relevant to our current discussion as dS and B22 
values are both related to the intermolecular interaction Hamaker constant A. In the case of dS 
there is a direct proportional relationship with A. In the case of B22, their values are ascribed 
to the sum of both attractive interactions (directly related to the Hamaker constant) as well as 
electrostatic interactions. It is concluded here that there are chromatographic precedents for 
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measuring experimentally the variations or heterogeneities in B22 as well as the average B22 
values usually reported. 
The two chromatograms shown in Figure 15 exhibit the same retention volume, based on a 
peak maximum analysis. However, this analysis can be misleading as a more detailed 
statistical analysis of the data shows the differences in both of the peak centre of masses, as 
well as the peak widths. Table 4 summarises the retention date for Figure 15 including a 1st 
moment analysis as well as the calculated standard deviation of the elution profile for both 
chromatograms. 
Table 4. Analysis of lysozyme SIC peak Shape Data from Figure 15 
 Peak Max.(min) 1
st
 Moment (min) Asymmetry Ratio Standard deviation  of the 
elution profile (min) 
Acetone 3.79 3.85 1.02 0.11 
Lysozyme 3.80 4.37 1.15 0.57 
 
 
It is clear from the asymmetry ratio shown in Table 4 for the lysozyme data that the use of a 
peak maximum analysis will result in a minimum error in the net retention volume of 15% in 
this study. When the dead volume correction is also factored in, this will result in even larger 
errors in B22. These corrections will direct effect the accuracy of B22 values obtained and are 
discussed in detail in Section 11. 
 
Tessier and co-workers (Tessier et al. 2002a) also observed that peak tailing became more 
pronounced when the pH conditions neared that of the pI of lysozyme and as ionic strength 
was increased. An example of the effect of increasing ionic concentration on chromatogram 
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asymmetry can be seen in Figure 20. The detailed data shown in Table 5 includes sets of 
summarised data for a series of lysozyme injections under a wide range of salt conditions. 
Columns E and F contain B22 data for both peak maximum and centre of mass based analysis. 
The relevant peak shapes for the rear and front boundaries were also analysed and the results 
were summarised in column G terms of standard deviation σ of the rear (-) and front (+) peak 
widths; σ+ and σ-. The normal level of longitudinal broadening for this work is approximated 
by the peak shape for acetone peaks summarised in Table 4. That is, a standard deviation of 
the peak widths σ of 0.11 min is used as a simple 0th order correction for all chromatographic 
data reported here. Data in column G is uncorrected for this normal longitudinal diffusion and 
the corrected data is reported in column H. Finally the corrected values for σ+ and σ- are 
added and subtracted from the mean B22 given in column F to give the range of B22 values at 
the one sigma confidence level. The data shown in column I highlights the wide range of B22 
values represented by the SIC data in normal operation. Peak shape variations are represented 
by σ+ and σ-, the standard deviation for the peak shapes. 
 
 
Figure 20. The effect of increasing ionic strength on SIC lysozyme chromatogram asymmetry 
(20mM sodium acetate buffer pH 4.5, 10µL injection, 0.5mL/min) 
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Table 5. Original and corrected values for B22 and retention data for Lysozyme (*B22 units - x 10
-4 
mL mol g-2) 
Column A B C D E F G H I 
 Dead 
Time 
(Peak 
Max) 
Dead 
Time 
(First 
Moment) 
Retention 
Time (Peak 
Max) 
Retention 
Time (First 
Moment) 
*B22 
(Peak 
Max) 
*B22 
(First 
Moment) 
σ
+
 and 
σ
- 
(min) 
σ
+
 and σ
- 
diffusion 
corrected 
(min) 
Range 
of *B22 
Mean +σ+ 
Mean -σ-   
0.5M 
NaCl 
3.61 3.60 3.81 4.23 -2.2 -7.0 σ
+ 
0.71 
σ
-
1.19 
σ
+
0.60 
σ
-
1.08 
0.0 
-18.0 
0.01M 
NaNO3 
3.61 3.60 3.12 3.40 5.4 2.3 σ
+
0.60 
σ
-
0.77 
σ
+
049 
σ
-
0.66 
7.0 
-5.0 
0.5M 
NaNO3 
3.61 3.60 4.19 4.68 -6.4 -11.9 σ
+
0.98 
σ
-
1.28 
σ
+
0.87 
σ
-
1.17 
-3.0 
-25.0 
1M 
NaNO3 
3.61 3.60 4.53 5.02 -10.1 -15.7 σ
+
1.03 
σ
-
1.55 
σ
+
0.92 
σ
-
1.44 
-6.0 
-32.0 
0.01M 
NaClO3 
3.61 3.60 3.24 3.47 4.1 1.4 σ
+
0.60 
σ
-
0.68 
σ
+
0.49 
σ
-
0.57 
-6.0 
-5.0 
0.1M 
NaClO3 
3.61 3.60 3.47 4.01 1.5 -1.7 σ
+
0.73 
σ
-
1.03 
σ
+
0.62 
σ
-
0.92 
5.0 
-8.3 
0.5M 
NaClO3 
3.61 3.60 4.18 5.09 -6.3 -12.8 σ
+
0.97 
σ
-
1.4 
σ
+
0.86 
σ
-
1.29 
-3.0 
-25.0 
0.8M 
NaClO3 
3.61 3.60 4.49 5.41 -9.7 -16.1 σ
+
1.02 
σ
-
1.85 
σ
+
0.91 
σ
-
1.74 
-6.0 
-35.0 
 
 
As useful as the average B22 values are, it is argued here that the spread in B22 values is also 
very important. Even for systems that are nominally very similar, say the data for NaClO3, 
the solution concentration of these ionic species can directly affect the heterogeneity of the 
protein-protein interactions measured. The chromatographic peak width, and thus the spread 
in B22 values, is ~2.5 times higher for 0.8M NaClO3 compared to 0.01M. Such highly 
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significant variations are not reflected in the mean values of B22 reported and represent real 
experimental variations in B22 values. 
 
The results listed in Table 5, and specifically column I, list a large range of B22 values at the 
first sigma confidence level. At first sight this range of values seems surprising. Can such a 
range of B22 results be possible? 
 
Grant (Grant 2001) has reported a detailed modelling study of the impact of various protein 
surface charging scenarios for lysozyme on B22 at 25ºC, pH 4.3 and 0.38 molar salt 
concentration; very similar conditions to those experimentally reported here. The author 
looked at a range of models of surface charging, taking into account specifically charge 
heterogeneity and charge fluctuations, and then used these models to predict B22 as a function 
of the Hamaker constant A. The data shows that the predicted B22 values fall on a curve 
which is a strong function of the Hamaker constant A. For lysozyme, a change in A from 4kT 
to 5kT in a 0.38M salt solution leads to a prediction that B22 will vary from 0 to -8. Local 
variations of +/-20% in A for a protein surface do not seem unreasonable based on our 
knowledge of the variations found in the dispersive surface energies of many organic 
crystalline materials (Heng et al. 2006). Therefore the range ΔB22 values reported in column I 
from 10 to 30 are not inconsistent with this data. Grant also concluded that charge patchiness 
and charge fluctuations, reduced the average electrostatic repulsion in solution, thus resulting 
in an enhanced overall attraction and more negative B22 values. 
 
The data shown in the bottom 3 rows in Table 5 shows the effect on concentration of NaClO3 
on the spread of B22 values. At a concentration of 0.01M from column I, the ΔB22 values are 
~10, increasing to ~30 units (x 10
-4
 mL mol g
-2
) for 0.80M, implying a much higher 
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enhancement of B22 variability in the more concentrated salt conditions. This implies a 
chemical electrostatic contributing factor to the observed variations in B22. 
 
Increase salt concentrations will result in increased salt screening of ionisable protein groups 
on lysozyme, resulting in decreased repulsive electrostatic interactions on average. Of course, 
locally on the protein surface, the degree of charge screening will be strongly correlated to 
the pI’s and the local charge status for the specific functional nucleic acids and side chain 
groups present e.g. lysine, aspartic, arginine etc. For example, at a pH of 4.5 glycine and 
lysine will be both positively charged, whilst glutamic and aspartic acid will be negatively 
charged. So though increasing salt concentrations will increase overall average surface charge 
screening, logically this charge screening could well be subject to significant local variations 
by its very nature. These local variations in shielding and therefore local electrostatic 
heterogeneity on the protein surface could well result in increased variations in B22 values. In 
this case the attractive van der Waals interactions will become more dominant resulting in 
more negative B22 values. In future studies it is planned to investigate this hypothesis in 
detail. 
 
 
10.6 Conclusions 
 
SIC chromatograms for lysozyme typically exhibit significant levels of peak asymmetry. This 
asymmetry is ascribed to the heterogeneous nature of the protein-protein interactions and 
such chromatograms require rigorous chromatographic analysis. Methods are described here 
for the measurement of both average and the standard deviation in B22 values at the 1 sigma 
confidence levels, having corrected the data for normal longitudinal chromatogram diffusion. 
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A wide range of statistically significant values for B22 were reported for a series of different 
buffer/salt solution conditions for lysozyme. A range of recommendations for best SIC 
practise is also proposed in the current work. 
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CHAPTER 11 
11 FIRST MOMENT SIC METHODOLOGY FOR MORE ACCURATE 
PREDICTION OF LYSOZYME ASSOCIATION BEHAVIOUR 
 
11.1 Introduction 
Protein aggregation is known to occur at every stage of the production process. Despite many 
technical advances in recent years, it is still a significant obstacle to biopharmaceutical 
product development and has become a major cause of economic and technical problems in 
the biotechnology and pharmaceutical industries (Cromwell et al. 2006). Therefore, the 
ability to predict, minimise, restrict or ideally reverse protein aggregation is crucial to the 
viable manufacture and formulation of biotherapeutics. Section 6 of this work provides 
information on the current methods of predicting aggregation propensity. The measurement 
of second virial coefficients, B22, has been identified as a method of great potential to 
quantify and predict protein-protein interactions in dilute solution. Currently, the use of B22 
for prediction of aggregation propensity has been largely qualitative and is based on trend 
analysis. In this section we analyse whether the use of first moment analysis on SIC 
chromatograms to determine B22 can help provide more robust and meaningful values for 
semi-quantitative prediction of aggregation propensity. 
Lysozyme was chosen as a model protein because its structure and properties are well known. 
It has been widely used in virial coefficient and aggregation studies, making it possible to 
draw comparisons with other studies on protein stability. Second virial coefficients for 
lysozyme have been reported with a variety of different techniques, most frequently either 
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static light scattering (George and Wilson 1994) or self-interaction chromatography (Tessier 
et al. 2002a). While the similar trends are seen, there is however a notable spread in the 
results reported. A paper by Ahamed et al (Ahamed et al. 2005) proposed that these 
variations may be due to the source and hence differing purity levels of egg lysozyme, the 
measurement technique used, experimental error or minor differences in solution conditions. 
However, it concludes that a major factor in these variations is that due to the involvement of 
only weak protein discrepancies in measuring parameters (dependent on technique) leads to 
substantial differences in B22. For SIC these inherent inaccuracies may arise from the 
assumptions discussed in Section 10.3. Other uncertainties come from experimental errors 
such as errors in the estimation of retention volumes and errors in determining the 
concentration immobilised on the column. Ahamed et al calculated that these inaccuracies 
could lead to differences in B22 of up to an overall maximum of ± 1 x 10
-4
 mol mL g
-2
.  
Hence, the accuracy in the employed measurement technique is vital. Almost all published 
SIC work uses peak maximum methodology and it has been recently argued that to obtain 
more accurate retention times good chromatographic analysis practice dictates that first 
moment methodology should be used in data analysis (Conder and Young 1979). This work 
postulates that using first moment methodology gives far more meaningful B22 values as 
small differences in retention times can result in massive differences in B22 values.  
 
11.2 Methods 
See Section 9.1. All mobile phase solutions of lysozyme were buffered with 20mM sodium 
acetate at pH 4.5 and 20mM sodium phosphate at pH 6.0 to pH 8.0. 
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11.3 Results and Discussion 
 
Figure 21. Comparison of peak maximum and first moment B22 values for lysozyme measured in 
this work and by 5 other authors under similar buffer conditions (20mM sodium acetate buffer pH 
4.5, 10µL injection, 0.5mL/min) with increasing concentrations of NaCl 
 
Figure 21 shows reported lysozyme B22 values from different published works for SIC under 
the same or similar solution conditions showing the effect of increasing sodium chloride 
concentration on B22 values. It also displays the difference between the B22 values obtained in 
this work using peak maximum and first moment methodologies for calculation of retention 
times from the same chromatograms. While the results of analysis with peak maximum 
methodology are in good agreement with results from other authors, using a first moment 
analysis gives significantly more negative virial coefficient values but follows the same 
overall trend. Using the peak maximum is an underestimate of retention time that results in an 
overestimate of B22, consistent with the observed discrepancies. The difference between the 
B22 values calculated using first moment and peak maximum methodologies becomes 
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increasingly large with increasing ionic concentration due to increased peak asymmetry or 
tailing observed in chromatograms under these conditions, an effect that has observed in 
other studies (Tessier et al. 2002a).  
In order to better understand whether these measured interactions give B22 values 
representative of observable protein aggregation behaviour, DLS experiments were 
performed to track the particle size of lysozyme molecules under the identical solution 
conditions. The following solution conditions were investigated: 
a) Changes in ionic strength  
b) Differences between various salts of the Hofmeister series 
c) Solution pH  
d) Effect of pharmaceutical excipients in solution (sucrose, arginine, trehalose) 
e) Changes in the PEG concentration and PEG molecular weights 
 
11.3.1 Ionic Strength and the Hofmeister Series 
Increasing ionic strength modulates downwards the electrostatic interactions between the 
charged groups within the protein as well as those between protein molecules. Even the 
addition of low concentrations of cations and anions will shield electrostatic repulsive forces 
between solvated protein molecules, and thus reduce electrostatic inter-protein repulsive 
forces. As a direct consequence, the colloidal stability of these protein systems is reduced in 
line with classical DVLO theory (Section 2.4). Ion type present in solution also has an effect 
on protein-protein interactions. The Hofmeister series (Hofmeister 1888) ranks the relative 
influence of different cations and anions on protein-protein interactions. In Hofmeister’s 
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original studies ions were arranged according to their ability to precipitate or “salt out” 
proteins. However, the Hofmeister series ranks the relative influences of ions not just based 
on salting-out effectiveness, but is relevant to a wide variety of aqueous processes including 
protein aggregation, crystallisation and solubility. The typical orders of the ions of the 
Hofmeister series in order of decreasing salting-out capacity can be seen in Figure 1. 
However, it should be noted that this series is empirical determined and not all proteins 
conform to this prediction, being highly dependent on both solution pH and the isoelectric 
point of the specific protein. 
The ion specific effects of the Hofmeister series are not well understood fundamentally. 
Originally it was thought that the solution presence of selected ions influence on protein 
properties was mainly caused by the “making” or “breaking” of the bulk water structure by 
kosmotropic and chaotropic respectively properties of the ions (Zhang and Cremer 2006). 
Ions to the left of the series are commonly described as kosmotropes and those towards the 
right as chaotropes (Figure 1). Kosmotropic species, by strengthening water structure 
decrease the solubility of proteins but at the same time have been proposed to stabilise 
proteins because the entropic cost of hydrating intermediate and native structures is greater 
than that for the native structure. They make water a poorer solvent and as such 
conformations that minimise the surface area of the protein are favoured. Ions that “break” 
water structure have the opposite effect, increasing the solubility of proteins and favouring 
unfolded or denatured protein conformations. While it has been shown in numerous 
experimental studies that kosmotropes and chaotropes do indeed have these effects on protein 
behaviour, it is now thought that the effects of bulk water structure are not central to this 
phenomenon. Instead, new models have been developed that indicate that the ion specific 
effects on protein behaviour depend upon direct ion–protein interactions as well as 
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interactions with water molecules in the ﬁrst hydration shell of the protein (Zhang and 
Cremer 2006). 
It has been widely demonstrated that the choice of anion has a much more pronounced effect 
than that of the cations on protein interaction.  Therefore anions are the focus of this current 
study. The cation used in this study was sodium as it is frequently reported in literature, 
commonly used in biopharmaceutical applications and is approximately in the middle of the 
cationic Hofmeister series.  
 
Figure 22. Lysozyme B22 values measured with SIC over a range of ionic strengths and salt types 
(20mM sodium acetate buffer pH 4.5, 10µL injections, 0.5mL/min flow rate). Open symbols signify 
that under the same conditions no aggregation was observed with DLS and closed symbols that 
aggregation was observed  
 
Hofmeister effects are strongest at high ionic concentrations (Curtis et al. 2002) with the salt 
concentrations used for protein precipitation being typically up to 3.0 M but are also 
important at intermediate salt concentrations;  0.01 to 1.0 M. (Tadeo et al. 2007). However, 
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for biotherapeutic and bioprocessing applications high salt concentrations are of minor 
importance since typical processing conditions tend to use much lower salt concentrations.  
For this reason this study focuses on the low to intermediate salt concentrations more relevant 
to the biopharmaceutical industry. 
Figure 22 shows the variation of B22 as a function of different ionic strengths of several salt 
types between 0.1M and 1.0M. Error bars are not shown for B22 values but are typically 
smaller than the data points used in Figure 22. For all salt types evaluated B22 values decrease 
monotonically with increasing ionic strength, indicating that attractive lysozyme-lysozyme 
interactions are becoming increasingly dominant because the proteins charge is increasingly 
screened with increasing ionic strength (Retailleau et al. 1997), (Retailleau et al. 2002).  
 
In the case of NaCl, (for comparison to other literature values) at low ionic strengths B22 
values were positive but a change in sign was observed at a NaCl concentration of 
approximately 0.20M NaCl when using first moment methodology for calculation of B22. 
Using peak maximum analysis B22 remained positive until a concentration of approximately 
0.35M NaCl in this investigation, whilst on average B22 values in literature could be 
approximated to become negative at about 0.40M. In order to determine at what 
concentration lysozyme aggregation is induced by NaCl the same solution conditions were 
studied using DLS to track particle size. Particle size is used here as a general measure of 
lysozyme aggregation behaviour. However, of course protein aggregation can be driven by 
vastly different mechanisms or processes and further analysis would be required to ascertain 
whether this eventually leads to amorphous sub-visible aggregation, liquid-liquid phase 
separation, precipitation, and gelation or crystallisation phenomena. Although in the 
“crystallisation slot” it would be expected that lysozyme self-assembly is due to 
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crystallisation whilst at B22 values more negative than the crystallisation slot then amorphous 
protein aggregation, precipitation and gelation would be more expected.  
 
The DLS results in Figure 24 show initial particle size of lysozyme solutions as a function of 
different ionic strengths of several salts between 0.1M and 1.0M using the same conditions 
that B22 values were measured under.  For reasons of clarity error bars are not included in 
DLS data but typical variations are around 10-20% of measured particle size. At around pH 
<~5.0 lysozyme has been reported to exist in monomeric form where its hydrodynamic 
diameter can be expected to be approximately 4 nm (Perez et al. 1999). Particle sizes larger 
than this dimension indicate the presence of some level of protein aggregation. It would 
therefore be predicted that negative B22 values should correlate with this increased particle 
size. Open symbols in Figure 22 denote no aggregation observed with DLS, whereas closed 
symbols indicate the presence of aggregated particles observed immediately after mixing. It 
is interesting to note that almost all of the negative virial coefficients correlate with observed 
protein aggregation behaviour and the reverse is true for the positive virial coefficients. 
 
Considering the B22 data for lysozyme with NaCl published by other workers as well as the 
data from this study analysed using the peak maximum method (Figure 21), it is clear that B22 
values in almost all cases do not become negative until concentrations of typically 0.40M or 
greater in NaCl. However, DLS data shows that at just half this concentration, 0.2M, the 
onset of aggregation can be clearly observed. However, retention times analysed using first 
moment methodology shows that B22 passes through 0 at 0.2M NaCl and clearly correlate 
much better with aggregation behaviour for these solutions. Broadly speaking a good 
correlation can also be observed between B22 values and aggregation kinetics examined using 
DLS of all solution conditions investigated. Those ionic concentrations and ion types 
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responsible for the greatest aggregation rates correspond to those with the most negative B22 
values; the same is also true respectively for the salt conditions under which lysozyme 
remained most stable.  
 
Figure 23. Initial hydrodynamic radius of lysozyme upon mixing in solutions of various ionic 
strengths and types (20mM sodium acetate buffer pH4.5) 
 
More specifically, looking at the data for sodium chloride and sodium iodide, the beginnings 
of aggregation can be observed at 0.20 M and 0.05 M concentrations respectively, with 
average particle sizes of 24 nm and 33 nm respectively. The second virial coefficient values 
measured for lysozyme at these concentrations were -0.13 and -1.13 x10
-4
 mL mol g
-2
. This 
data is just beginning to enter into the negative B22 range where attractive intermolecular 
forces dominate. The same trend is evident for sodium sulphate, sodium nitrate, sodium 
chlorate. The correlation between increased initial particle size and hence aggregation rates 
with increasingly negative virial coefficient values (as shown in Figure 24)  is strong enough 
that the results could be considered at the minimum to be semi-quantitative.  
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As can be seen from the data in Figure 22 and Figure 23 the second virial coefficient 
measurements and observed aggregation behaviour of lysozyme at pH 4.5 show that this 
protein follows a reverse Hofmeister series at this pH and that anions such as iodide and 
chlorate very effectively induce protein association. This effect was originally described by 
Ries-Kautt and Ducruix (Rieskautt and Ducruix 1989) who attributed this phenomenon to the 
effectiveness of anions in promoting protein crystallisation, which is dependent on the net 
charge of the protein. Therefore, acidic proteins can be expected to follow the salting-
in/salting-out effects of the Hofmeister series, while for basic proteins like lysozyme the 
effect and order are reversed. In a systematic study using small angle X-ray scattering 
(SAXS), Finet et al (Finet et al. 2004) demonstrated that a Hofmeister reversal for pH<pI is 
observed not only for lysozyme but for a range of small proteins including crystallins and 
BMV. 
 
Figure 24. Correlation between SIC measured B22 values and initial hydrodynamic radius of 
lysozyme measured in salt solutions of varying concentration and ion type (20mM sodium acetate 
buffer pH 4.5) 
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11.3.2 pH 
The effect of pH on protein-protein interactions was not considered by Hofmeister (1888) as 
the concept of pH was not introduced until 1909 by Sørenson. However, pH affects the 
protonation state of charged groups on the protein surface and is clearly a very important 
consideration. pH can have a notable impact on protein-protein interactions as it changes the 
charge distribution of the protein and modifies the magnitude and geometry of ionic 
interactions. Figure 25 shows the effect of solution pH on B22 over a range of NaCl 
concentrations. Increasing pH results in increasingly negative B22 values but the effect of 
NaCl on B22 values at higher pH becomes reduced as the pH approaches the pI of lysozyme; 
pH 11.0. At a pH of 11.0 lysozyme would exhibit a overall neutrally charge and therefore 
increasing the pH progressively reduces the surface charge of lysozyme and as a result the 
electrostatic charge screening effect is reduced  
 
Figure 25. The effect of pH on SIC measured B22  values of lysozyme as a function of increasing NaCl 
concentration (20mM sodium acetate buffer at pH 4.5 and 20mM sodium phosphate buffer at pH 
6.0 - 8.0, 10µL injection, 0.5mL/min) 
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11.3.3 Pharmaceutical Excipients 
 
Protein stability can be improved by the use of certain solution excipients which include 
amino acids, polyols and sugars, and surfactants. For example, non-ionic surfactants are 
added to protein solutions to prevent aggregation, though they often cause a reduction in 
protein thermodynamic stability (Chi et al. 2003b). Surfactants generally do not interact with 
the protein directly (Hoffmann et al. 2009). Polyols and sugars have been reported to stabilise 
proteins through the mechanism of preferential exclusion from the protein surface (Lee and 
Timasheff 1981). The disaccharides sucrose, mannitol and trehalose are naturally occurring 
osmolytes that have been shown to stabilise protein structures in this manner. The mechanism 
is through the disaccharides which exhibit preferential interaction with water. This causes the 
disaccharides to migrate away from the surface of the protein creating an excluded volume 
that is proportional to the protein’s solvent exposed surface area. As these excipients are 
depleted in the protein domain, the protein surface is thus enriched in water. In turn the 
proteins favour the most compact conformation in the native state ensemble. Most amino 
acids are known to stabilise proteins also by preferential exclusion, however, two amino 
acids, arginine and histidine are reported to stabilise protein due to their weak binding 
capacity (Arakawa et al. 2007), (Katayama et al. 2006).  
Figure 26 and Figure 27 show the B22 values of lysozyme under various concentrations of 
four well known pharmaceutical excipients often used as stabilisers (Sucrose, Mannitol, 
Arginine and Trehalose) at two different NaCl concentrations known to induce protein 
aggregation. 
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Figure 26. The effect of various concentrations of arginine, sucrose, mannitol and trehalose on the 
SIC measured B22 of lysozyme solutions destabilised by the addition of 0.50M NaCl (20mM sodium 
acetate buffer pH 4.5, 10µL injection, 0.5mL/min) 
 
 
Figure 27. The effect of various concentrations of arginine, sucrose, mannitol and trehalose on the 
SIC measured B22 of lysozyme solutions destabilised by the addition of 0.75M NaCl (20mM sodium 
acetate buffer pH 4.5, 10µL injection, 0.5mL/min) 
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It can be seen from the B22 values in Figure 26 and Figure 27 that the presence of all these 
excipients do contribute some stabilising effect on lysozyme solutions. The addition of NaCl 
increases attractive hydrophobic interactions (Curtis et al. 2002). Notably high sucrose and 
trehalose compensate greatly for the charge screening effect of the NaCl at 0.50M 
concentration and nearly stabilise lysozyme to a point where no aggregation would be 
expected. The effect is achieved as the presence of this cosolvent favours the proteins most 
compact form, reducing protein volume but also surface hydrophobicity. These results are 
comparable to the data reported by Valente et al (Valente et al. 2005b).  
 
 
Figure 28. The correlation between SIC measured B22 values and initial hydrodynamic radius of 
lysozyme measured by DLS in solution with various concentrations of arginine, mannitol, sucrose 
or trehalose and either 0.50M or 0.75M NaCl (20mM sodium acetate buffer pH 4.5) 
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Figure 28 shows all of the data obtained in this section with aggregate size plotted as a 
function of B22. Not only is there an excellent linear correlation for this data set, but the data 
crosses the origin within 0.3 B units.  It can be concluded that this data shows that B22 is an 
excellent predictor for protein solution aggregation propensity of excipient stabilised 
solutions, with critical values of B22 lying in the range of -1 to 0 x 10
-4
 mL mol g
-2
.  
 
11.3.4 Polyethylene Glycol 
 
Figure 29. The influence of PEG molecular weight on B22 of lysozyme solutions (measured by SIC) 
as a function of increasing concentration (20mM sodium acetate pH 4.5, 10µL injection, 
0.5mL/min) 
 
Polyethylene glycols (PEG) are generally known as protein precipitating agents. The 
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4.5. Under the tested solution conditions, the B22 values were all positive for the three tested 
PEG qualities with molecular weights of 6000, 4000 and 400 g/mol (Figure 29). Increasing 
the PEG concentration led to further increased B22 values. These findings are in agreement 
with trends observed by Le Brun et al (Le Brun et al. 2010a). Under these conditions protein 
precipitation could be assumed to be unlikely and indeed DLS experiments showed that 
lysozyme remained in its monomeric state.  The presence of PEG 400 showed little or no 
effect on B22 values in concentrations between 0 and 25 % PEG 400. However, it has been 
shown by Tessier et al (Tessier and Lenhoff 2003) that for certain solution conditions, PEG 
can also act as a precipitation reagent.  
 
11.4 Conclusions 
In this Chapter, it has been demonstrated that B22 measurements can provide a high-
throughput tool for predicting the aggregation stability of proteins and for screening studies 
to identify solution conditions that minimise protein aggregation. I have also shown that use 
of first moment analysis of self-interaction chromatographic peaks provides more accurate 
B22 values reflected by improved correlation with observed protein aggregation behaviour. In 
support of my thesis, I have presented DLS aggregation data for lysozyme in different 
solutions along with the corresponding B22 of lysozyme-lysozyme interactions under those 
conditions. Comparisons between measured B22 values and measured protein aggregate sizes 
gave good linear correlations for a range of systems including excipient-protein solutions, 
and B22 values of <0 x 10
-4
 mL mol g
-2
 were found to be good predictors of protein 
aggregation propensity.  
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CHAPTER 12 
12 THE SECOND VIRIAL COEFFICIENT AND AGGREGATION 
BEHAVIOUR OF THREE MODEL PROTEINS 
 
 
12.1 Introduction 
 
So far this thesis discusses the B22 values of proteins. However, B22 has units of volume mol
-1
 
mL
-1
 g
-2
 (as is apparent from Equation 12.1) and therefore its value is dependent on the 
molecular weight of the protein. Molecular weights used for lactoferrin, catalase and 
concanavalin A were 89kDa, 250kDa (tetramer) and 102kDa (tetramer) respectively. As 
such, it is more appropriate for comparison of different proteins to be made in terms of the 
dimensionless second osmotic virial coefficient (b2). B22 can be related to b2 through the 
following equation (Bonnete and Vivares 2002); 
Equation 12.1 
In this equation b2 is normalised by the excluded volume contribution of a sphere of equal 
volume B2
HS
 which is simply four times the molecular volume. Na is Avogadro’s number, Mw 
is the weight average molecular weight and σ is the equivalent diameter of the protein, which 
can be calculated from its correlation with molecular weight (Neal and Lenhoff 1995). The 
values used for lactoferrin, catalase and concanavalin A, calculated from their molecular 
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weights, were 5.5nm, 7.9nm and 5.9nm respectively. The b2 values can easily be converted to 
B22 using the protein molecular weights (Section 8). 
This work presents b2 and particle size measurements for three model proteins with very 
different solution behaviours compared to lysozyme which are intended to determine whether 
there is a broader basis for the observed correlation between the second virial coefficient and 
protein aggregation. In this section b2 is measured for lactoferrin, catalase and concanavalin 
A under various solution conditions. Concanavalin A and catalase both have similar pI’s of 
between pH 4.5 and 5.5 and pH 5.4 respectively, whilst lactoferrin is basic protein with a pI 
~8. Catalase is the largest molecule at 250kDa in its tetrameric form. Lactoferrin and 
concanavalin A are much smaller proteins at 89 kDa and 102 kDa (tetrameric form) 
respectively. 
 
12.2 Method 
Proteins were immobilised onto Toyopearl particles and packed into a column through a 
method similar to that described in Section 9.1.2. Between 70 and 110 mg of each protein 
were dissolved 10 mL of solution (Lactoferrin in 20mM phosphate pH 7, Catalase in 5mM 
MES pH 6.5 containing 0.1M NaCl, Concanavalin A 20mM sodium acetate pH 4.5). 
Immobilisation reaction was catalysed with EDC (Sehgal and Vijay 1994) for catalase and 
concanavalin A and lactoferrin with sodium cyanoborohydride. All experiments were 
performed using the equipment and techniques described previously, including B22 
calculations (Section 9.1). The phase ratios used for lactoferrin, catalase and concanavalin A 
were 15.96 m
2
/mL, 13.52 m
2
/mL and 15.53 m
2
/mL (interpolated from the work of 
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(DePhillips and Lenhoff 2000). Experiments were carried out for each protein to assess the 
effect of and optimise flow rate, injection concentration and size. Flow rate used for all 
experiments was 0.5mL/min, and injection concentrations and volumes used were 15 mg/mL 
and 10 µL. Unless otherwise specified the buffer used is 20mM sodium phosphate at pH 7.0.   
DLS experiments were carried out by the same method described in Section 9.2. 
 
12.3 Experimental Results 
12.3.1 Effect of Salts 
Figure 30 illustrates that protein-protein interactions can be either repulsive or attractive over 
a wide range of ionic concentrations (0.01 – 1.50 M NaCl). Lactoferrin b2 values remain 
strongly positive at all NaCl concentrations right up to 1.50M NaCl suggesting that 
lactoferrin is very stable and that protein-protein interactions are repulsive under these 
conditions; NaCl has little or no effect on protein interactions.  
At low ionic strengths b2 values for catalase and concanavalin A are notably very negative 
indicating that protein-protein interactions would be expected to be strongly attractive. Upon 
an initially increasing NaCl concentration, b2 increases indicating a decrease protein-protein 
attractive interactions. However, at about 0.3M the behaviour of catalase and concanavalin 
begins to diverge. Between 0.30M and 0.60M NaCl b2 for concanavalin A becomes positive 
suggesting that protein-protein interactions under these conditions would be expected to be 
repulsive. Above 0.60M NaCl b2 values become increasingly negative again and by 1.50M 
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NaCl b2 values are similar to those at 0.01M NaCl for concanavalin A pointing to an overall 
dominance of attractive protein-protein interactions. Catalase b2 values gradually increase 
with increasing NaCl concentration but do not become positive until 1.50M NaCl indicating 
that NaCl has a stabilising effect on catalase but that protein-protein interactions remain 
attractive up until 1.50M NaCl. Error bars are not included on b2 values shown as they are 
typically smaller than the data points used. 
 
Figure 30. The reduced osmotic second virial coefficient values obtained for Lactoferrin, catalase 
and concanavalin A, measured by SIC as a function of increasing NaCl concentration (20mM 
sodium phosphate buffer pH 7.0, 10µL injection, 0.5mL/min) 
 
Figures 31, 32 and 33 below show b2 values measured for lactoferrin, catalase and 
concanavalin A respectively for salts of the Hofmeister series at varying ionic strengths. The 
trends are similar to those observed with sodium chloride. From Figure 31 it is clear that 
Lactoferrin b2 remains strongly positive for all salt types over the full range of 
concentrations, suggesting protein-protein interactions are repulsive and lactoferrin is a very 
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aggregation stable molecule. This is a quite remarkable observation and raises some 
extremely seminal questions as to what confers such incredible stability to this specific 
protein molecule. Even at low to medium ionic concentrations there is little difference 
between b2 values for the different salt types but all b2 values decrease slightly with 
increasing ionic strength indicating a gradual weak screening of repulsive ionic interactions. 
At ionic strengths above 1.0M it becomes apparent that lactoferrin follows the order of 
reactivity sodium sulphate > sodium chloride > sodium nitrate > sodium chlorate > sodium 
iodide. This corresponds to the order observed in the Hofmeister series (Hofmeister 1888). 
 
 
Figure 31. The reduced osmotic virial coefficient for lactoferrin in solution measured by SIC as a 
function of increasing ionic strength for various salt types (20mM sodium phosphate buffer pH 7.0, 
10µL injection, 0.5mL/min) 
 
 
At low concentrations of all salt types b2 values clearly indicate that catalase interactions are 
attractive, and the trend observed is that same as that for sodium chloride. Catalase is most 
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acetate > sodium chloride > sodium nitrate > sodium chloride. At high salt concentrations 
sodium sulphate and sodium acetate induce a decline in b2 at roughly 0.60M sodium sulphate 
and 0.90M sodium acetate. This data indicates that catalase interactions may follow a direct 
Hofmeister series of reactivity at high salt concentrations. 
 
 
Figure 32. The reduced osmotic virial coefficient for catalase in solution measured by SIC as a 
function of increasing ionic strength with various salt types (20mM sodium phosphate buffer pH 
7.0, 10µL injection, 0.5mL/min) 
 
 
At low salt concentrations concanavalin A interactions are clearly attractive, and the trend is 
the same as previously observed for sodium chloride with catalase. However, the stabilising 
effect of different salt ions on concanavalin A at low concentrations follows the order sodium 
sulphate > sodium acetate > sodium chloride > sodium nitrate > sodium chloride. At high salt 
concentrations b2 values are observed to decline once more and this effect also follows the 
order sodium sulphate > sodium acetate > sodium chloride > sodium nitrate > sodium 
chloride. This series follows the order of the Hofmeister series (Hofmeister 1888). 
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Figure 33. The reduced osmotic virial coefficient for concanavalin A in solution measured by SIC as 
a function of increasing ionic strength with various salt types (20mM sodium phosphate buffer pH 
7.0, 10µL injection, 0.5mL/min) 
 
 
The b2 values for these protein-salt systems present a wide range of attractive and repulsive 
protein-protein interactions. In order to determine whether b2 values are truly representative 
of protein-protein interactions in solution DLS investigations to track particle size were 
carried out under the same solution conditions. Particle size is used here as a first order 
indicator of protein aggregation behaviour.  But without further investigation it is not possible 
to say whether increases in particle size are due to protein aggregation or other self-
associative behaviour. However, it would be expected that b2 values falling within the 
“crystallisation slot” could lead to crystallisation behaviour and b2 values still more negative 
than that would lead to protein aggregation. 
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A single recombinant lactoferrin monomer can be expected to be roughly 3.3nm (based on 
bovine lactoferrin hydrodynamic radius), a catalase tetramer has a hydrodynamic radius of 
5.2nm, and a concanavalin A tetramer a hydrodynamic radius of 4.3nm. Particles or entities 
with a greater hydrodynamic radius than these dimensions are assumed to be evidence of 
protein self-assembly processes. Figures 34, 35 and 36 show a correlation between 
lactoferrin, catalase and concanavalin A and particle size in solution and b2 respectively with 
varying co-electrolytes at a selection of concentrations 0.10M, 0.20M, 0.50M, 0.70M, 1.0M, 
1.25M and 1.50M. For reasons of clarity error bars are not included in DLS data but typical 
variation is around 10-20% of measured particle size. 
 
 
Figure 34. The correlation between reduced osmotic virial coefficient (measured by SIC) and initial 
hydrodynamic radius (measured by DLS) for lactoferrin in solution with various salt types over a 
range of concentrations (20mM sodium phosphate buffer pH 7.0) 
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Figure 35. The correlation between the reduced osmotic virial coefficient (measured by SIC) and 
the initial hydrodynamic radius (measured by DLS) for catalase in solution with various salt types 
over a range of concentrations (20mM sodium phosphate buffer pH 7.0) 
 
 
Figure 36. The correlation between reduced osmotic virial coefficient (measured by SIC) and initial 
hydrodynamic radius (measured by DLS) for concanavalin A in solution with various salt types over 
a range of concentrations (20mM sodium phosphate buffer pH 7.0) 
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Generally speaking the measured b2 values for all three proteins show a good correlation with 
protein aggregation. However, time dependent aggregation studies were also performed on 
lactoferrin and it was found that at sodium sulphate concentrations of above 0.80M the 
formation of ~200nm (hydrodynamic radius) aggregates was observed within a period of 24 
hours. As such b2 values do not properly describe aggregation propensity of lactoferrin under 
these conditions. It is likely that high concentrations of sodium sulphate results in an 
unfolded or partially unfolded lactoferrin conformation that is the aggregation prone species. 
Even small number of aggregation prone species in solution can result in protein aggregation 
over time. As the second virial coefficient measures overall protein-protein interactions it is 
effectively a weighted result from all protein species present. As such, under conditions 
where the predominant species is the native protein small changes in the population of the 
unfolded or partially unfolded protein do not contribute significantly towards the net 
interaction measured by the second virial coefficient. Similar findings been reported for 
several other aggregation cases in literature (Bajaj et al. 2006). Interestingly, at high sodium 
sulphate concentration significant peak tailing is observable on SIC chromatograms and is 
mostly responsible for the more significant reduction in b2 values observed between 0.90M 
and 1.50M sodium sulphate as peak maximum values do not alter as significantly. Thus, a 
detailed analysis of SIC peak shape and the spread of b2 values as discussed in Section 10 
could provide indications of long term aggregation trends. However, as the kinetics of 
aggregation are governed by the concentration of the aggregation prone species 
characterisation of this species is more useful than the determination of net protein 
interactions for assessing stability of protein formulations for long term storage. Despite this, 
the osmotic virial coefficient is still useful for qualitatively predicting stability trends in the 
long term, particularly when coupled with a more detailed peak analysis. Figures 35 and 36 
for catalase and concanavalin A show a more quantitative trend. Increase in particle size in 
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the majority of cases corresponded to negative virial coefficients indicating attractive protein-
protein interactions. Overall, the more negative the measured b2 value, the larger the initial 
observed hydrodynamic radius indicating rates of aggregation are faster when b2 values are 
most negative. As such the second virial coefficient is likely of greater use for assessing 
protein stability in process development. 
 
Figure 37. The SIC peak shapes obtained for acetone, lactoferrin, catalase and concanavalin A at 
0.2M NaCl concentration (20mM sodium phosphate buffer pH 7.0). Normalised to appear on the 
same scale and adjusted to the same peak maximum for shape comparison. Acetone peak shown 
is from catalase immobilised column but acetone peaks from all columns have very similar peak 
dimensions and symmetry. 
 
This result prompted comparison of SIC chromatogram peak shapes and the polydispersity of 
hydrodynamic radii of protein solutions. Figure 37 displays results for lactoferrin, 
concanavalin A and catalase SIC chromatograms normalised and peak shifted to appear on 
the same scale and in the same position (and plotted against acetone for comparison). Peaks 
for catalase and concanavalin A are noticeably broader than lactoferrin, according to the 
hypothesis from Section 10 this could mean a wider range of b2 values reflecting a 
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heterogeneity of protein-protein interactions in solution. When compared with the size range 
of aggregates measured by DLS (Figure 38) catalase and concanavalin A also display a wider 
polydispersity which is supportive of the theory of a range of magnitude and geometry of 
protein-protein interactions under any given solution conditions and that while measuring 
average interactions through b2 values is useful, more information can be gained by looking 
at the spread of b2 values. 
 
Figure 38. The size distributions obtained in one DLS run for lactoferrin, catalase and concanavalin 
A under pure buffer conditions (20mM sodium phosphate pH 7.0) 
 
The physical causes of the experimentally observed changes in b2 values and hence protein-
protein interactions are not readily understood. Protein-protein interactions are complex and 
current models still cannot reliably describe the full scope of effects salt, pH and other 
excipients have on them. It can therefore be difficult to pinpoint with certainty the molecular 
origins of b2 trends. However, general information on the physical chemistry of proteins 
allow assumptions to be made on the cause of b2 trends. The traditional approach to describe 
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the effect of salt on protein-protein interactions stems from the DLVO theory of colloidal 
interactions (Section 2.4) which considers protein-protein interactions a balance of repulsive 
ionic forces and attractive van der Waals forces. As such it ascribes the change in protein-
protein interactions to the effect of salt screening of the repulsive ionic interactions between 
protein molecules. This theory has been widely applied to lysozyme (Coen et al. 1995), 
(Muschol and Rosenberger 1997), (Velev et al. 1998) and is also applicable to a few other 
proteins. Ribonuclease A and α-chymotrypsinogen also display DLVO-like b2 trends where 
b2 decreases as a function of increasing ionic strength in a specific set of solution conditions 
(Velev et al. 1998), (Antosiewicz et al. 1994). However, inconsistencies with DLVO theory 
are apparent for these proteins under certain solution conditions. From a global perspective of 
the effect of salt on protein interactions the behaviour exhibited by lysozyme is fairly 
unusual. This is reflected by the b2 values measured for lactoferrin, catalase and concanavalin 
A. Lactoferrin is shown to be a very stable molecule and the effect of salts on lactoferrin 
interactions is minimal even at high concentrations. Catalase and concanavalin A both exhibit 
strongly attractive interactions at low salt concentrations which is a trend that has been 
observed for a number of other proteins including ribonuclease A, α-chymotrypsinogen and 
β-lactoglobulin (Velev et al. 1998), (Pjura et al. 2000), (Piazza and Iacopini 2002), (Tessier et 
al. 2003), (Dumetz et al. 2007). The physical origin of this interaction can be interpreted to be 
due to attractive ionic forces resulting from the anisotropy of protein surface charge 
distribution. This theory is supported by the fact that attraction is screened at lower ionic 
strengths for sodium sulphate and then the screening at any given ionic strength decreases in 
line with the Hofmeister series and then by medium ionic concentrations attractive 
interactions are almost completely diminished. These are characteristic features predicted by 
Debye-Huckel theory (Israelachivili 1992). 
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12.3.2 pH 
 
 
 
Figure 39. The reduced osmotic virial coefficient (b2) for lactoferrin (measured by SIC) as a function 
of pH with increasing NaCl concentration (20mM sodium phosphate buffer, 10µL injection, 
0.5mL/min) 
 
 
The pH of a solution affects the nature of protein-protein interactions through three main 
mechanisms. Firstly, it alters the protonation state of amino acid charge residues on the 
protein surface which in turn changes the overall surface charge distribution. Given that the 
charge distribution changes the magnitude and geometry of ionic interactions (Section 2.2) 
that have a notable influence on protein interactions at low salt concentrations. At high ionic 
concentration ionic interactions are screened and as a result the effects of pH changes become 
more subtle. Secondly, changes of pH have been shown to induce conformational changes, 
for instance a reversible change known as the Tanford transition has been shown to occur in 
β-lactoglobulin A and B (Tanford and Nozaki 1959), (Qin et al. 1998), (Taulier and Chalikian 
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2001) around pH 7.5. Thirdly and finally, pH effects protein hydration as a result of the 
differing hydration states of amino acids in their deprotonated and protonated forms. The pH 
alters the energy requirement of desolvation when two protein molecules come into contact. 
Given that charged residues are the most strongly hydrated this effect is potentially 
significant (Shirts and Pande 2005). 
 
Figures 39, 41 and 43 show b2 values for lactoferrin, catalase and concanavalin A 
respectively in solutions of NaCl as a function of pH. Figure 39 shows that pH appears to 
have very little effect on lactoferrin-lactoferrin interactions. There is no discernable 
difference in trend as pH is varied.  
 
 
Figure 40. The correlation between reduced osmotic virial coefficient (b2) (measured by SIC) and 
initial hydrodynamic radius (measured by DLS) for lactoferrin in solution as a function of pH with 
increasing NaCl concentration (20mM sodium phosphate buffer) 
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Figure 41 shows a different trend for catalase. At low salt concentrations of below 0.30M 
NaCl, b2 values indicate attractive protein-protein interactions, with the exception of pH 4.0 
under which protein-protein interactions are repulsive. Between pH 6.0 and 9.0 a trend exists 
that sees b2 values rising with increasing NaCl concentration before plateauing. The trend 
observed at pH 4.0 and 5.0 is different with b2 values decreasing steadily with increasing 
NaCl concentration. As such catalase stability would be expected to be highest at high pH 
and medium ionic concentrations or low pH and low salt concentrations. Figure 42 shows the 
correlation between b2 and initial hydrodynamic radius as a function of pH for catalase. The 
agreement is good, no self-associative behaviour is observed for positive virial coefficient 
values and increases in initial hydrodynamic radius increase in line with increasingly negative 
b2 values. 
 
Figure 41. The reduced osmotic virial coefficient (b2) for catalase (measured by SIC) as a function of 
pH with increasing NaCl concentration (20mM sodium phosphate buffer, 10µL injection, 
0.5mL/min) 
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Figure 42. The correlation between reduced osmotic virial coefficient (measured by SIC) and initial 
hydrodynamic radius (measured by DLS) for catalase in solution as a function of pH with increasing 
NaCl concentration (20mM sodium phosphate buffer) 
 
Figure 43 shows the effect of NaCl concentration on concanavalin A as a function of pH. The 
trends are similar to catalase. At low salt concentrations of < 0.30M NaCl, b2 values indicate 
attractive protein-protein interactions, with the exception of pH 4 and 5 for which protein-
protein interactions are repulsive and decrease with increasing ionic strength at these pH’s. 
Between pH 6.0 and 9.0 b2 values rise with increasing NaCl concentration before plateauing. 
Measured b2 values for pH 7.0 and 6.0 then begin to decrease at NaCl concentrations above 
~0.70M. Figure 44 shows the correlation between b2 and initial hydrodynamic radius is good 
and similar to that described previously for catalase and concanavalin A. 
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Figure 43. The reduced osmotic virial coefficient (b2) for concanavalin A (measured by SIC) as a 
function of pH with increasing NaCl concentration (20mM sodium phosphate buffer, 10µL 
injection, 0.5mL/min) 
 
Figure 44. The correlation between reduced osmotic virial coefficient (b2) and initial hydrodynamic 
radius (DLS) for catalase versus pH with increasing NaCl concentration (20mM sodium phosphate 
buffer) 
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As with the studies in salt solutions the pH dependent protein-protein interactions of catalase 
and concanavalin A are once again reminiscent of that observed for ribonuclease A and α-
chymotrypsinogen A, and has also been observed for other globular proteins such as 
monoclonal antibodies (Sule et al. 2012). At low pH both proteins display repulsive protein-
protein interactions but at high ionic strengths the interactions become predominantly 
attractive. At high pH the opposite dependence on ionic strength is true. This is once again 
very different to the behaviour observed for lysozyme (Section 11.3.2), (Velev et al. 1998), 
(Rosenbaum and Zukoski 1996). Lactoferrin pH behaviour is different again but could be 
better compared to interactions of myoglobin and bovine serum albumin which display 
repulsive protein-protein interactions over a range of pH values, which are diminished 
somewhat at high ionic strengths but not sufficiently to induce attractive protein-protein 
interactions (Asanov et al. 1997), (Tessier et al. 2002a). 
 
The similarity in behaviour of catalase, concanavalin A, ribonuclease A, α-chymotrypsinogen 
and certain mAbs is potentially due to the uneven distribution of surface charge observed for 
each protein (Coen et al. 1995), (Dumetz et al. 2007), (Tessier et al. 2003), (Yadav et al. 
2010), (Sule et al. 2012) and pH hydration effects. Unlike the other proteins catalase and 
concanavalin A are acidic and as such they only have a positive charge at low pH, that 
positive charge leads to repulsive protein-protein interactions but as the ionic strength is 
increased the ionic repulsion is increasingly screened resulting in reduced repulsion and even 
attractive protein-protein interactions, including increased attractive interactions due to 
diminished hydration of proteins at low pH (Kuntz and Kauzmann 1974). When pH is near 
the pI of the proteins net charge is reduced and the protein is least soluble and hence unstable. 
Low concentrations of salt stabilise protein-protein interactions by increasing solubility. Also, 
at near neutral local charge distributions (rather than overall charge) and interactions between 
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these specific groups on different proteins becomes more important leading to attractive 
interactions. However, high ionic strengths screen charge sufficiently to induce attractive 
interactions. It is likely that the pH dependent quaternary structure and conformational 
differences of these proteins plays a role in this effect. Catalase has shown only to function 
enzymatically at physiological pH (indicating conformational change away from this pH) and 
concanavalin A has been shown to exist as a dimer at pH’s below 6.0 and as a tetramer above 
pH 7.0.  Increasing pH diminishes the effect of high ionic strength on protein-protein 
interactions due to increased protein hydration caused by the deprotonation of acidic groups 
(Tessier et al. 2003), (Kuntz and Kauzmann 1974). Ionic and pH interdependence of proteins 
is clearly a complex phenomenon with many contributing factors and the root of observed 
protein-protein interactions not easily rationalised. 
 
 
12.3.3 Stabilisers 
 
Protein aggregation is often inhibited in industry through the alteration of the chemical 
environment of the protein through the addition of stabilising excipients/additives. A range of 
such cosolutes are used including sugars and polyols, amino acids, polymers, salts and 
surfactants. Trehalose, sucrose and mannitol have been extensively studied as protein 
stabilisers that stabilise protein conformation through a mechanism of preferential exclusion 
discussed in Section 1.4.4. While some amino acids also stabilise through the mechanism of 
preferential exclusion, arginine is thought to suppress aggregation through the interaction of 
its guanidinium group with aromatic side chains (Tsumoto et al. 2004), (Baynes et al. 2005). 
The level of stabilisation generated by sugars and polyols has been shown to be dependent on 
their concentration in solution. To achieve significant stabilisation of the protein structure it 
has been suggested that the minimum necessary concentration is 0.30M (Arakawa et al. 
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1993). Therefore, in the following investigation a concentration of 0.40M was studied for 
trehalose, mannitol and sucrose and arginine at a concentration of 0.5M based on research 
carried out by Tsumoto et al (Tsumoto et al. 2004). 
 
Figure 45. The reduced osmotic virial coefficient (measured by SIC) for lactoferrin, catalase and 
concanavalin A in solution with the addition of the stabilisers trehalose, mannitol, sucrose and 
arginine (20mM sodium phosphate buffer pH 7.0, 10µL injection, 0.5mL/min) 
 
Figure 45 shows that the addition of stabilisers effected b2 values for all three proteins. In all 
cases the addition of arginine has the smallest effect on b2 values, having almost no effect on 
b2 of lactoferrin. The addition of trehalose, mannitol and sucrose to lactoferrin in solution 
only caused a very small increase in b2 values and hence protein-protein repulsion. Catalase 
and concanavalin A stability was most increased through the addition of mannitol, followed 
by trehalose and then sucrose. Figure 46 shows the correlation of the effect of these 
stabilisers on b2 and initial hydrodynamic radius. A strong correlation can be observed 
suggesting b2 values would be of use for screening stabilising molecules. 
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Figure 46. The correlation between reduced osmotic virial coefficient (measured by SIC) and initial 
hydrodynamic radius (measured by DLS) for lactoferrin, catalase and concanavalin A in solution 
with the stabilisers sucrose, arginine, trehalose and mannitol (20mM sodium phosphate buffer pH 
7.0) 
 
 
12.4 Conclusions 
 
Variations in the dimensionless osmotic second virial coefficient (b2) were measured for 
lactoferrin, catalase and concanavalin A for a range of solution conditions including pH, ionic 
strength and salt type and the addition of stabilisers. Results for catalase were in good 
agreement with those cited in literature, and SIC b2 values for lactoferrin and concanavalin A 
are reported for the first time. Catalase and concanavalin A showed similar b2 profiles, 
though quite distinct from that of lysozyme but similar to that observed for a number of other 
globular proteins. The solution parameters with greatest impact on b2 values were pH and 
ionic strength changes. Notably, unlike lysozyme, stability was improved with increasing 
ionic strength. Lactoferrin b2 values remained strongly positive (a sign of repulsive protein-
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protein interactions) for all conditions tested indicating that it is a remarkably stable protein 
under a wide range of typically unfavourable solution conditions.  
 
A strong correlation between b2 and protein aggregation behaviour was observed under a 
variety of solution conditions. Positive b2 values resulted in little or no evidence of protein 
aggregation and association in solution on initial measurement of particle size DLS. While 
increasingly negative b2 values corresponded to increasingly large initial particle size of 
aggregates and as such faster rates of aggregation. However, monitoring of lactoferrin in 
solution with high concentrations of sodium sulphate over a period of 24 hours revealed time-
dependent aggregation processes. As such b2 may be of limited use in assessing long term 
stability when the rate limiting step is a time dependent change in protein conformation to the 
aggregation prone species. This conclusion has also been noted by a number of other authors 
for different proteins. However, b2 may still be of use qualitatively to assess long term 
stability if first moment analysis of SIC chromatograms are employed and a spread of b2 
values are determined that can be used to determine the heterogeneity of conformational 
states in solution. 
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CHAPTER 13 
13 THE SECOND VIRIAL COEFFICIENT AND INSIGHTS INTO 
THE DENATURATION AND AGGREGATION OF A DOMAIN 
ANTIBODY 
 
13.1 Introduction 
 
In the 30 years since the advent of monoclonal antibodies (Kohler and Milstein 1975) they 
have quickly emerged as a leading division of biotherapeutics that are effective in low 
concentrations and often have less side effects than their small molecule counterparts. At 
present there are 25 monoclonal antibodies (mAbs) approved for therapeutic use worldwide 
and another 200 other mAbs are currently in the development pipeline (Dimitrov and Marks 
2009), (Reichert et al. 2005). MAbs are complex protein molecules of roughly 150kDa, 
consisting of two copies of light and heavy chains (Wang et al. 2007). Due to their charges 
(Mach et al. 2011), mAbs can be thought of as amophteric polyelectrolytes. However, the 
charged groups on the surface of mAbs are not evenly distributed but instead form an 
intricate surface mosaic that can result in rather complicated protein assembly processes. 
Moreover, the existence of hydrophobic and hydrophilic groups also accords them 
heteropolymer characteristics, rendering their physiochemical nature decidedly non-trivial 
(Finkelstein 2002). Globular proteins such as mAbs display a substantial propensity to self-
association and aggregation processes. 
The solution properties of mAbs are rarely considered during selection for development as 
the main technical criteria is their ability to firmly and specifically bind to target antigens. As 
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such many mAb drugs exhibit highly irregular self-association behaviour (Weiss et al. 2009), 
(Daugherty and Mrsny 2006), (Shire et al. 2004). While there have been exceptional 
advances in protein engineering to enhance the conformational and colloidal stability of 
mAbs (Wu et al. 2010), (Worn and Pluckthun 2001), (Perchiacca et al. 2011), (Pepinsky et al. 
2010) the predominant method for improving the biophysical characteristics of mAbs is 
through optimisation of solution and formulation conditions (Shire et al. 2004), (Manning et 
al. 2010), (Gibson et al. 2011).  
Conventional mAbs are crucial therapeutic and diagnostic tools but despite their success there 
are still significant issues with the manufacture of mAbs (e.g. mammalian cell expression is 
essential). As a result the production of smaller fragments of mAbs that can be manufactured 
via yeast or bacterial cell culture (allowing for production more quickly, at higher volumes, 
with less batch to batch variability and reduced cost) has been gaining popularity as a new 
class of drug known as single domain antibodies or dAbs. Furthermore, their smaller size 
often results in reduced immunogenicity and allows for more efficient penetration into solid 
tumours and across the blood-brain barrier. 
Antigen binding of mAbs generally takes place via paired light and heavy chain variable 
domains. Ward et al (Ward et al. 1989) demonstrated that comparable binding affinities could 
be achieved with just half of the typical antigen binding site (a dAb). A dAb is less than tenth 
the size of a full antibody and corresponds to either the variable domain of an antibody light 
chain (VL) (Pereira et al. 1998) or heavy chain (VH) (Ward et al. 1989).  
This section will focus on anti-tumour necrosis factor α dAb. Tumour necrosis factor (TNF)α 
is a pro-inflammatory cytokine that is a key intermediary in a number of inflammatory and 
autoimmune diseases such as Crohn's disease, rheumatoid and psoriatic arthritis and 
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ankylosing spondylitis. There are multiple anti-TNFα agents already registered serving this 
large market (> $16bn in 2008) (La et al. 2009) (e.g. infliximab and adalimumab) but also 
some still in development such as the dAb in question. 
This study investigates the nature of anti-TNFα dAb interactions under varying salt 
concentrations, as well as thermal and chemical stresses (urea). Ionic strength and ion type 
were also investigated because it is one of the most fundamental parameters used to optimise 
the colloidal stability of protein therapeutics. Thermal stress and chemical stress were studied 
to gain insights into the denaturation of anti-TNFα dAb. Protein denaturation involves 
changes to the native protein structure that can result in alterations of the chemical, biological 
and physical properties of the protein. These changes are manifestations of a conformational 
change. While the majority of models in literature assume a single aggregation prone 
monomer state, both native and non-native monomers can participate in aggregation (Roberts 
2007). All current methods of preventing aggregation through optimisation of solution 
conditions involve interactions between solute and solvent that stabilise the protein native 
state thereby limiting attractive protein interactions between non-native as well as native 
protein conformations. As such denatured proteins are potentially of equal importance in 
determining a proteins propensity to aggregate. However, it is problematic to characterise 
proteins in their denatured state because unfolded proteins have been shown to rapidly 
transform into a multitude of different conformational states of comparable energies (Dill and 
Shortle 1991), (Liu et al. 2005b). As such the denatured state should be considered a 
distribution of numerous microstates that vary with protein sequence and solution conditions. 
Furthermore, it is dependent on the type of stress that caused denaturation (Cieplak and 
Sulkowska 2005), (Paci and Karplus 2000), (Irback and Mitternacht 2006). 
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The three sets of conditions described are all expected to change the way a protein molecules 
will interact and as such can be measured by the second virial coefficient. There are 
numerous examples of the effect of ionic concentration and type on protein-protein 
interactions as measured by B22 (Tessier et al. 2002a), (Ahamed et al. 2007), (Dumetz et al. 
2007). There are also examples of investigations into the B22 of denatured lysozyme. Liu and 
co-workers studied the effect of increasing or decreasing the concentration of guanidinium 
chloride on B22 for lysozyme (Liu et al. 2005b) and Le Brun et al looked at the effect of 
thermal stress (Le Brun et al. 2009). Further experiments were performed with NTA to 
determine size distribution of protein molecules in solution and consequently extent of 
aggregation under the same conditions. NTA has been shown to be very accurate for sizing 
both monodisperse and polydisperse samples, with substantially better peak resolution than 
DLS and required significantly less sample (Filipe et al. 2010). Capillary electrophoresis was 
only used to assess the effect of chemical and thermal stresses as it cannot be accurately used 
at high salt concentration. Capillary electrophoresis is predominantly a separation technique; 
however, this study uses it to monitor changes in protein structure. There have been other 
investigations that have used this approach to monitor protein folding and aggregation 
(Righetti and Verzola 2001), (Dai and Krull 1998), (Stellwagen et al. 1999), (De Lorenzi et 
al. 2002). 
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13.2 Method 
13.2.1 SIC and B22 Determination 
Anti-TNFα dAb was donated by Fujifilm Diosynth (Billingham, UK). Details can be found in 
Section 8.5. The Toyopearl particles were mixed with 10mL of anti-TNFα dAb solution and 
immobilisation procedure was the same as described earlier (Section 9.1.2). The integrity of 
the packed column was assessed by analysing its height equivalent to a theoretical plate, peak 
shape and symmetry when acetone was passed through the column. Additionally, 
investigations were performed to evaluate the effect of flow rate and injection concentration 
on B22 values in order to evaluate a range of conditions in which retention times were 
independent of these conditions. Injection concentration had little effect on B22 between 
1.0mg/mL and 4.3mg/mL stock concentration revealing that chromatographic behaviour is 
linear under these conditions. Stock concentration was preferred for this investigation as it 
gave the strongest signal. A larger injection volume of 20µL was used, also in order to 
enhance signal strength.  Flow rates of between 0.25mL/min and 1.00mL/min had little effect 
on B22 values but observed peaks were quite broad so in order to speed up analysis a slighter 
higher velocity of 0.75mL/min than described previously was used.  
13.2.2 NTA 
As described in Section 9.3. 
13.2.3 Capillary Electrophoresis 
As described in Section 9.4. 
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13.2.4 Thermal stress 
Thermal stress was assessed at 4ºC, 21ºC, 40ºC and 60ºC after ~12 hours of incubation in 
glass vials filled with 2mL of anti-TNFα dAb solution. As a control, pure buffer solution was 
treated in the same manner. 
 
13.3 Experimental Results 
13.3.1 Solution Salts 
 
Figure 47. B22 values of anti-TNFα dAb measured by SIC for three salt types as a function of 
increasing ionic concentration (20mM sodium phosphate buffer pH 7.0, 20µL injection, 
0.75mL/min) 
 
Ionic strength and salt type is one of the most fundamental parameters used to optimise the 
colloidal stability of protein therapeutics. Figure 47 shows B22 values determined via SIC for 
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anti-TNFα dAb for three salt types of the sodium anion portion of the Hofmeister series over 
concentrations ranging from no salt to 1.0M. An example of a typical chromatogram for anti-
TNFα dAb (against acetone for comparison of shape) is shown in Figure 48. 
The influence of sodium sulphate, sodium chloride and sodium chlorate were tested in the 
concentration range of 0-1.0M in pH 8.0 20mM sodium phosphate buffer. Up to a 
concentration of 0.25M for all salt types, the addition of salt increased B22 indicating a 
stabilisation of protein structure. A straightforward explanation for this behaviour is that there 
are paired ionic interactions between patches of oppositely charges residues on the protein 
surface (Coen et al. 1995), (Tessier et al. 2003), (Sule et al. 2012). This rationalisation is 
supported by evidence from computational studies that have identified specific pairwise 
protein configurations that take part in attractive ionic interactions (Neal et al. 1998), 
(McClurg and Zukoski 1998). Moreover, mAbs are typically composed of domains with both 
basic and acidic isoelectric points, therefore near neutral pH’s they would contain oppositely 
charged domains. Further increasing ionic concentration beyond 0.25M decreases B22 
reflecting the fact that ionic screening reduces the repulsive charge interactions between 
protein molecules; this trend is in line with DLVO theory. Ionic repulsive forces typically 
decrease with the increased concentration of salt ions as a result of their inverse dependence 
on ionic strength. This corresponds to a similar effect seen in other antibodies (Sule et al. 
2012) and indeed in other globular proteins such as those discussed in Section 12.3. In all 
cases the addition of salt in low concentrations increases protein colloidal stability up to a 
point, beyond which increases in ionic strength result in increases in attractive protein 
interactions.  
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Figure 48. Typical anti-TNFα dAb and acetone chromatograms. Absorbance has been normalised 
for comparison (1M NaSO4 20mM sodium phosphate buffer pH 7.0, 20µL injection, 0.75mL/min) 
 
 
Figure 49. Sample video frame from Nanoparticle Tracking Analysis of anti-TNFα dAb aggregation 
(0.75M NaSO4 20mM sodium phosphate buffer pH 7.0) 
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Figure 50. An example of the 3D graph of scattered light intensity versus particle size provided by 
the NTA software for anti-TNFα dAb (0.75M NaSO4 20mM sodium phosphate buffer pH 7.0) 
 
In terms of salt type, there was little difference between the three different salts investigated 
here despite spanning the greatest range of the Hofmeister series. However, it does appear 
that at high salt concentrations for which the Hofmeister series of reactivity is most relevant 
that the order of the destabilising effects of the salts is sodium sulphate> sodium chloride> 
sodium chlorate. This order is consistent with the Hofmeister series. However, it should be 
noted that at low salt concentrations the stabilising effect of the salts also occurs in that order. 
 
The critical question is whether B22 values can be linked to protein aggregation. 
Theoretically, a positive B22 value would infer the presence of a colloidally stable protein 
system that is unlikely to aggregate. In contrast, negative B22 values suggest aggregation 
prone protein molecules that would have a tendency to interact to form protein aggregates. A 
possible correlation between more attractive B22 values and more pronounced growth of 
aggregates was discussed by Li et al (Li et al. 2010) and in Sections 11 and 12. NTA was 
used here to analyse the size distribution of anti-TNFα dAb solutions under the same salt 
solution conditions as used to determine B22 values. Examples of a sample video frame and 
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the intensity plot obtained via NTA are shown in Figure 49 and Figure 50. The size 
distribution results for all salt types and concentrations are displayed in Figure 51, Figure 52 
and Figure 53. In this study the increase in particle size for anti-TNFα dAb solutions was 
consistent with increasing or decreasing B22 values as depicted in Figure 48 which shows the 
mean concentration weighted particle size plotted against B22. The aggregate size 
distributions showed that the smallest particles sizes observed were for the 0.25M salt 
concentration, the same conditions which exhibited the highest B22 values (see Figure 46) 
While the trend was consistent with the effect of ion-specific protein interactions, due to the 
standard deviation of results and the relatively small differences in B22 values it is difficult to 
draw very firm conclusions on this matter.  
 
  
Figure 51. The size distribution of anti-TNFα dAb particles in solution measured by NTA as a 
function of increasing sodium sulphate concentration (20mM sodium phosphate buffer pH 7.0) 
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Figure 52. The size distribution of anti-TNFα dAb particles in solution measured by NTA as a 
function of increasing sodium chloride concentration (20mM sodium phosphate buffer pH 7.0) 
 
 
Figure 53. The size distribution of anti-TNFα dAb particles in solution measured by NTA as a 
function of increasing sodium chlorate concentration (20mM sodium phosphate buffer pH 7.0) 
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Interestingly though, both SIC chromatograms and NTA peaks were very broad, potentially 
indicating a heterogeneity of interactions within the sample in line with the hypothesis 
proposed in Section 11. It has come to be generally accepted that heterogeneity, particularly 
charge heterogeneity, is a common characteristic of monoclonal antibodies (Liu et al. 2008). 
The observed trends in peak broadness may be a result of this trait. 
 
 
13.3.2 Urea 
 
Protein unfolding induced by chemical denaturants such as urea is a common method of 
investigating protein folding in vitro. Chemical denaturation results when a chemical such as 
urea is able to form bonds with the functional groups of a native protein that are stronger or 
equal in strength to those that form the structure of the native protein hence disrupting protein 
conformation. Urea is an example of a strong denaturant, it is known to bind the carbonyl 
groups of the polypeptide chain and disrupt helical structures. High concentrations of urea 
have been shown to inhibit aggregation but in lower concentrations some proteins aggregate 
in solution with urea (Fischer et al. 1993). Generally this occurs as a result of the formation 
of disulphide bonds between sulfydryl groups made accessible by protein unfolding. 
Denaturants also alter the solubility of protein molecules through hydrogen bonding and 
changing the water structure surrounding the protein (Roseman and Jencks 1975), 
(Makhatadze and Privalov 1992). Urea is also commonly used to improve protein refolding 
and recovery (Chen et al. 2009) due to its ability to increase the solubility of proteins and 
minimise aggregation. For this approach to be successful a fine balance must be struck 
because whilst urea can increase solubility and inhibit aggregation, too high a concentration 
will also result in denaturation. Anti-TNFα dAb was exposed to urea concentrations ranging 
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from 2.0 to 8.0M. While a majority of proteins are totally denatured in 8.0M urea, it is 
commonly accepted that there is a critical, protein-dependent concentration of urea at which a 
given protein will completely unfold. 
 
In order to probe protein-protein interactions under these conditions B22 was measured, 
starting from native protein with increasing concentration of urea. Figure 54 shows B22 for 
anti-TNFα dAb against increasing urea concentration. The results show that B22 decreases 
with increasing urea concentration, indicating that ionic repulsion between protein molecules 
is decreasing with increasing denaturant concentration when starting with the native protein. 
This reason for this behaviour is that as the protein unfolds in increasing concentrations of 
denaturant, hydrophobic regions of the protein that are normally buried internally become 
solvent exposed causing the protein to become more aggregation prone. This increases 
attractive protein-protein interactions and hence decreases B22. The observed minimum B22 
value at 4.0M urea is the result of a crossover point between two competing effects when 
protein-protein interactions and by extension protein aggregation are at their maximum. The 
first effect is that the protein is denatured, thereby increasing the concentration of aggregation 
prone species in solution. However, this effect is balanced by the second effect whereby 
attractive protein-protein interactions are weakened due to the increased solubility of the 
protein molecules. Hydrophobic interactions between protein molecules are decreased as 
protein-urea and urea-water interactions are favoured. The effect of a solubility minimum has 
been reported previously by De Young and co-workers (Deyoung et al. 1993) for 
apomyoglobin in urea and theoretically explained using mean field theory by Stigter and Dill 
(Stigter and Dill 1993). 
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Figure 54. B22 values obtained via SIC for anti-TNFα dAb as a function of increasing concentrations 
of urea (1 x TBE buffer pH 8.0) 
 
 
Capillary electrophoresis (CE) has been demonstrated to be a powerful device for the 
separation of structurally similar proteins. CE analysis detects variations in electrophoretic 
mobility which can arise as a result of changes in hydrophobicity, charge, secondary structure 
or single base mutations. The potential to detect changes in protein conformation was 
previously discussed by Rush and co-workers (Rush et al. 1991). CE was used to study the 
magnitude of the change in charge (and hence conformational change) of anti-TNFα dAb 
upon denaturation with urea. There are a number of reports in which CE has been used to 
investigate protein denaturation but for the most part the interpretation of results has focussed 
on changes in the protein size. However, there is evidence that denaturation of a protein can 
result in a significant change in the isoelectric point of the protein (Candiano et al. 1986). 
Given that the electrophoretic mobility of a molecule is much more sensitive to charge than 
to molecular size this indicates that the analysis of results may have been oversimplified by 
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some investigators. This analysis was suggested by Bermudez and co-workers (Bermudez 
and Forciniti 2004) who studied the charge change upon denaturation of HSA and IgG with 
urea. Given that electrophoretic mobility is dependent on both size and charge of a protein, in 
order to decouple the two effects the results must be interpreted in combination with size 
distributions obtained with NTA. 
 
Figure 55 shows an example of the reproducibility of peaks in the capillary electrophoresis 
results examined. Figure 56 shows the electrophoretic mobilities of anti-TNFα dAb in pure 
buffer and buffer with 2.0M, 4.0M, 6.0M and 8.0M urea. Thiourea is used as a neutral 
marker. 
 
Figure 55. An example of electropherogram showing the reproducibility of the electrophoretic 
mobilities of anti-TNFα dAb samples treated with 2M urea (x1 TBE buffer pH 8.0) 
 
 
187 
 
 
Figure 56. An electropherogram of anti-TNFα dAb samples treated with increasing concentrations 
of urea (1x TBE buffer pH 8.0) 
 
 
Anti-TNFα dAb has a theoretical pI of 8.66 (information supplied by Fujifilm Diosynth 
Biotechnologies), therefore at pH 8.0 anti-TNFα dAb would be expected to be almost neutral 
or slightly positive and therefore emerge around the same time as the neutral marker thiourea. 
However, when comparing with particle size results from NTA (Figure 57), large aggregates 
form under these conditions and this increase in particle size should result in a decrease in 
electrophoretic mobility. As such if the theoretical pI is 8.66 the combination of positive 
charge with protein aggregation should result in anti-TNF dAb emerging before the thiourea 
marker. Therefore it is probable that the experimental pI is lower than the theoretical pI. In 
the plots of samples treated with 2.0M to 6.0M urea all of the electroosmotic mobilities are 
positive. Anti-TNFα dAb consists of 8 negatively charged residues and 10 positively charged 
residues so in its fully unfolded form anti-TNFα dAb will possess a small positive charge. In 
addition the protein is becoming larger either through unfolding and aggregation processes 
and this factor should also decrease electrophoretic mobility. This analysis is the case up until 
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a concentration of 4.0M urea. However, above 4.0M urea the size of aggregates observed 
with NTA decrease which is likely the reason that electrophoretic mobility increases until at 
8.0M urea it is the same electrophoretic mobility as the marker. At 8.0M urea, the slight 
positive charge of the anti-TNFα dAb is again balanced by the aggregation of the protein, 
although this time the aggregates are significantly smaller due to increased solubility and as 
such this would imply that the positive charge of anti-TNFα dAb may be greater in its native 
than its unfolded form. As has been claimed for other antibodies it appears that the 
denaturation transition is a smooth one and does not occur sharply at any given concentration 
of urea. Overall, there is very little change in the electrophoretic mobilities of anti-TNFα dAb 
suggesting that the difference in charge between folded and unfolded states since charge has a 
greater effect on electrophoretic mobility than size and it is clear from NTA results that there 
is a large change in particle size (over 10 fold). This analysis of trends observed with CE and 
NTA is in agreement with observed B22 values that decrease up to a value of 4.0M urea 
indicating an overall increase in attractive protein-protein interactions as the protein unfolds 
at which electrophoretic mobility is observed to be slowest and aggregates the largest. 
However, above 4.0M urea B22 increases again as a result of a decrease in attractive protein 
interactions due to the increased protein solubility observed by an increase in electrophoretic 
mobility and a decrease in particle size. 
 
Interestingly, there is a distinct change in peak shape and size in the electropherograms with 
increasing urea concentration. They also display a multiplicity of peaks in urea 
concentrations above 2.0M reflecting the heterogeneity of the antibody postulated from the 
broad peaks observed in SIC chromatograms. The peaks are not individually resolved in the 
electropherogram but can be identified individually on an equiphase diagram provided by the 
software, allowing visualisation of each different type of aggregate or protein conformation. 
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It is important to note the transition of peak shapes evident between 0 and 8.0M urea. At 
2.0M urea the peak shape is slightly broadened but overall retains similar characteristics to 
0.0M urea peak. At 4.0M and 6.0M urea a sharp frontal peak forms with a rear peak starting 
to form as well at 6.0M urea and the peak begins to flatten on the rear side. At 8.0M urea the 
peak broadens and flattens completely with small sharp peaks on either side. The 
denaturation and aggregation of anti-TNFα dAb is reflected in the electropherograms as a 
split peak that is not present in the absence of urea. A similar trend is evident in NTA results 
(Figure 57), it is clear that an increase in urea concentration starts to break apart the large 
aggregates causing the split peaks. The size of aggregates is the similar until 2.0M urea then 
increases at 4.0M and begins to split into separate peaks decreasing at 6.0M and 8.0M 
concentrations. The change in electropherograms occurs after a concentration of 4.0M urea is 
reach which corresponds to the minimum observed B22. SIC chromatogram peaks increase in 
broadness with increasing urea concentration, decreasingly slightly between 6.0M and 8.0M 
urea. 
  
Figure 57. Size distribution results obtained from NTA measurements for anti-TNFα dAb as a 
function of increasing urea concentration (1x TBE buffer pH 8.0) 
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13.3.3 Temperature 
 
The relationship between unfolding and aggregation can be studied by the evaluation of 
protein thermal stability. Measurements of unfolded protein subpopulations at increased 
temperatures are commonly employed to evaluate the thermal stability, and by extrapolation, 
the conformational stability of proteins. The influence of temperature on B22 of anti-TNFα 
dAb was tested in the range of 4-60ºC at pH 8.0. No information was available on the 
denaturation temperature of anti-TNFα dAb so separate columns were prepared for 40ºC and 
60ºC investigations, other studies were performed in order of increasing temperature. As seen 
in Figure 58 protein-protein interactions as assessed by B22 were not significantly modified 
by change in temperature. Increasing the temperature at which SIC experiments are carried 
out from 4ºC to 40ºC only slightly decreased B22 values. Similar trends have been described 
for concanavalin A and Proteinase K (Liu et al. 2011) as well as ovalbumin (Antipova et al. 
1999). It is probable that B22 values decrease in these instances as an increase in temperature 
results in partial unfolding, exposing hydrophobic groups normally buried in the interior and 
leading to increased attractive protein-protein interactions. However, other proteins such as 
lysozyme have shown the opposite trend (Gripon et al. 1997), (Valente et al. 2005a), which 
has been explained by way of solubility enhancement of lysozyme with increasing 
temperature. The temperature dependence in both cases is likely to stem from hydrophobic 
interactions rather than ionic as they are known to depend strongly on temperature and 
mediate very short ranged protein interactions (Piazza 2004b). This is the case for 
temperatures well below denaturation temperature of the protein. B22 increases at 60ºC likely 
due to thermal denaturation of the protein. Denatured proteins have often been shown to 
result in reduced aggregation compared to partially unfolded states and sometimes even no 
aggregation whatsoever (Kelly 1996), (Fink 1998), (Speed et al. 1996), (Kim et al. 2003), 
(Vendruscolo et al. 2003). 
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Figure 58. B22 values measured by SIC for anti-TNFα dAb as a function of increasing temperature 
 
For CE experiments solutions of anti-TNFα dAb were incubated overnight at various 
temperatures. For comparison these were run against a sample of anti-TNFα dAb that was not 
incubated and thiourea, a neutral marker. At all incubation temperatures there is an observed 
decrease in electrophoretic mobility suggesting the formation of aggregates (Figure 60). All 
samples also show a similar pattern in terms of the change in peak shape that suggests that 
anti-TNFα dAb is either starting to change its conformation or forming aggregates in 
incubated samples or both. Using equiphase diagrams it is possible to view the wide peak as a 
series of different signals close together. The resolving power evident in the 
electropherograms could be improved by using a longer capillary. 
 
The picture becomes clearer when SIC and CE results are considered alongside NTA results 
(Figure 59). NTA results show similar aggregate size at all temperatures of incubation, 
although the largest aggregates and the greatest polydispersity of sample is observed when 
the sample is incubated at 40ºC which also corresponds with the widest CE and SIC peaks 
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and the most negative B22 value. Anti-TNFα dAb is potentially denatured at 60ºC and at this 
temperature observed aggregate size at 60ºC is significantly smaller than at other 
temperatures and corresponds to the least negative B22 and the smallest shift in 
electrophoretic mobility. To be certain further investigations into structural changes of the 
protein would be required, for example with FTIR and/or DSC. However, as previously noted 
it is quite usual that fully unfolded proteins exhibit lower aggregative propensity than 
partially unfolded species so it is reasonable to assume in this case that the dominant protein 
species at 60ºC. Additionally, observed peaks much narrower at 60ºC for all techniques 
utilised, indicating less heterogeneity of protein structures at this temperature also suggesting 
that the protein population consists mainly of a single conformation (probably the completely 
unfolded state) at this temperature rather than at lower temperatures where a range of 
different folding states and hence aggregates may coexist in solution. The overall changes in 
mobility are relatively small, this is likely to be due to the fact that these changes are likely 
mostly due to alterations in aggregate size rather than changes in charge which CE is more 
sensitive to. 
 
Figure 59. Size distribution of anti-TNFα dAb aggregates measured by NTA obtained following 
overnight incubation at various temperatures 
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There is only a small difference between observed B22 values at the varying temperatures this 
correlates well with NTA and CE results in that there is very little difference in overall 
aggregate size at the various temperatures. However, there is a relatively large difference 
between the aggregate size and number of aggregates of those samples that have been 
incubated overnight and anti-TNFα dAb that was not incubated but measured at 21ºC, 
indicating that there is a significant time-dependent element to protein aggregation but that 
B22 values are still indicative of overall trends of protein aggregation. 
 
 
Figure 60. An electropherogram displaying the relative electrophoretic mobilities of anti-TNFα dAb 
samples incubated overnight at various temperatures (1x TBE buffer pH 8.0) 
 
 
13.4 Conclusions 
 
This section investigates the aggregation and possible denaturation of an industrial 
therapeutic domain antibody. Three techniques were used to follow aggregation and 
denaturation to offer complementary information. Results are presented of the dependence of 
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B22 for anti-TNFα dAb on ionic concentration and type, urea concentration and temperature. 
Using capillary electrophoresis and NTA B22 values were assessed for their usefulness as an 
indicator of aggregation propensity. Capillary electrophoresis captured changes in size to 
charge ratio and hence structural changes that are likely to occur as a part of denaturation and 
aggregation. However, alone capillary electrophoresis cannot easily detect the presence of 
aggregates. To this end NTA was used as a complementary method, it cannot detect structural 
or charge changes but is a sensitive method for measuring the size distribution of protein 
particles. Studies have indicated the potential temperature range and urea concentration at 
which anti-TNFα dAb denature. Results presented show that B22 is a useful quantitative 
method for assessing the sign and magnitude of protein-protein interactions under a wide 
range of solution conditions. 
 
Interactions of anti-TNFα dAb showed a weak dependence on ionic strength with b2 values 
highest (and therefore protein stability highest) at low to moderate ionic concentrations. Salt 
type had no discernable effect on b2 values. B22 was found to decrease with increasing urea 
concentration up to a minimum of 4.0M urea at which protein-protein interactions are 
expected to be most attractive. Between 4.0M and 8.0M urea B22 values increase once more 
indicating a decrease in attractive interactions. The observed minimum at 4.0M urea is the 
result of a crossover point between two competing effects. The protein is denatured under 
increasing urea concentrations, thereby increasing the concentration of aggregation prone 
species in solution. However, this is balanced by the second effect whereby attractive protein-
protein interactions are weakened due to the increased solubility of the protein molecules.  
 
The influence of temperature on B22 of anti-TNFα dAb was tested in the range of 4-60ºC at 
pH 8. Between 4ºC and 40ºC B22 values were not significantly modified by changes in 
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temperature, though B22 increases at 60ºC were likely due to thermal denaturation of the 
protein. Generally, a good correlation was observed between B22 values for ionic strength, 
urea concentrations and temperature and the size distribution and electrophoretic mobilities 
measured under the same conditions.   
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CHAPTER 14 
14 CROSS VIRIAL COEFFICIENTS FOR PREDICTING SELF-
INTERACTIONS 
 
14.1 Introduction 
 
Almost all experimental studies of protein-protein interactions in literature focus on single 
protein systems (George and Wilson 1994), (Tessier et al. 2002a). Cross virial coefficients 
(B23) have previously been measured to assess the effect of interactions dissimilar molecules 
may have on solution properties of protein mixtures (Cheng et al. 2008), (Moon et al. 2000). 
Here, I plan to determine whether interactions between unlike proteins as measured by a 
series of B23 can be used to estimate B22 through mean field theory analysis of the B23 data. 
The technique employed here is cross-interaction chromatography and is a variant of self-
interaction chromatography that provides data that can be interpreted in terms of B23 (Tessier 
et al. 2004), (Teske et al. 2004a). The interpretation of B23 results proposed here is a 
completely novel technique known as Similar Interaction Chromatography (SimIC). Results 
presented are B23 and B32 values obtained for 4 model proteins (lysozyme, lactoferrin, 
catalase and concanavalin a). The B22 values used here are those reported on earlier in this 
thesis. The osmotic second cross virial coefficient can be related to the cross-interaction 
chromatography retention factor through the following equation (Tessier 2004); 
 
197 
 
Where k’ is the retention factor, ρs is the number of immobilised protein molecules per unit 
area, ф is the phase ratio (value obtained from the work of DePhillips and Lenhoff 
(DePhillips and Lenhoff 2000)), B23,HS is the excluded volume or hard sphere contribution 
(2/3 π [r2 + r3]
3
 for spheres where r2 and r3 are the radii of the two proteins). 
In the work proposed here a mean field approximation approach will be used to estimate B33 
from B23 and B32 data sets. The mean field approximation is a simple first order analysis that 
has been used in a wide range of thermodynamic problems during the past 50 years. For 
example, Fowkes used successfully a geometric mean approximation in his seminal work on 
estimating the surface energy of solid surfaces (Fowkes 1963). Mean field approximations 
are used in many problems in solution thermodynamics, including estimating the enthalpy of 
mixing for regular solutions as well as in the Flory-Huggins theory for polymer solutions. For 
problems with positive only variables, geometric means are commonly used, whilst for 
variables that can assume positive or negative values, then arithmetic means can be used. 
Using these precedents the following equation for B23 can be written as a simple arithmetic 
mean of B22 and B33 is proposed: 
Equation 14.1 
 
This approach, if effective, would eliminate the need for immobilisation of the new target 
proteins onto a chromatographic support. Immobilisation of the protein of interest is the most 
time-consuming step in SIC. Furthermore it can be problematic to achieve the necessary 
immobilisation density, particularly if strategies for immobilisation are not known. It also 
means smaller quantities of the protein of interest are required as immobilisation requires the 
most significant consumption of protein required in SIC. In this new proposed approach, a 
series of standard protein columns could be used and the B23 of the protein of interest against 
2
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B
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the proteins on those columns could allow approximation of B22 for the protein of interest. 
This would mean that the B22 values could potentially be determined in just a few hours.  
 
14.2 Experimental Method 
 
Column preparation is the same as described for SIC (Section 9.1.2, 10 and 12.2). The 
difference between cross and self-interaction chromatography is simply that the protein in the 
mobile phase is different to that immobilised on the column. Investigations were performed 
to assess the effect of and optimise flow rate, injection concentration and size. Flow rate used 
for all experiments was 0.5mL/min, and injection concentrations and volumes used were 
15mg/mL and 10 µL. All experiments were performed using pH 7.0 using a 20mM sodium 
phosphate buffer. 
 
14.3 Results 
 
Cross-interaction Chromatography measurements were conducted between lysozyme, 
lactoferrin, catalase and concanavalin A, with each protein immobilised on a column and all 
the others used as the mobile phase as a function of increasing NaCl concentration. 
 
14.3.1 Chromatographic Considerations 
 
The effect of injection concentration, surface coverage and flow rate were assessed to 
determine their effect if any on B22 of cross interactions. Only the lysozyme and concanavalin 
A combination was exhibited a small dependence on injection concentration, even up to high 
injection concentrations of 40mg/mL (Figure 61). 
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Figure 61. Dependence of B23 on injection concentration for lysozyme-concanavalin system (20mM 
sodium phosphate pH 7.0, 10µL injection, 0.5mL/min) 
 
 
Figure 62. Lysozyme mobile phase run on three columns with different proteins immobilised over 
a range of NaCl concentrations (20mM sodium phosphate pH 7.0, 10µL injection, 0.5mL/min) 
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Figure 63. Lactoferrin mobile phase run on three columns with different proteins immobilised over 
a range of NaCl concentrations (20mM sodium phosphate pH 7.0, 10µL injection, 0.5mL/min) 
 
 
Figure 64. Catalase mobile phase run on three columns with different proteins immobilised over a 
range of NaCl concentrations (20mM sodium phosphate pH 7.0, 10µL injection, 0.5mL/min) 
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Figure 65. Concanavalin A mobile phase run on three columns with different proteins immobilised 
over a range of NaCl concentrations (20mM sodium phosphate pH 7.0, 10µL injection, 0.5mL/min) 
 
 
Figure 66. The effect of interchanging the immobilised protein on virial cross coefficient values for 
catalase-lysozyme systems and lactoferrin- concanavalin a for various NaCl concentrations (20mM 
sodium phosphate buffer pH 7.0, 10µL injection, 0.5mL/min) 
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Figure 62 to Figure 65 show the 12 sets of results obtained for B23 (as well as B32) results for 
lysozyme, lactoferrin, catalase and concanavalin obtained at 3 different NaCl concentrations. 
 
B22 results for lysozyme are taken from Chapter 11. The b2 results for lactoferrin, catalase and 
concanavalin a presented in Section 12 were converted to B22 using the equation: 
 
 
 
 
         Equation 14.2 
In this equation b2 is normalised by the excluded volume contribution of a sphere of equal 
volume B2
HS
 which is simply four times the molecular volume (16/3 π r3). Na is Avogadro’s 
number, Mw is the weight average molecular weight and σ is the protein diameter.  These 
results are summarised in Table 6 below. 
 
Table 6.   B22 values as determined using SIC data 
Protein Lysozyme Lactoferrin Catalase Concanavalin A 
    
NaCl Concentration 0.1M 0.3M 0.5M 0.1M 0.3M 0.5M 0.1M 0.3M 0.5M 0.1M 0.3M 0.5M 
B22 x 10
-4
 mL mol g
-2
 (SIC) 0.75 -4.0 -5.9 24.4 22.5 21.0 -23.1 -6.4 -4.0 -15.9 -1.2 2.8 
 
 
Experimental data shown in Table 7 is taken directly from Figure 62-65. Theoretical 
predictions for B23 were made using Equation 14.1 with the B22 data from Table 6. 
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Table 7.   Theory and Experimental Values for B23 determined using Cross Interaction 
Chromatography 
Protein Lysozyme Lactoferrin Catalase Concanavalin A 
    
NaCl Concentration 0.1M 0.3M 0.5M 0.1M 0.3M 0.5M 0.1M 0.3M 0.5M 0.1M 0.3M 0.5M 
*B23 Lysozyme (Exp) x x x 16 15 14 -17 -3 -7 -13 -4 -1 
*B23 Lysozyme 
(Theory) 
x x x 13 9 8 -11 -5 -5 -8 -3 -2 
*B23 Lactoferrin (Exp) 16 15 14 x x x 4 9 10 6 10 13 
*B23 Lactoferrin 
(Theory) 
13 9 8 x x x 1 8 8 4 11 12 
*B23 Catalase (Exp) -17 -2 -7 5 9 10 x x x -21 -5 -2 
*B23 Catalase (Theory) -11 -5 -5 1 8 8 x x x -20 -4 -1 
*B23 Concanavalin 
(Exp) 
 -13 -5 -2 7 10 12 -22 -5 -2 x x x 
*B23 Concanavalin 
(Theory) 
-8 -3 -2 4 11 12 -20 -4 -1 x x x 
*B23 units are x 10
-4
 mL mol g
-2 
 
Figure 67. Master Plot of all Experimental B23 and B32 data versus Theoretical B23/B32 values for 
Cross Interaction Chromatography 
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14.4 Discussion 
 
The aim of this Chapter was to experimentally validate a new approach to the estimation of 
B22 values which I have described as Similar Interaction Chromatography (SimIC). 
 
Before, I discuss the results obtained for this study, a first essential part of the experimental 
work was to confirm the validity of the experimental data obtained. In this study a series of 
B23 and B32 data sets are generated from the 4 different mobile phases used and the 4 different 
protein immobilised columns. From a fundamental and from an experimental perspective B23 
values should equal B32 values.  That is, whether the protein is in the mobile phase or is the 
immobilised phase should make no difference to the B23 values determined. However, this 
equality cannot be assumed as any one of a number of experimental factors could 
compromise this result. Should the data fail this test, then it is improbable that the SimIC 
approach could be used. 
 
Figure 66 shows 6 sets of results for catalase-lysozyme and lactoferrin-concanavalin A 
systems. In the case of catalase-lysozyme for three different salt concentrations, B23 and B32 
data agree with 0.5 units (x 10
-4
 mL mol g
-2
); an uncertainty of between 5 and 10% in the B 
values. In the case of lactoferrin- concanavalin, the differences are larger at about 1.0 units (x 
10
-4
 mL mol g
-2
), corresponding to a typical uncertainty of between 5 and 15% in B23. Data 
for these two protein pairs and the other 4 pairs tested are compiled in Table 7. The data 
shown in Figure 66 represents the worse and best case protein pairs, with a typical difference 
for all 6 protein pairs less than 1 unit between experimentally measured B23 and B32 data.  
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It is therefore clear, that the experimental data reported here is fully independent of whether 
the protein is in the mobile phase or in the stationary phase. Therefore, the data sets are 
robust and suitable for use in a SimIC study. 
 
Experimental B23 and B32 data are summarised in Table 7 as well as the predicted B23 / B32 
data based on an arithmetic mean calculation. 
 
Figure 67 plots a comparison of the experimentally measured B23 and B32 data with the 
theoretically predicted data for all 6 protein systems at all three salt concentrations. All data 
reported has been included in this plot.  
 
This Figure shows a clear linear trend with a respectable linear correlation coefficient of 0.95 
with the line of best fit passing very close to the 0,0 axis origin point as would be predicted. 
The slope of the plot is 0.79, though ideally it should be 1.00. This difference shows that the 
simple arithmetic treatment used here is underestimating some of the predicted B23 / B32 
values.  Nevertheless, this analysis still gives a very good correlation.  Moreover, for every 
one of the 36 data points tested, the theory predicted correctly the sign of the experimental 
B23 or B32 data. However, there is clearly still much room for optimisation of this approach, 
particularly when choosing which proteins to immobilise on the columns. Current choice 
covers a range of pI values and molecular weights but concanavalin A may not be the best 
choice for such an application as it will specifically interact with glycosylated proteins 
(Dufau et al. 1972). 
 
The ambition for the SimIC approach is to develop a rapid high throughput screening 
approach which would predict a probability of aggregation based on experimentally 
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estimated B23 data.  The data reported in this Chapter confirms that such an approach is 
feasible, and should be suitable for rapid screening. It is likely that the SimIC method would 
simple need to predict whether B22 was in certain ranges, rather than need to give high 
fidelity data. For example, the SimIC test might simply need to make the following decisions: 
 
B22 > 10 x 10
-4
 mL mol g
-2
  Very stable system 
B22> 5 x 10
-4
 mL mol g
-2
  Stable system 
B22>2 x 10
-4
 mL mol g
-2
  Marginally stable system 
B22<2 x 10
-4
 mL mol g
-2
  Poor stability 
B22<-5 x 10
-4
 mL mol g
-2
  Very poor stability 
 
Based on the 4 protein systems reported here, it should be feasible to estimate B22 values with 
sufficient accuracy to rank proteins into one of these 5 categories.  
 
14.5 Conclusions 
 
It has been demonstrated that for catalase, lysozyme, lactoferrin and concanavalin A that the 
experimental SIC determinations of B23 and B32 gave very nearly equal results. This confirms 
that whether a protein was in the mobile phase or immobilised in the column, this did not 
affect the B23 / B32 results obtained. 
 
It has been shown that B23 can be reliably estimated from the arithmetic mean of known B22 
and B33 values for two known proteins. For the 4 proteins systems studied here across 3 
different salt concentrations a good linear correlation between experimentally measured and 
theoretically predicted B23 values was achieved. Indeed for all 36 experimental 
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measurements, this simple arithmetic mean was able to correctly predict the sign for B as 
observed experimentally. 
 
It can therefore be anticipated that in the proposed SimIC method, the measurement of B23 
results for a target protein in a mobile phase with known protein immobilised columns should 
allow the rapid estimation for B22 for this target. Moreover, this should be with typically 
accuracy of +/-1 B unit (x 10
-4
 mL mol g
-2
) which is sufficient for its aggregation propensity 
to be rapidly classified. 
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CHAPTER 15 
15 CONCLUSIONS 
 
This thesis examines the experimental B22 profiles of 5 different proteins using SIC over a 
wide range of solution conditions; Lysozyme, Lactoferrin, Catalase, Concanavalin A and 
anti-TNF-dAb. 
 
The thesis begins by presenting an improved methodology for calculating B22 for aqueous 
protein solutions from SIC chromatograms and a range of recommendations for best 
experimental practise for SIC studies. Detailed analysis of SIC chromatograms for lysozyme 
revealed that SIC peak shapes typically exhibit significant levels of peak asymmetry. This 
asymmetry reflects a non-linear chromatography retention process that was ascribed to the 
heterogeneous nature of the protein-protein interactions. Such SIC chromatograms require 
rigorous chromatographic analysis and methods are described in the thesis for the improved 
measurement of the average B22 values, as well as the standard deviation in B22 values at the 1 
sigma confidence levels. This new standard deviation measurement incorporates a correction 
for normal longitudinal chromatogram diffusion. A wide range of statistically significant 
values for B22 were reported for a series of different buffer/salt solution conditions for 
lysozyme.  
 
The aggregation behaviour of the protein systems studied in this thesis was quantified using a 
simple first order experimental measurement of aggregation size. The initial aggregate size 
was measured using DLS immediately after the protein solution was mixed, and this 
measurement was used as a descriptor of the solutions propensity to aggregate.  
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It has also been demonstrated that use of first moment analysis of SIC peaks provides more 
accurate B22 values compared to peak maximum analysis. B22 data reported here agrees better 
with observed protein aggregation behaviour reported in the literature, than other authors 
reported SIC literature values of B22 for lysozyme. Specifically, the use of peak maximum 
methodology to analyse SIC chromatograms reported by many other authors results in an 
underestimation of retention times and consequently an overestimation of B22. 
 
Variations in B22 were systematically investigated for a number of proteins by changing pH, 
ionic strength, salt type as well as through the addition of stabilisers such as polyols, sugars 
and amino acids. Those B22 variations reflected changes in protein-protein interactions, 
particularly involving ionic and hydration forces.  
 
For all of the systems studied in this thesis, comparisons between measured B22 values and 
measured protein aggregate sizes gave very good correlations, and B22 values were therefore 
established to be a good predictor of protein aggregation propensity.  
 
Results for catalase were in good agreement with those sited in literature and SIC b2 values 
for lactoferrin and concanavalin A are reported for the first time. Catalase and concanavalin 
A showed similar b2 profiles, though quite distinct from that of lysozyme but similar to that 
observed for a number of other globular proteins. The solution parameters with greatest 
impact on b2 values were pH and ionic strength changes. Notably, unlike lysozyme, stability 
was improved with increasing ionic strength. Lactoferrin b2 values remained strongly positive 
(a sign of repulsive protein-protein interactions) for all conditions tested indicating that it is a 
remarkably stable protein under a wide range of typically unfavourable solution conditions.  
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In evaluating the performance of solution excipients and stabilisers for lysozyme, trehalose 
was found to offer improved protein solution stability at intermediate NaCl concentrations 
(0.5M), but not for high concentrations (0.75M). B22 was observed to be an excellent 
predictor for protein solution aggregation propensity of excipient stabilised lysozyme 
solutions. 
 
A strong correlation between b2 and protein aggregation behaviour was observed under an 
extensive range of solution conditions. Positive b2 values resulted in little or no evidence of 
protein aggregation and association in solution on initial measurement of particle size DLS. 
While increasingly negative b2 values corresponded to increasingly large initial particle size 
of aggregates and as such faster rates of aggregation. However, for one system studied, 
monitoring of lactoferrin in solution with high concentrations of sodium sulphate over a 
period of 24 hours revealed time-dependent aggregation processes. As such b2 may have a 
limitation for use in assessing long term stability in systems when the rate limiting step is a 
time dependent change in protein conformation to the aggregation prone species. However, b2 
may be at the minimum be used qualitatively to assess long term stability if first moment 
analysis of SIC chromatograms are employed and a spread of b2 values are determined that 
can be used to determine the heterogeneity of conformational states in solution.  
 
The aggregation and possible denaturation of an industrial therapeutic domain antibody, anti-
TNFα dAb is reported here for the first time and was investigated through the use of three 
complementary techniques. Results are presented of the dependence of B22 for anti-TNFα 
dAb on salt concentration and type, urea concentration and temperature. Using capillary 
electrophoresis (CE) and Nanoparticle Tracking Analysis (NTA) B22 values were assessed for 
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their usefulness as an indicator of aggregation propensity. Once again a favourable 
correlation was observed. 
 
Initial data is presented for a new methodology- Similar Interaction Chromatography- which 
does not require immobilisation of the protein of interest onto a column packing. Here a 
series of standard protein columns are used to determine the B23 for the target protein of 
interest against the standard proteins immobilised on those standard columns.  Through a 
simple mean field approximation, B23 values can then be used to determine an approximation 
of B22 for the protein of interest. 
 
In an extensive experimental validation study, catalase, lysozyme, lactoferrin and 
concanavalin A were used as both mobile and immobilised phases for B23 and B32 
measurements. The SIC cross virial coefficient values obtained had very little dependence on 
whether protein was immobilised or in the mobile phase; that is measured B23 and B32 values 
were virtually identical. It has been shown that B23 can be reliably estimated from the 
arithmetic mean of known B22 and B33 values for each pair of proteins studied. Experimental 
B23 and B32 values gave a good linear correlation with predicted B23 / B32 values (r
2
=0.95). 
Indeed for all 36 experimental measurements, this simple arithmetic mean was able to 
correctly predict the sign for all B23 / B32 values measured experimentally. It can therefore be 
anticipated that in the proposed SimIC method, the measurement of B23 results for a target 
protein in a mobile phase with known protein immobilised columns should allow the rapid 
estimation for B22 for this target. Moreover, this should be with typically accuracy of +/-1 B22 
unit (x 10
-4
 mL mol g
-2
) which is sufficient for its aggregation propensity to be rapidly 
classified. 
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CHAPTER 16 
16 FUTURE WORK 
 
The results of this thesis raise even more questions than they answer; there is still a lot of 
interesting work to be done in this field. There are several lines of research arising from this 
work that could be pursued. Here I give a brief summary of key investigations that would 
directly compliment the work detailed in this thesis: 
 
 Protein Heterogeneity in SIC 
 
In Chapter 10 the concept of heterogeneity of protein-protein interactions represented 
by a range of B22 values is introduced. In order to further probe this idea it would be 
of interest to study the adsorption isotherm data of protein-protein interactions in SIC 
experiments. A simple technique that could be employed is the elution on a plateau 
method. In this method small quantities of protein sample are injected onto a column 
that is first pre-equilibrated at various given plateau concentrations of the sample 
protein in the mobile phase. This would allow the nature of the heterogeneity of the 
protein adsorption process to be established as a function of protein surface coverage. 
 
 Protein Conformational and Structural Changes 
 
Chapters 11 to 13 present virial coefficient data for 5 different proteins over a range 
of solution conditions and postulates the reasons for observed values in terms of 
conformational changes and protein interactions on a molecular level. Further study of 
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the structural changes that accompany protein aggregation and changes in B22 values 
would help elucidate the molecular mechanisms by which proteins interact in solution 
and the use of B22 for predicting these changes, which are an important factor in 
aggregation propensity of proteins. Such work could be achieved using a number of 
techniques including circular dichromism and Fourier Transform IR spectroscopy. 
 
 Protein Aggregation Kinetics and Thermodynamics 
 
Chapters 11 through 13 also discuss the correlation between B22 values and the 
kinetics of protein aggregation. Further detailed data describing protein aggregation 
kinetics and thermodynamics for these systems would strengthen our understanding of 
the relationship between B22 and as such its usefulness for predicting protein 
aggregation behaviour. Together with information on structural changes it could give 
a more complete picture of the fundamental mechanism by which aggregation is 
taking place. These studies would be best performed using complimentary methods 
such as isothermal titration calorimetry and light scattering. 
 
 
 Refinement of Similar Interaction Chromatography 
 
Chapter 14 provides proof of concept data a novel technique for the simplified 
estimation of B22 values; Similar Interaction Chromatography. While initial results are 
positive the technique is in need of further refinement. Further data collection on a 
wider range of immobilised and mobile protein systems are required, perhaps 
investigating relationships between estimated B22 values and pI and molecular weight 
ranges of the immobilised proteins. It is also possible that proteins may not be 
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necessary at all and columns used are each of a particular characteristic on interest in 
protein-protein interactions i.e. hydrophobic/hydrophilic, positively or negatively 
charged. This work should be augmented with data on real industrial proteins.  
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